incivo is used to treat the virus that causes hepatitis c infection in adults who are at risk of chronic hepattis
do not take incivo if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor before taking inciVO . if your doctor has told you that you are taking peginterferon alfa / ribavirin because of their contraindications ( e .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will prescribe the appropriate dose regimen . the recommended dose regimen is one 3 mg tablet each day . this may be taken with or without food . take the tablets with food , preferably at least 6 hours before or 2 hours after a meal . for children and adolescents ( 6 years of age and older ), the recommended dosage regimen is two 2 mg tablets each day ( preferably in the morning and evening ). for children ( 6 months to less than 6 years old ), your doctor may prescribe incivo for both hepatitis c virus infection and human immunodeficiency virus infection . if your doctor prescribes efavirenz , the recommended dosing recommendation is one dose regimen of 3 mg and 8 mg per day , depending on the type of medicine your
like all medicines , this medicine can cause side effects , although not everybody gets them . rash tell your doctor immediately if you develop an itchy skin rash . the rash may progress to a severe skin reaction . tell your healthcare professional immediately , if your rash develops into a rash and / or other symptoms of the r . you may also get a skin r later on . in rare cases , you may need to stop taking incivo . other symptoms that may be associated with a sudden onset of a sore skin reaction ( see section 2 ). if this happens , or if it happens suddenly , tell your health care provider immediately . when you develop a sun rash you should tell your doctors immediately : if there is a possibility that your r may progress and , in rare instances , be severe and 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle after " exp ". the expiration date refers to the last day of that month . incivo tablets should be stored in the original bottle and keep the bottle tightly closed in order to protect from moisture . this medicinal product does not require any special temperature storage conditions .
what incivo contains - the active substance is telaprevir . each tablet of inciv contains 375 mg of tellaprevir as active substance . - other ingredients : tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrously , sodium lauryl sulphate , croscarmellose sodium , and sodium stearyl fumarate . film - coating polyvinyl alcohol , macrogol , the congestive heart valve , debossed with ' gsi ' on one side . macrogol green , lattice , titanium dioxide ( e171 ), iron oxide yellow ( ionising ). what if you have not taken inciVO ,
the active substance in zinbryta is daclizumab beta , a monoclonal antibody . what zinberytta looks like and contents of the pack zin Bryte is a white to off - white hybrid of two different proteins that are found in the body . zinberryt is used to treat multiple sclerosis ( ms ) in adults who have failed to respond to therapy , and who are unable to complete two mms treatment , or who have had other treatments that have caused inflammation or loss of the protective sheath ( called myelin ) around the nerves in the central nervous system , including the brain and spinal cord . this loss of myelanin ( demyelinability ) can lead to relapsing mS with repeated attacks ( relapses ). patients with
you must not be given zinbryta : - if you previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine listed in section 6 . - warnings and precautions talk to your doctor or nurse before you are given zbrytes : talk to you doctor or , pharmacist before you have been given zac . your doctor may need to adjust your dose . see section 6 " how to take zinblita ". liver problems . before you receive zinberytta you should tell your doctor if : you have any other autoimmune disorders . you are taking any other medicines , including herbal supplements , while being given zecco . tell your pharmacist if any medicines or supplements you take may increase the risk of liver side effects . these medicines should be avoided during treatment with zinbyt
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to inject the recommended dose of zinbryta is 150 mg once a week . your doctor will decide whether this dose is right for you , depending on the results of a blood test that carried out on your liver . if your doctor has told that you can inject zinberytta yourself , you should not inject more than one dose of 40 mg once each week , because a higher dose may be required . you will need to have this blood test before you take the medicine . before you have the test , your doctor may decide that this dose may not be right for your condition . to get the best results your doctor can give you this blood check . inject yourself zinblita under the skin on your thigh
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . your doctor may decide to change your dose , interrupt or stop your treatment for a short time . serious side effects liver problems ( common , may affect up to 1 in 10 people ) unexplained nausea ( feeling sick ) or vomiting ( being sick ), stomach pain increased tiredness loss of appetite ( anorexia ) your skin or the whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon , might affect upto 1 in 100 people severe inflammation of the liver , which may lead to death . you must contact your doctor immediately if your liver is damaged and you cannot control the damage . other side effects tell your doctor
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the zinbryta pre - filled sYringe in original package in order to protect from light . you may remove a new saryringe / pen from the refrigerator . zinberytta s / pens may be stored at room temperature up to 30 , but must be kept away from direct heat or direct light ; for a maximum of 30 days , the date of the first use is recorded on the label and the date after which it should be discarded . once thawed , zinbli
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 mg daclizab beta in 1 ml . - each pre- filled pen contains 150 micrograms daclizuab Beta in 1 microlitre . the other ingredients are sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zinblita has sodium '). what zbrytoa looks like and contents of the pack zinberytta is a colourless to slightly yellow , clear to slightly opalescent , colourless and essentially free from visible particles . it is supplied as a sYringe / pen ( pre  - loaded pen with an attached needle ).
wilzin belongs to a group of medicines known as metabolism products . wilszin is used to treat willson ' s disease caused by a rare inherited defect in copper excretion . it affects the liver , the cells in the eyes and the brain , causing liver damage and neurological disorders . the medicine works by reducing the amount of sugar in the intestine and its further accumulation in the body . this reduces the amount and the amount in the blood , and thus slows down the worsening of wlson . you should continue to take this treatment as long as your doctor has told you .
do not take wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilszin . warnings and precautions talk to your doctor or pharmacist before taking willzin wILzin will be administered to you under the supervision of your doctor . your doctor will perform initial therapy to monitor signs and symptoms of a certain type of whiilson ' s disease that is currently being treated with another anti - copper agent , penicillamine . wiliazin will only be administered during the initial treatment , in combination with other anti  copper agents , including peniciillamine , until your symptoms go away . during the treatment a ' maintenance dose ' will be taken to monitor you . you will be asked to drink plenty of water before you are given the product . this will be in the presence of blood and urine to check
what wilzin is the active substance of wilszin is adolescent . the different dose regimens are available . 25 mg or 50 mg tablets for 1 patient : wILzin 50 mg in the 2 - dose regimen : 1 patient: a willzin 25 mg inthe 1 - mg dose ; wlzin 50mg in the 3 - ml dose . 2 tablets : an aortic , 2 mt : one willetzin 25mg / 1 patient who weighs 1 to 6 pounds ; 1 patient of a similar dose : the usual dose of witzin 25 mu / m2 ; 2 wilia : 25 mu + 1 mu - 2 mu  1 mu + 2 mu + 3 mu & 1 mu mu s & 2 mu mu + m
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effect in 1 to 10 users in 100 ) uncommon ( affect in 1 , 000 ) rare ( affect 1 to10 users in 10 to 10 ,000 ) very rare ( effect on less than 1 patient in 10 and less than1 user in10 , 10 . 000 ). very rare if you experience that effect , please inform your doctor as soon as possible . wilszin intake may cause gastric irritation and may be severe . your doctor will monitor you during treatment . changes in blood tests may show : an increase in some liver and pancreatic enzymes and a decrease in blood red and white cells . reporting of side effects 10 if your
keep out of the reach and sight of children . do not store above 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc , 83 . 92 mg ( zinc acetate dihydrate ) or 50 mg of Zin ( corresponding to 167 . 85 mg of magnesium stearate ). the capsule shell is composed of gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( wmc ). each hardcopied hard capsule of wilszin 25 mg contains zinc ; each hardcover hard capsule is composed by printing ink containing a black ink with " gilzin 50 " and " hdpe " printed in black inked on the body . the printing inked is composed mainly of black iron oxide ( a type a ) and shellac . what ilzin looks like and contents of the pack wILzin 25 micrograms
biktarvy contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . the other ingredients are emtricitabine , which is an antietrovirals medicine known als a nucleoside reverse transcriptasasE inhibitor ( nrti ) tenofovir alafenamide , who is an antibiotic retroviral medicinal medicine known only as a nuclear nucleonine reverse transcript asse inhibitor ( notrtti) biktaviry is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection . biktarivy reduces the amount of hiv in your body . this will improve your immune system and reduce the risk of developing illnesses linked to hiv infection , but it
do not take biktarvy : - if you are allergic to bictegravir , emtricitabine , or tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). - do not combine biktarivy with any of these medicines :- rifampicin , used to treat some bacterial infections , such as tuberculosis - saint john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking bikTARvy and if any of them apply to you . talk to you doctor or nurse before taking this medicine : you should tell your doctor if : your doctor thinks this applies to you and tell them to
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended doses are : antacids ( used to treat stomach ulcers , heartburn and acid reflux ) and aluminium and magnesium hydroxide mineral supplements ( used for vitamins , magnesium and iron ). see section 2 under ' biktarvy contains lactose '. these medicines can be taken with or without food . biktarivy is not recommended if your doctor determines it is safe for you to take it . if bikty is being taken on dialysis , your doctor may recommend that you take biktaby if there is no dialytic option available . take bikarvy as soon as you can , unless your doctor thinks it has been taken . patients who
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the following side effects you should contact your doctor immediately : - inflammation or infection . in some patients with advanced hiv infection ( aids ) and a history of opportunistic infections ( infections that occur in people with a weak immune system ), signs and symptoms of inflammation from previous infections may occur soon after hiv treatment is started . it is thought that these symptoms are due to an improvement in the body ' s immune response , enabling the body to fight infections that may have been present with no obvious symptoms . these may be due to autoimmune disorders ( when the immune system attacks healthy body tissue ), particularly when taking medicines for hiv infections . reporting of side effects 25 if your doctor or pharmacist gives you this medicine , you can also report side effects directly via the national
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the seal after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the seal tightly closed . if the seal has been open , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktegy tablet contains bictategravir sodium equivalent to 50 mg bictesgravir and 200 mg emetricit abine . the active ingredients are ten ofovir altafenedamide fumarate equivalent to 25 mg tenovir atafène . tablet core microcrystalline cellulose , which contains croscarmellose sodium , and magnesium stearate . film - coating polyvinyl alcohol , titanium dioxide , macrogol , the talc , iron oxide red and iron oxide black . what bikitarvY looks like and contents of the pack biktarivy is a white , capsule - shaped ,
novonorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonourm is used to control type 2 diabetic patients as an add - on to diet and exercise : treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) your blood glucose . none of the ingredients in novonlorm can be taken with metformin , another medicine for diabetes .
do not take novonorm : if you are allergic to repaglinide or any of the other ingredients in this medicine ( listed in section 6 ). if your doctor thinks you may have type 1 diabetes . if the acid level in your blood is raised ( diabetic ketoacidosis ). warnings and precautions talk to your doctor before taking novonorgm if : you have a severe liver disease you take gemfibrozil ( a medicine used to lower increased fat levels in the blood 47 you have liver problems . take special care with novonourm - if any of these apply to you , do not use novonörm . you have moderate liver disease . talk to you doctor before you take novoorm in case you have or have had a severely liver disease or kidney problems , as there is insufficient experience of the use of novono
always take this medicine exactly as your doctor has told you . check with your doctor if you are not sure . the recommended dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each meal , preferably at least 4 hours before or 30 minutes after each main meals . your doctor may increase your dose to 16 mg once a day if your blood sugar is too low ( such as a hypo ). you should not take more novonorm than your doctor tells you to . if this happens to you , your doctor will stop your treatment with novonORm unless you have discussed this with your partner or caregiver .
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect is hypogycaemia which may affect up to 1 in 10 people ( see hypo in section 2 ). if you get a hypo in paragraph 2 , hypogliescaemic reactions are generally mild / moderate but can occasionally develop into hypoglcaeic unconsciousness or coma . allergic allergy is very rare ( may affect more than 1 in 1 , 000 people ). symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this may be a sign of anaphylactic reaction . other side effects have been reported since the marketing of oral syringes . if any of these side effects become severe , please tell your doctor or pharmacist .
what novonorm contains - the active substance is repaglinide . - it is made from microcrystalline cellulose ( e460 ), calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol 89 %, magnesium stearate , meglumine , and poloxamer . the other ingredients are iron oxide yellow ( w - 1 ) and iron oxide red ( oblong ). see section 2 " novonORm contains iron oxide black ". what novoorm looks like and contents of the pack novonmorm tablets are pale yellow , capsule shaped , with " 0 . 5 " on one side and " 1 " on the other . they are marked with " 2 " on either side and plain on the
what pumarix is pumarice contains the active substance pumarique . pumarize is a vaccine for use in adults from 18 years old to prevent pandemic flu ( influenza ). pandemie flu is essentially influenza . it happens at intervals that vary from less than 10 years to many decades . the signs of pandelic flu are similar to those of ordinary flu but may be more serious . how pumarx works when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumaris may not fully protect all persons who are vaccinated .
pumarix should not be given : if you have previously had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the substances that may be present in trace amounts as follows : egg and chicken protein , ovalbumin , formaldehyde , sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if any of these effects occur , the vaccine may be given as medical treatment in case of an allergy reaction . warnings and precautions talk to your doctor or nurse before having pumarx . children and adolescents pumarize is not recommended for use in children below 33 years of age . the use of pumaris is not expected to cause any allergic reaction other than a spontaneous life  - potentially life threatening allergy to
pumarix is intended for use in adults aged 18 years and older . pumarice must be administered in a clinical study designed to be compared to a similar h5n1 as03 for adults aged less than 18 years . how pumarx is given the vaccine is intended to be given to adults of all ages . the recommended dose of pumarize is based on body weight . it is used in infants and children aged 3 - 9 years and adolescents aged 3 months to 17 years of age . your doctor or nurse will decide on the appropriate dose of Pumarix . Pumarx will be given as an injection into a muscle . this will usually be in the upper arm . if you have any further questions on the use of this vaccine , ask your doctor , pharmacist or nurse .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions which may cause you to have dangerously low blood pressure . if this is not treated it may lead to shock . doctors are aware of this possibility and have emergency treatment available for use in such cases . other side effects include : very common ( may affect more than 1 in 10 people ) pain where the injection is given headache feeling tired aching muscles or joint pain common ( might affect up to 1 in every 10 people redness and swelling where the inject is given fever sweating shivering diarrhoea feeling sick common ( can affect upto 1 in 100 people ).
keep this vaccine out of the sight and reach of children . before the vaccine is mixed : do not use the suspension and the emulsion after the expiry date which is stated on the carton . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . do not freeze . after the vaccine has been mixed , use the vaccine within 24 hours and do not store above 30 .
what pumarix contains active substance : split influenza virus , inactivated , containing antigen * equivalent to : a / vietnam / 5 / 2005 ( h5n1 ) like strain used ( pr8 - ibcdc - reg2 ) equivalent to approximately 0 . 5 ml of haemagglutinin . during the pandemic , the vaccine contains an ' adjuvant ' as03 . this adjuvan contains squalene , all , one dose of dl - 1 - tocopherol , polysorbate 80 and water for injections . adjutants are used to improve the body ' s response to the vaccine . other ingredients : sodium chloride , disodium hydrogen phosphate / potassium dihydrogen phosphat
somakit toc is a radiopharmaceutical product for diagnostic use only . the powder in the powder is reconstituted with a nuclear medicine called gallium ( 68ga ) chloride . it is essentially white to off - white . when a doctor or surgeon administers this procedure , the doctor will inject gallium( 68Ga ] edotreotide into the body . this medicine is given by mouth as an injection into a vein . in adults , it can be felt insignificant and could be felt later on in adult patients . eotreakit is injected into body areas using a medical imaging procedure called positron emission tomography . your doctor and the nuclear medicine doctor have been involved in this medical procedure . images are then taken to help identify the abnormal cells and tumours that have developed in the body and
do not use somakit toc if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). signs of allergic reaction are listed in sections 4 and 5 . warnings and precautions talk to your doctor before using somamakit tc : if your kidney or liver problems have been confirmed . if the patient has renal or hepatic disease . in particular , in children and adolescents ( below 18 years ), somma kit toc is not recommended for patients . take special care with somamikit to cm : in order to avoid dehydration . the examination should be undertaken within 28 days . other medical conditions that affect the entire body such as cushing syndrome ( inflammation of the nervous system ), thyroid disease or tumour ( of pituitary gland , lung , brain , breast
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakit toc will only be used in special controlled areas . this product will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide on the quantity of somákit tob , which will be decided by the nuclear doctor . it will be the smallest quantity necessary to get the desired information . quantity to be administered usually recommended for an adult ranges from 100 to 200 mbq ( megabecquerel , the unit used to express radioactivity ) per kilogram body weight , given once every three weeks . administration of somaskit tof will depend on the conduct of the procedure .
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ). somakit toc may cause symptoms such as warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may include stinging at the injection site , but this should be treated with ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects 10 if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : - for radiolabelling , see section 4 . - store in a refrigerator ( 2 8 ). - do not freeze . keep out of the reach and sight of children . do not use somakit toc after the expiry date which is stated on labels and cartons . it is recommended that every time you use somaskit tot , the product is stored at room temperature ( not above 25 ) and not used . any unused medicine or waste should be disposed of in accord with local requirements .
what somakit toc contains - the active substance is edotreotide . one vial of powder contains 40 mg of edeotreotrotide ( as 10 - phenanthroline ). - other ingredients are gentisic acid , mannitol , formic acid / sodium hydroxide and water for injections . the solvent contains no sodium . after radiolabelling , the solution contains hydrochloric acid and is used for radiopharmaceutical preparation . what somaskit to cm looks like and contents of the pack somamakit tc is a glass vial with black flip - off caps . it is essentially white to off - white powder . a white powder is contained in aglass vial ( yellow flip ' off cap ). it is supplied as a clear
afinitor is an anticancer medicine containing the active substance everolimus . everolim reduces the size of the tumour and slows down the growth and spread of cancer cells . afinitour is used in adults as hormone receptor - positive advanced breast cancer ( postmenopausal women ) when non - steroidal aromatase inhibitors do not tolerate the disease or are not able to take a medicine , called exemestane ( a steroids aromatainse inhibitor ) as hormonal anticanc therapy for advanced tumours ( neuroendocrine tumours that are found in the stomach or bowels ) in women able and willing to take food without assistance .
you will be monitored closely by your doctor and other cancer treatment staff while you are being treated with afinitor . don ' t use afinitour if you are allergic to everolimus , sirolimus / temsirolius or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking afinitoral . if there is anything you do not understand , ask your doctor , nurse or pharmacist for advice . do not use afinior if any of these apply to you and / or you are not sure . warnings and precautions talk to your doctor before using afinitur if : you have any problems with your liver or if your liver has been damaged by any disease . your doctor may prescribe a different dose of agonylurea . you have diabetes ( high level
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . swallow the tablet whole with water . don ' t chew , crush or split the tablet . if possible , your doctor may prescribe a lower dose of afinitor ( 5 mg once daily ). if your doctor thinks you may have liver problems , you may need a higher dose of a low dose of aspirin ( 5 . 5 mg ) or 7 . 7 mg once or twice daily . your doctor will decide how much you should take . you should swallow the tablets whole with a glass of water , with or without food . this will help you to remember to take it . it is important that you take the dose recommended by your doctor every day , as it helps you to sleep
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and seek medical help immediately if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps the following side effects have been reported with afinitour : very common : may affect more than 1 in 10 people - increased temperature - chills ( signs of infection ) - fever - coughing - difficulty breathing - wheezing , inflammation of the lung ( pneumonitis ) common - may affect up to 1 in every 10 people common ; may affect less than 1in every 10 persons - decreased temperature ; chills or infection ; fever ; coughing or difficulty breathing ( signs and symptoms of inflammation
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . open the blister just before taking the tablets . check that the pack is still in its box . this medicine does not require any special temperature storage conditions . in the event of tampering , the tablets should be returned to their original package . these measures will help to protect the environment .
what afinitor contains - the active substance is everolimus . - afinitour 2 . 5 mg : each tablet contains 2 , 5 mg of everoli Mus . afinittor 5 mg: each tablette contains 5 mg everolim . pouritor 10 mg , each tablet includes 10 mg of Everolimus ( as mesilate ). - other ingredients are butylhydroxytoluene ( e321 ), magnesium stearate , lactose monohydrate , hypromellose , and crospovidone ( containing lactoses anhydrous ). what afinior looks like and contents of the pack afinitoral 2 : 5 mg tablets are white to slightly yellowish , round and marked with " a5 " on one side . they are embossed with " 322 " on the other side
what laventair ellipta is lavent air ellippta contains two active substances umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what laVENTair ellpttais used for laventAIR elliрta ist used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles around the airways tighten . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the bronchitis . when used regularly , it can help to control your breathing difficulties .
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before using lavent air ellippta : - you have asthma ( don ' t use laVENTair elept a to treat asthma ). talk to you doctor if : you have heart problems or high blood pressure . you have an eye problem called narrow - angle glaucoma . your doctor may want to monitor you more closely . - your doctor might monitor you less closely , especially if your prostate is enlarged , difficulty passing urine or a blockage in your bladder . talk to the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use laventair ellipta regularly it is very important that you use laVENTair elipta every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . laventAIR ellippa should not be used to relieve a sudden attack of breathlessness or wheezing . if your attack is severe , you must use a quick - acting reliever inhaler ( such as salbutamol ). how to use
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you get any of the following symptoms after taking laventair ellipta stop using this medicine and tell your doctor immediately . uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) or redness rare side effects( may affect less than 1 in 1 , 000 people ]: swelling mainly of the face or mouth ( angioedema ) becoming very wheezy , coughing or having difficulty in breathing suddenly feeling weak or light headed ( which may lead to collapse ) collapse , feeling very cold ( anaemia ) feeling very tired ( fatigue ) being sick ( vomiting ) diarrhoea feeling sick ( nausea ) vomiting itching , redness of the skin ( dermatitis ) uncommon side effect (
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umeclinium bromidie ) and 22 microgram ( 8 microgram ) vilantrol ( as trifenatate )- the other ingredients are lactose monohydrate ( see section 2 under ' laventaire ellippa contains lactoses ') and magnesium stearate . what laVENTair ellpte looks like and contents of the pack lavent air ellimpta is an inhalations powder , pre - dispensed . the ellipatta inhaler consists of a light grey plastic body 
tremfya contains the active substance guselkumab , a monoclonal antibody . this medicine attaches to a specific target substance called " il - 23 ". it is used to treat adults with psoriasis with moderate to severe " plaque ppsorasi ", an inflammatory condition affecting the skin and nails . tremefy will improve the condition of the skin by reducing the appearance of nails and reduce symptoms such as scaling , shed , flaking , itching , pain and burning .
do not use tremfya - if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before you are given trempya and if your doctor thinks you may be allergic . warnings and precautions talk to your doctor , pharmacist or nurse before you receive tremefy : - an active infection - have active tuberculosis warnings , precautions and checks your doctor will check whether you are getting an infection . tell your healthcare provider if : you have an infection which is serious , including tubercusis . you have ever had tubercolosis or are suspected to have tubercleosist . it is important that you tell your provider , healthcare provider or nurse if 36 you think
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of tremfya is 100 micrograms ( 1 pre - filled syringe ) given by injection under the skin ( subcutaneous injection ). the first injection should be given between 4 and 8 hours after the first dose . your doctor will decide the dose you should receive . if your doctor decides that you should inject more trempya than he should trerfyya will be given to you by your doctor over several weeks . follow your doctor ' s instructions about when to inject the next dose , and about how long you should continue to inject tremefy . it is very important that you follow your instructions about how to inject yourself . do not try to inject your medicine on your own . for further instructions
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following side effects you may need urgent medical attention : serious allergic reaction - you may have difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , with a red rash or raised bumps other side effects include : tell your healthcare professional if any of these side effects get serious . some side effects may be serious common ( may affect up to 1 in 10 people ): upper respiratory infections common side effects ( may effect up to1 in 10 persons ) headache joint pain uncommon ( may impact up to 10 peoples ) joint pain bruising , redness of the lips bruizing , itching , rash reporting of side effects 25 if your doctor gets
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the pre - filled syringe after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pre- filled
what tremfya contains the active substance is guselkumab . each pre - filled syringe contains 100 mg of guzelkUMab in 1 ml solution . the other ingredients are histidine , histamine monohydrochloride monohydrate , polysorbate 80 , sucrose , water for injections . what TREmfYa looks like and contents of the pack solution for injection is clear and colourless . trempya is available as a carton pack containing one single - dose glass sYringe or as  a multipack containing 2 ( 3 packs of 1 ) single  dose pre  filled yringers . not all pack sizes may be marketed .
the active substance of trepulmix is treprostinil . treprastinkil belongs to a class of medicines called prostacyclins . prostacycles are hormones that reduce blood pressure by relaxing blood vessels . prosacyclines also prevent blood from clotting . what trepmix is used for tre Pulmix is indicated in the treatment of inoperable chronic thromboembolic pulmonary hypertension ( cteph ) in adult patients with persistent or recurrent ctesph who have not responded to surgical treatment or whose exercise capacity has not improved or is not controlling symptoms of the disease . chronic thmboembric pulmonary hypotension is when blood pressure is too high it can affect the blood vessels of the heart and lungs .
do not take trepulmix if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may be at risk of developing a disease called " pulmonary veno - occlusive disease ". this is a condition in which the blood vessels in the lungs become swollen and / or have a higher pressure in the blood vessel(s ) between the heart and the arteries . if so , your doctor may want to monitor you more closely . warnings and precautions talk to your doctor or pharmacist before taking tre Pulmix : if : you have severe liver disease you have ever had a heart problem or have had , or have ever have had, a cardiac attack ( myocardial infarction ) in the last six months you have had severe
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . trepulmix is given as a continuous subcutaneous infusion ( under the skin ) using a small tube ( cannula ) in the abdomen or thigh . you will also be given tre Pulmix via a portable pump . your doctor will tell you how many ml of trepmix to give to you , and will tell how many infusions to take . the pump will then be connected to the infusion line so that there is no accidental overdose ( see section 1 ). your doctor may decide to increase the dose or delay the dose by 2 . 5 mL , or 5 - 10 m2 of your body surface area . how much to give your doctor can decide how many doses to give you
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people widening of blood vessels pain at the infusion site reaction , at the site of infusion / bleeding or bruising at the scene of the inffusion site headaches , nausea , diarrhoea jaw pain common ; may affect up to 1 in every 10 people dizziness , light - headedness / fainting due to low blood pressure skin rashes , muscle pain ( myalgia ) joint pain ( arthralgi ) swelling of feet , ankles / foot , knee pain ( osteonecrosis ) uncommon : can affect upto 1 in 100 people swelling of ankles or feet ( oedema ); swelling of hands ( stomatit
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . a trepulmix vial may be kept at room temperature ( up to 30 ) for continuous subcutaneous infusion . when diluted , a single reserve ( syringe ) of undiluted tre Pulmix is recommended for use within 72 hours . this medicine must not be used if it is noticed that it shows signs of damage , such as discolouration or other signs of deterioration .
what trepulmix contains - the active substance is treprostinil . trepmix 1 mg : each vial contains 1 mg of treprast inil ( as sodium salt ). trepemix 10 mg / ml : one vial of 10 mL contains 10 mg of " treprestinkil " ( as salt ) in each viall . the other ingredient is sodium salt in the vial . what TREpulmix looks like and contents of the pack trepelmix 2 . 5 mg - each vially contains 2 , 5 mg of ( as potassium salt ), 10 mg or 25 mg of [ 1 - treparstinningil ( AS sodium salt and ) during preparation , trepumix 5 mg ", 5 % trepentinils ( as water for injections ) and
thorinane contains the active substance enoxaparin sodium , which is a low molecular weight heparin ( lmwh ). thoinana works in two ways . 1 ) stopping existing blood clots from getting any bigger . this helps your body to break them down and stop them causing you harm . 2 ) stop blood coagulations in your blood . thourinan , when used , can prevent blood  clottes from forming in your body . it is important to keep the number of blood clats in your system in order to reduce the risk of blood pools forming within your blood and prevent blood from clottings from re - occurring in your urine . before and during your operation if you have an acute illness . the recommended dose is unstable angina ( angina )
do not take thorinane if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include : rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if your doctor thinks you may be allergic to any of these , you must not take the tablets . warnings and precautions talk to your doctor before taking thoinana : whether you are taking heparin or other low molecular weight heparains such as nadroparin , tinzaparin / dalteparin you may experience a reaction to heprin such as such as with a severe drop in the number of your clotting cells ( platelets ). this reaction is called 
like other similar medicines ( medicines to reduce blood clotting ), thorinane may cause bleeding which may potentially be life - threatening . in some cases the bleeding may not be obvious . if you experience any bleeding event that does not stop by itself or if there is suspicion of excessive bleeding ( exceptional weakness , tiredness , paleness / dizziness ), headache or unexplained swelling , consult your doctor immediately . your doctor may decide to keep you under closer observation or change your medicine . stop taking thourinana and see your doctor if any of the following apply to you : - you experience a severe allergic reaction ( e .g . difficulty breathing , swelling of the lips , mouth , throat or eyes ) - your doctor will advise you how to minimise the risk of blockage of a blood vessel by a large
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 25 . after dilution the solution should be used within 8 hours . use this medicinal product immediately . discard any unused product . for single use only . only use the thorinane pre - filled syringes provided in the box to protect from light .
what thorinane contains - the active substance is enoxaparin sodium . each ml contains 100 mg of ennoxaparain sodium in 0 . 2 mL solution . one pre - filled syringe contains 2 , 000 mg of the active ingredient enomaparIN sodium - added to the solvent . - solution for injections : 0. 2ml solution for infusion in a pre  - injected sYringe . what THorinans looks like and contents of the pack thoinana is a clear , colourless type i neutral glass ssyre barrel with fixed needle and needle shield , with chlorobutyl rubber stopper and a blue polypropylene plunger rod . pack size of 2 . 10 pre –
senstend contains two active substances lidocaine and prilocaine . these belong to a group of medicines called local anaesthetics . senstennd is used for the treatment of lifelong premature ejaculation in adult men . it works by increasing the head of the penis to increase the rate of ejeculation .
do not use senstend : - if you are allergic to lidocaine or prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using senstende . if your doctor has told you that you have a history of allergy or sensitivity to other local anaesthetics , especially amide - type local anesesthesias . senstendend is not recommended if : you have been diagnosed with a genetic disease or other condition that affects your red blood cells ( glucose - 6 - 8 - glutamyltransferase or phosphate deficiency , anaemia or methaemoglobinaemia ). in these situations medicine sensitivities may increase , particularly if patients with sensitivity have developed severe
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of senstend is 3 sprays ( 3 spray trays ) of 1 ml each foreskin of the head of the penis and 3 spray bags of 24 mL ( 2 - 4 m ) each for up to 24 hours . after dilution of the spray container , the pump mechanism is activated by a valve . this prevents contact with eyes , nose , mouth and ears . before the pump is used , 1 spray ( 3 trays of 1 mg ) is applied to the fore skin of the cap of the panis and / or valve , and 1 spray (3 trays per minute ) to the head and the penises . each spray will last about 5 minutes 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection feeling in the penis feeling of burning in the back of the penises uncommon ( may effect up to1 in 100 people ] headache local irritation of the throat , irritation of or the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling of the tinnitus or discomfort in the pegasis pain or discomfort on the penist pain itching not known ( frequency cannot be estimated from the available data ) hiccup reporting of side effects 23 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 25 in the original package , in order to protect from light . after first opening , use within 12 months . keep the metal container in the outer carton in order not to puncture , break or burn it . return the container to the metal store in the refrigerator ( 2c 8c ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . - each ml of solution contains 150 mg lidocabine and 50 mg prilacaine - one spray delivers 50 microlitres which contains 7 . 5 mg lidofcaine & 2 . 4 mg pctfe . what senstentd looks like and contents of the pack senstennd is a clear , colourless to light yellow cutaneous spray , solution supplied in an aluminium spray container with metering valve . each pack contains 1 spray container of 6 . 6 mL or 5 mbq of solution .
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melamine a , which has spread beyond the original tumour and cannot be completely removed by surgery ( adjuvant therapy ). advanced non - small cell lung cancer a new type of lung cancer is called advanced advanced renal cell carcinoma a different type of advanced kidney cancer has been shown in adults classical hodgkin lymphoma a mixed in people who have not responded to previous therapies ( including an autologous stem - cell transplant ) or in adults where a transplant is planned . advanced cancer of the head and neck in adults advanced urothelial carcinoma , bladder and urinary tract cancer . the active substance in opondivo , nivolumab , is essentially a monoclonal antibody . it is designed to
do not use opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using oppdivo and during treatment : if there is a problem with your heart such as a change in the rhythm or rate of the heartbeat or an abnormal heart rhythm . if your lungs get blocked or you have breathing difficulties or cough . these may be signs of inflammation of the lungs ( pneumonitis or interstitial lung disease ). if any of these apply to you , tell your doctor immediately . your doctor may need to monitor you more closely . tell your physician if : you have diarrhoea ( watery , loose or soft stools ) you have any symptoms of inflammation or of the digestive systems ( colitis ),
what opdivo is the usual dose of oodivo in adults is 240 mg once a week , divided into 2 doses of 480 mg or 4 doses . when oppdivo , when used in combination with ipilimumab , is the preferred treatment for patients with advanced kidney cancer . the recommended dose of the opondivo package is 1 iu of nivolumab per kilogram of your body weight , given once  a day . your doctor will work out the right dose for you . how much opedivo you should take opradivo depends on the type of medicine you are taking ( ml ) of iip ig - g , or nebuliser ( gz - 250 mbq / kg , m2
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . opdivo may be stored at room temperature ( up to 25 ) for up to 48 hours in  a freezer . from a microbiological point of view , the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nnivolmaB ( 40 mg / m2 ). each vial contains either 4 mg , 100 mg x 10 mL or 240 mg X 24 mg of the active ingredient ninvolum . the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " oodivo contain sodium "). the other ingredient ( s ) of oprama : mannitol ( e421 ), pentetic acid , polysorbate 80 , water for injections . what apdiva looks like and contents of the pack oppdivo is a clear , colourless to pale yellow solution . it comes in 
clopidogrel tad contains clopogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clopinogreil ttaD is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboses , that can lead to atherotrothrombotic events ( such as stroke , heart attack , or death ). you should take clopionogre
do not take clopidogrel tad 30 if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has told you that you suffer from severe liver disease . do not use clopinogreil t ad if any of these apply to you . warnings and precautions if the above apply to your situation , tell your doctor before taking clopionogrelly ttaD : if : you are bleeding , such as from a medicine that puts you at risk of internal bleeding ( such as the contents of a breast ulcer ). you have a blood disorder that makes you prone to internal bleeding  ( bleeding inside any tissues ,
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day . if your doctor decides that you should take more cloplatin than you should , contact your doctor immediately or go to the nearest hospital emergency department because of the increased risk of bleeding . you should leave out the medicine 12 hours or more after you have taken your tablet . in case of an overdose , you should simply take the next tablet at the usual time . do not take a double dose to make up for a forgotten tablet , 32 if
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the sun . this may be the signs of an allergic reaction .
what clopidogrel tad contains the active substance is clopogrell . each film - coated tablet contains 75 mg of clopinogrelly ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( elektronic acid ), yellow iron oxide , the talc and macrogol 3000 in the film . what clupidogral TAd looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 and 14 film  s containing 14 film- coatings are available . not all pack
tacforius contains the active substance taccrolimus . it is an immunosuppressant . following your organ transplant ( e . g . liver , kidney ), your body ' s immune system will try to reject the new organ . tacforis is used in adults to control your body'  s response enabling your body to accept the transplanted organ , enabling you to accept any previous treatment you were taking at the same time , and this will help to improve the effect of your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking tacforitus . if your doctor is allergic to siroli Mus or to any macrolide - antibiotic ( e .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed to you by a doctor with experience in the treatment of transplant patients . make sure that you receive the same taccrolimus medicine every time you collect your prescription , unless your transplant specialist has agreed to change to a different taccrolumus medicine . if the opposite applies to you , your doctor will tell you to take this medication . always take the same dose as this medicine , in the same way each time . do not change the dose yourself . when to take tacforius take this medicinal product with food . it is important that you take the right medicine to prevent the rejection of your transplanted organ . the usual dose , depending on your body weight , will be determined by your doctor calculated according to your bodyweight . initial dose
like all medicines , this medicine can cause side effects , although not everybody gets them . infections are most likely to happen during treatment with tacforius . severe effects may occur , including allergic and anaphylactic reactions . benign and malignant tumours may occur following tacforinius treatment . cases of pure red cell aplasia ( a very severe reduction in red blood cell counts ) and agranulocytosis (  a severely lowered number of white blood cells ) have been reported . haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ) as well as febrile neutropenia ( increase in the number of these types of whiteblood cells , which fight infection ) were reported , in addition to the usual response . red blood aaplopia ( hla - b * 57
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after exp . the expiration date refers to the last day of that month . use all the prolonged - release hard capsules within 1 year of opening the aluminium wrapping . store in the original package in order to protect from moisture .
what tacforius contains - the active substance is tacrolimus . tacforinius 0 . 5 mg : each capsule contains 0. 5 milligrams of tacrolin ( as monohydrate ). tacforitus 1 mg / 1 mg capsule contains tacrolivimus ( as homohydrate ) each capsule of tacforeius 3 mg containing 3 mg of tacrollimus ( AS monohydrate the active ingredient in tacfortius 5 mg per capsule contains 5 mg of , 5 mg tacrolimimus ( As monohydrate) the other ingredients are : capsule content hypromellose 2910 ( ethylcellulose ), lactose , magnesium stearate . what tacfurius looks like and contents of the pack tacforkius kikwit kikik kikki kikuchi kiu
clopidogrel zentiva contains clopogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clopinogreil zentivea is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboses , that can lead to atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogre
do not take clopidogrel zentiva if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if the patient is from asian origin . If your doctor knows that you suffer from severe liver disease . do not stop taking clopinogreil zentivea unless your doctor advises you to . warnings and precautions if any of these apply to you , or you are not sure , talk to your doctor before taking , and while taking ' clonogrela zenta , you should tell your doctor immediately : if there is a risk of bleeding such As - a mental
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if your doctor feels that you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral  Zentiva ( 1 tablet of 300 mg or 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - day regimen of ' clopatra '. - the recommended starting dose is one75 mg tablet . you should
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the sun . this may be the signs of an allergic reaction .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . clopidogrel zentiva is for single use only . once reconstituted in water for injections , use within 30 days . however , clopogrell zentivea is also available in all aluminium blisters . this medicine does not require any special storage conditions . no special storage condition is necessary . contact your pharmacist for advice if you notice any visible sign of deterioration . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what clopidogrel zentiva contains the active substance is clopogrell . each tablet contains 75 mg of clopinogrelor ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' cloclopid zentivea contains lactose ' and ' do not use clopionogreil zenta contains hydrogenated castor oil '): mannitol ( e421 ), hydrogenated castingor oil and microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose . the other ingredient is lactoses monohydrate ( milk sugar ). tablet core : hypromellose ( е464 ), triacetin ( é1518 ), red iron oxide ( EDGE ), titanium dioxide ( i171 ), car
yttriga is a radioactive medicine . it is used when your doctor has agreed to switch from another medicine containing tiny radiation doses . the treatment will be supervised by a doctor who is experienced in the use of radiolabelled medicinal product .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yittrig - when you are pregnant or think you may be pregnant . warnings and precautions talk to your doctor or pharmacist before using yttingtrige - you will not receive yttestrigam - as yTriga is a radioactive medicine . it may be used in combination with another medicinal product or with radiopharmaceuticals . ytestrigal contains radioactive material , which may be harmful to radioactive medicinal products . children and adolescents ystrig
your doctor will determine the appropriateness of the treatment and will determine how much yttriga you should receive . method of administration yttestrig consists of radiolabelling of medicinal products , which are used to identify specific diseases . administration of yttingtrige in case of overdose will be overseen by a physician who will decide on appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if any of the side effects get serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist . reporting of side effects you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects your doctor may change your dose . this includes any possible side effects NOT listed in the leaflet or mp3 player . you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of local regulations for radioactive substances . the following information is intended for the specialist only . keep out of the sight and reach of children . do not use after the expiry date which is stated on the label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . any unused product or waste material should be disposed of in accordance with local regulations .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 g of hydrochloric acid . the other ingredient is water for injections ( see section 3 " yttestrig consists of a v - shaped bottom and a colourless type i glass vial of 10 mL containing a flat bottom , closed with a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciama is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . in this case , in a clinical trial , the combination of ciambalot and csplatin was chosen for the initial treatment of patients with advanced stage of lung cancer ; in this clinical trial your doctor will decide whether ciabomb can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; ciaMBa is also a treatment for patients with certain types of lung carcinoma whose disease has progressed after other initial
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciama ( listed in section 6 ). - when you are breast - feeding ; you must discontinue breast  - feed during treatment with ciambamba . - you have recently received or are about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or hospital pharmacist before receiving ciaMBa . you have previously had problems with your kidneys . before receiving the infusion of ciembra you will have samples of your blood taken to evaluate if your kidney and liver function are adequate . your doctor may decide to change the dose or give you ciaba if these have not been adequately controlled . when receiving cisplatin , your doctor will make sure that you receive appropriate treatment with the
the dose of ciambra is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your own body . you should use this body surface area to workout the right dose for you . this dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor will have mixed the ciama powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection before it is given to you , so that it can be given to your doctor or nurse . the amount of cisplatin that you will receive is based on your height  and weight . depending on the size of your area , your doctor will work out your dose . it is usually given by infusion into
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : 52 fever or infection ( common ): if your medicine has a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if u / u get chest pain due to a fast heart rate . this may be accompanied by pain , redness , swelling or sores in your mouth . allergic reaction : a type of skin rash ( very common in people ) / burning or prickling sensation , fever , skin reactions : very common ( may affect more than 1 in 10 people ). if any of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . chemical and physical in - use stability of the infusion solution of pemetrexed has been demonstrated for 24 hours at 2  8 and at 15 to 25 . from a microbiological point of view , the reconstituted solution should be used immediately after preparation . if not used immediately , in  4 hours storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours 2 , 8 , 15 to 25, . this medicine is for single use only . any unused solution must be discarded .
what ciambra contains the active substance is pemetrexed . ciama 100 mg : each vial contains 100 milligrams of pemetrexxed ( as pemetreXed disodium hemipentahydrate ). ciambambarton 500 mg ; each viall contains 500 milligramms of Pemetrexéd ( als pemetreixed disodium haemipENTahydrate). after reconstitution , the solution contains 25 mg / ml of pemeterxedu . further dilution by a healthcare provider is required prior to administration . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for further phe adjustment ). see section 2 " ciampa contains sodium ". what
immunogam belongs to a group of medicines known as immunoglobulins ( antibodies ) used to prevent certain infections . immunogam works by making your blood stronger , which may result in increased levels of human hepatitis b immunoglobuulin s ( igg ). immunoglobular g ( ilg ) is produced from blood plasma of screened individuals . if you have any questions about how immunogam may work or why this medicine has been prescribed , ask your doctor .. immunogame is used to treat hepatis a virus in haemodialysed patients . vaccination is usually initiated by means of administration of a hep b virus carrier . this ensures an immune response and produces measurable heparin b antibodies . vaccine is not a substitute for continuous prevention in order to prevent others from becoming infected with hepe
do not use immunogam if you have ever had an allergic reaction to human immunoglobulins or to other blood products . this is because immunogam contains trace amounts of human immunogl - containing proteins . in case of an iga deficiency , an allergic response may occur . iga containing products should be used only in a hospital . use in children and adolescents immunogam is not recommended for use in people under 18 years of age since the use of immunogam has not been studied in this age group . adverse reactions may occur such as chills , headache , fever , vomiting , and allergic reactions such as nausea . cases of arthralgia ( joint pain ), low blood pressure and moderate low back pain . patients must make antibodies against hepatitis b immunoglobuulin regularly and human hepatis - B immunoglobunin injection
immunogam is intended for vaccination against hepatitis b virus . the first vaccine dose should be given by a doctor or nurse trained in the use of human hepatis - b immunoglobulin . dose and administration prevention for heptis
like all medicines , immunogam can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effect in 1 to 10 users in 100 ) uncommon ( affect in 1 , 000 ) rare ( affect 1 to10 users in 10 to 10 user in 10,000 ) very rare ( effect on less than 1 users in10 ,000 ) not known ( frequency cannot be estimated from the available data ) undesirable effects have been reported in clinical trials with immunogam . increase in the amount of muscle contractions has been observed very commonly ( affect more than1 user in 100 and more than 7 users in 1200 ). the most frequently reported undesirable effects were nausea , fatigue , induration and swelling of the face . reporting of side effects 22 if you get any side effects talk to your doctor
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and the label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2c - 8c ). do not freeze . keep the vial in the outer carton in order to protect from light . before administration , immunogam should not be used if the solution is cloudy or has deposits . medicines should not disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . immunogam 1 ml solution for injection contains 5 mg of human plasma protein , 96 % protein in the form of polysorbate 80 . what immunogame looks like and contents of the pack immunogam is a solution for injecting in a glass vial . the clear to slightly opalescent and colourless to pale yellow liquid . pack size of 1 vial
remicade contains the active substance infliximab . inflimimabe is a monoclonal antibody a type of protein that attaches to a specific target in the body called tnf ( tumour necrosis factor ) alpha . rericade belongs to ' ttf blockers '. it is used in adults for the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew 's disease ) p soriasis . you should see a doctor at least every 6 months for : crohn '
do not take remicade : if you are allergic to infliximab or any of the other ingredients of relicade ( listed in section 6 ). if this applies to you , tell your doctor and do not start remade until you have checked with your doctor . if  you are not sure , talk to your doctor or pharmacist before taking remikade as it may be harmful to others . warnings and precautions talk to you doctor before taking the medicine if any of these apply to you before you take , or if your doctor thinks you may be allergic ( hypersensitive ) to remonade or to any of their medicines . children and adolescents remitade is not recommended for children and teenagers aged under 18 years . other medicines and reMICade tell your doctors or pharmacist if they are taking ,
rheumatoid arthritis the usual dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psesoriasis , ulcerative colitis and crohn '
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however some patients may experience serious side effects and may require treatment . side effects may also occur after your treatment with remicade has stopped . tell your doctor straight away if you notice any of the following : signs of an allergic reaction such as swelling of your face , lips , mouth or throat which may cause difficulty in swallowing or breathing , skin rash , hives , swelling of the hands , feet or ankles . some of these reactions may be serious or life - threatening . an allergic response could happen within 2 hours of your injection or later . more signs of allergic side effects that may happen up to 12 days after your injection include pain in the muscles , fever , chills , nausea , vomiting , diarrho
remicade will be stored by the health professionals at the hospital or clinic . the storage details should you need them are as follows : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and the carton after exp . it is usually stored in a refrigerator ( 2 8 ). this medicine can also be stored in the original carton outside of refrigerated storage up to a maximum of 25 for a single period of up to six months , but not beyond the original expiry . remade is stable for infusion in the hospital and is stable at 2 8 for up to 28 days and an additional 24 hours at room temperature ( up to 25 ). after removal from refrigeration , the product must be used immediately . this medicine is for single use only . any unused medicine must be discarded after withdrawal of
what remicade contains - the active substance is infliximab . each vial contains 100 mg of influximabe . after preparation each ml contains 10 mg of imfliximiab ( as sucrose ). - other ingredients are polysorbate 80 , monobasic sodium phosphate and dibasic salt phosphat ( e215 ). what retimicades looks like and contents of the pack remikade is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white . relicade comes in packs of 1 , 2 , 3 , 4 , or 5 vials . not all pack sizes may be marketed .
rasagiline mylan is used to treat parkinson ' s disease in adults . it can be used together with or without levodopa ( another medicine that is used in treatment of parkinsons ' disease ). with parkinSON 's disease , there is a loss of cells that produce dopamine in the brain . dopine is essentially a chemical in the body that is involved in movement control . rasagilline myLAN helps to increase and sustain levels of dopa in the mind .
do not take rasagiline mylan - if you are allergic to rasagilline or any of the other ingredients of this medicine ( listed in section 6 ). - you have severe liver problems . do not use the following medicines while taking rasagine mylan: - monoamine oxidase ( mao ) inhibitors ( e . g . for treatment of depression or parkinson ' s disease , or used for any other indication ), including medicinal and natural products without prescription e. ., st . martin 's wort . this medicine contains pethidine ( a strong pain killer ). you must wait at least 14 days after stopping rasagaline myLAN treatment and starting treatment with mao inhibitors or pethtine . warnings and precautions talk to your doctor before taking rasagaline myLAN - for
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 tablet of 1 mg taken by mouth once daily . rasagiline mylan may be taken with or without food . if your doctor determines that rasagaline myLAN is not suitable for you , contact your doctor immediately . take the rasaginiline Mylan carton with you to show the doctor or nurse how to take it . you should take rasaggi line mylan at the same time each day . it does not matter whether you take it with or after food , drink or just after food or between meals . for example , if the doctor thinks that it may be necessary to take your medicine at the exact time of the day , take your dose as soon as you remember . however , should you take
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects reported in association with the use of placebo were of the following frequency : very common side effects ( affects more than 1 user in 10 ) common effects ( effect in 1 to 10 users in 100 ) uncommon uncommon effects ( effects in 1 , 000 ) rare rare side effects (10 ,000 ) very rare side effect ( affect in less than 1 patient in 10000 ). very common abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) general feeling of being unwell neck pain , chest pain ( angina pectoris ) not known ( frequency cannot be estimated from the available data ): feeling of spinning ( vertigo ) feeling of weakness ( dystonia ) being unsteady ( paraesthesia ) reporting of side effects 22 if you get any side
what rasagiline mylan contains - the active substance is rasagilide . each tablet contains rasagigaline tartrate equivalent to 1 mg rasagile . - other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maizestarch / maize , talc , searic acid and water for injections . what rasaagiline myLAN looks like and contents of the pack rasagigiline tablets are 11 . 5 mm in diameter and 6 mm wide . they are white to off - white , round , biconvex tablets with " gilead " and " 1 " on one side . the tablets are provided in blister packs of 7 , 10 , 28 , 30 , 100 and 112 tablets with perforated blister . not all pack sizes may be marketed
do not use hulio : if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a severe infection , including tuberculosis . warnings and precautions talk to your doctor before using hULio as it may cause symptoms of infections , e . g . fever , wounds , feeling tired , dental problems . have moderate or severe heart failure . your doctor may want to monitor you more closely . had or have , or have had , any history of a serious heart condition . allergic reaction if any of these apply to you , do not take huluiio and tell your doctor immediately . allergy reactions can be life - threatening . symptoms can include chest tightness , whe
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is : polyarticular juvenile idiopathic arthritis in adults from 2 to 17 years of age : 10 to 30 mg hulio is available as a 20 mg tablet . children and adolescents from 2 years to 17 year of age: 30 mg the doctor may decide to give hULio as he or she may decide a 40 mg tablet depending on body weight . enthesitis - related arthritis in children and teenagers from 6 to 17year of age who weigh 15 kg to less than 30 kg : the doctor will decide the right dose . for hülio 20 mg tablets and the 20 mg capsules are available as well . in children from 6 months to 17- year of old : 30 kg
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . you may need urgent medical treatment . side effects may occur up to 4 months or more after the last hulio injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash , or hives swollen face , hands or feet , trouble breathing , swallowing , pale complexion , dizziness , persistent fever , possibly with bruising or bleeding . signs and symptoms of infection include fever ; feeling sick ; diarrhoea , vomiting ; nausea and vomiting . common : may affect up to 1 in 10 people a worsening of the liver enzymes . uncommon : will show up in tests . tell
what hulio contains the active substance is adalimumab . the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid , and water for injections . what hurio looks like and contents of the pack hULio 40 mg solution for injection in vials is supplied as a sterile solution of 40 mg aad alimUMab in 0 . 8 ml . it is clear to slightly opalescent and is supplied in a clear glass vial with a rubber stopper . hkulio is available in packs containing 1 or 2 vial syringes , 1 steril injection sYringe , one sterility needle , 2
what yellox is yellax contains bromfenac , which belongs to a group of medicines called non - steroidal anti - in - inflammation drugs ( nsaids ) that reduce inflammation . what Yelloxis used for yellx is used in adults to reduce eye inflammation following cataract surgery .
do not use yellox : - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). - warnings and precautions talk to your doctor or pharmacist before using yellax if : you have asthma , skin allergy or intense inflammation in your nose you are taking other nsaids . other said types are also available : the other ' naaids' are acetylsalicylic acid , ibuprofen , ketoprofened and diclofenoc . if any of these apply to you , do not take this medicine . you are also taking topical steroids ( such as cortisone ) to prevent unwanted side effects . talk to you doctor or nurse before taking yellx . this is because bleeding problems in patients
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop of yellox in your eye ( s ) once a day in the morning and one drop in your other eye (
what yellox contains - the active substance is bromfenac . each ml of solution contains bromfed ( as sodium sesquihydrate ). each vial contains 33 mg brom Fenac as the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , to name a few , and tyloxapol , povidone ( k30 ), disodium edetate and sodium hydroxide . what Yellox looks like and contents of the pack yyelloX is a clear yellow liquid ( solution ) that is supplied in a 5 mL glass vial with a screw cap .
dzuveo contains the active substance sufentanil , which belongs to a group of strong painkillers called opioids . sufenteanil is used to relieve sudden moderate - to - severe pain in adults .
do not take dzuveo - if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). - you have a serious lung or breathing problem . warnings and precautions talk to your doctor before taking dzveo and if : - your doctor has told you that you are taking any condition that interferes with your breathing ( such as asthma , wheezing or shortness of breath ). you should be aware that dZveo may affect your breathing more than usual during treatment . - the doctor may decide to reduce the dose or stop treatment temporarily or permanently . talk to you doctor if any of these apply to you . you have had a head injury or brain tumour . problems with your heart and circulation such as slow heart rate , irregular heartbeat , low blood volume or low blood pressure .
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the single - dose administration device is for use in adults only . you should take this medicinal product for as long as your physician continues to prescribe dzuveo and will always take the strength painkillers recommended by your doctor ( sufentanil 30 mg / m2 ) as directed by your physician . your doctor may decide to increase your dose of the sublingual tablet by using the disposable single – dose applicator . - the applicators should be inserted under your tongue only as the tablets dissolve under your mouth and will provide you with pain relief . it may take 10 minutes or more before your tongue is empty . how long to take d zuveo you will usually take a daily dose of 720 mg . after you have taken
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side impacts : - severe breathing problems . these may be serious . - slow and shallow breathing . any of these side effects should be reported immediately . very common side effects ( may affect more than 1 in 10 people ):  nausea ( feeling sick ), vomiting ( being sick ) and feeling hot . common side effect ( may effect up to 1 in10 people ), are : failure or difficulty sleeping , feeling dizzy or feeling hot common side impacts ( may impact up to1 in 10 persons ) include : difficulty sleeping ( insomnia )  difficulty sleeping [ non - somnia ] ( loss of consciousness ) common side affects up to 2 in 10 individuals ) are ; inability or difficulty
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , bottle and blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the bottle tightly closed in order to protect from light and oxygen . this medicine does not require any special temperature storage conditions . dzuveo should not be used if there is any visible sign of deterioration . as with all medicines , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg of sufENTanil ( as citrate ). - other ingredients are mannitol , dicalcium phosphate , hypromellose , crohn' s wort ( maize ), croscarmellose sodium , indigo carmine ( e132 ), the stearic acid and magnesium stearrate . what dungveo looks like and contents of the pack dzveo is a white to off - white tablet with round edges , marked with 3 mm in diameter . it is provided in a single - dose applicator ( labelled [ sublingual tablet ].]). the applicators contains one sufenil 30 mg film - coated tablet . pack sizes of 5 and
erleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has spread to other parts of the body or cannot be removed by surgical treatments . erledad is used in adult men to treat sensitive prostate cancer which has spread within the body and cannot be eliminated by surgical treatment . in adult male patients , the amount of testosterone that is produced is too low and cannot remain stable , a condition known as castration - resistant prostate cancer . the active ingredient in erlesad , androgens , is used when the cancer has grown and is resistant to androgents . apalutaMIDe works by blocking the activity of prostate cancer cells .
do not take erleada if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if there is a possibility that you may be pregnant , or could become pregnant ( see pregnancy , contraception section ). take special care with this medicine it is not known if it is safe or effective to use this medicine . tell your healthcare professional if any of these effects apply to you and tell your pharmacist . warnings and precautions talk to your doctor before taking this medicine and during treatment : if : you have a history of seizures . you are taking any medicines that prevent blood clots ( e .g . warfarin or acenocoumarol ), if your doctor thinks any heart or blood vessel conditions or heart rhythm problems
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg three times a day ( taken two times , one in the morning and one inthe evening ). you should take erleada the following day . take this medication by mouth . you can take ERleade with or without food . do not take other medicines with erledad . if your doctor decides that you should stop taking erlesadda , you may get side effects . keep taking ersleadra for as long as your physician tells you to . don ' t stop taking more erlada than your doctor tells your doctor . it is important that you do not get any side effects while you are taking ERLEad. er lead the pack with
like all medicines , this medicine can cause side effects , although not everybody gets them . patients treated with erleada may experience the following symptoms : - reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be preceded by fever and flu -like symptoms ( toxic epidermal necrolysis ). other serious side effects tell your doctor or pharmacist if you get any of the following side effects after taking erlesad : fit - up seizure . this is uncommon ( may affect up to 1 in 100 people ). if this happens to you , stop taking ERleade and tell your physician straight away . - stomach
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalutaMIDe -the other ingredients are colloidal anhydrous silica , croscarmellose sodium , all - hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose and silicified microcrystalline cellulose . the film lining contains iron oxide black ( e172 ), iron oxide yellow ( else ), macrogol , polyvinyl alcohol , the talc , and titanium dioxide ( ED171 ). what ersleade looks like and contents of the pack erlesad , film – coated tablets are beige , round , slightly yellowish , biconvex , oval shaped , approximately 8 .
this medicine is a radiopharmaceutical product for diagnostic use only . axumin contains the active ingredient fluciclovine . it is used to perform a type of scan ( a pet scan ) in adults who have previously received treatment for prostate cancer . before the scan , your doctor will use other tests to find out whether a specific type of prostate specific antigen ( psa ) is present in the cancer , and an aXumin pet scan can be performed in order to better understand the location of the cancer and its significance . your doctor and the nuclear medicine doctor have considered that the clinical benefit of this procedure with the radiopharmaceutician outweighs the risk of being exposed to radiation .
do not take axumin : - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking aXumin and if any of these apply to you : kidney problems . you should not take this medicine if the you are on a low sodium diet . a doctor or a nurse will give you a copy of the aexumin scan one day after the xumIN scan . it is recommended that you take 4 tablets before the scan and then go back to your usual medicines . the usual dose is 60 minutes after the first dose of the the apoumin injection . talk to a healthcare professional or nurse immediately if this happens . driving and using machines it is preferable to drive or use machines . however , a
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be used in specially controlled areas . this medicine will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . dose the nuclear medicine doctor supervising the procedure will decide on the quantity of aXumin to be used by . it will be the smallest quantity necessary to get the desired information . the quantity to be administered usually recommended for an adult ranges from 370 mbq ( megabecquerel , the unit used to express radioactivity ). administration of  aexumin and conduct of the procedure apumin is given into a vein . after a flush of sodium chloride solution is used
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , side effects were : uncommon ( may affect up to 1 in 100 people ) - the medicine did not deliver the desired effect . side effects of axumin uncommon ( MAY affect upto 1 in 1 , 000 people ), pain , rash , altered taste in the mouth , and altered sense of smell . this radiopharmaceutical will deliver low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects 10 if you get any side effects talk to your nuclear medicine doctor . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . keep this medicine out of the sight and reach of children . do not use axumin after the expiry date which is stated on the label after exp . hospital staff will ensure that the product is stored and thrown away correctly and not used after the stated expiry expiry , even if the product has been discarded .
what axumin contains - the active substance is fluciclovine . aixumin 1600 mg : each tablet contains 1600 mg of flucclovine ( as 1600 mg or 16000 mg ). aexumin 3200 mg / 1000 mg apr contains 3200mg of  Fluciclovin ( as 3200 or 32000 mg ) - - other ingredients : sodium citrate , concentrated hydrochloric acid , sodium hydroxide ( see section 2 " adsorbed on sodium "). what if aXumin looks like and contents of the pack axxumin 16000mg / 1600mg is a clear , colourless , multidose tablet , packed in packs of 1 or 10 vials containing 1600 to 16000 iu . and aaxumbin
the active substance of azopt , brinzolamide , belongs to a group of medicines called carbonic anhydrase inhibitors , which work by reducing pressure within the eye . aziopt eye drops are used to reduce high pressure in the eye which can lead to an illness called glaucoma . the pressure in your eye is too high , so it can cause damage to your sight .
do not take azopt if you have severe kidney problems . you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). you are also allergic to medicines called sulphonamides ( medicines used to treat diabetes , infections or diuretics ( water tablets )). warnings and precautions talk to your doctor before taking azyopt : if your doctor thinks you may be allergic , ask you to stop taking . if there is too much acidity in your blood ( hyperchloraemic acidosis ) while taking , or if any of these apply to you . talk to the doctor before you take , have kidney or liver problems if : you have dry eyes or cornea problems you are taking other sulphphonamide medicines to treat glaucoma . your doctor may ask you not to take 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . only use azopt for your eyes . 1 ) put the bottle in the eye . it is for single use only . do not swallow or inject . the recommended dose is one tablet in the affected eye or eyes , once a day . aziopt can be used in children and adolescents . for children aged 1 year and above , adolescents and adults , the recommended dosage is 2 to 3 g / ml . take the azyopt bottle and put it back in the refrigerator . wash your hands . pull down the cap . when the cap is removed , if the numbness comes loose , it must be put back on a shelf . after snap collar is removed from the bottle , and
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , e . g . eye pain , eyes discharge , itchy eye , dry eye ; abnormal eye sensation ; redness of the eye other side effects include : bad taste . uncommon side effects may affect more than 1 in 100 people ). - infections of the lower eye . reporting of side effects get this information if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . keep the bottle tightly closed in order to protect from moisture . a pack containing a single bottle should be used within six months .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzola . - other ingredients are benzalkonium chloride , carbomer 974p , edetate disodium , human ema , purified water , sodium chloride and tyloxapol . the active substances are hydrochloric acid and sodium hydroxide . these are used to keep acidity levels ( ph levels ) normal . what  azamopt looks like and contents of the pack azyopt is a milky liquid ( a suspension ) that comes in a 5 mL clear , colourless , droptainer - bottle with a 10 mll plastic ( droptaineer ) bottle with or without a screw - up cap . one pack
forxiga contains the active substance dapagliflozin . this belongs to a group of medicines called " oral anti - diabetics ". these are medicines taken by mouth for diabetes . they work by lowering the amount of sugar ( glucose ) in your blood . forxika is used in adults aged 18 years and older . it is used : - to treat diabetes in adult patients - with type 1 diabetes where your body does not make any insulin . - in combination with diet and exercise , forxica may be used for type 1 in adults , and is also used in those who are overweight or obese .- in type 2 diabetes where the body does NOT make enough insulin or is not able to use the insulin it produces properly . your doctor will test your blood to make sure that it is the right type of diabetes in your body .
do not take forxiga if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxika . tell your doctor immediately if : you experience feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , or a fruity or metallic taste in your mouth , an odour to your urine or sweat or rapid weight loss . any of these may be signs of " diabetic ketoacidosis " a serious , sometimes life - threatening problem you can get with diabetes because of increased levels of " ketone bodies " in your urine and blood or urine , and / or urine abnormalities . your doctor may want
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take forxiga is for adults and type 2 diabetes . the recommended dose is 10 mg once a day . your doctor may prescribe a lower dose of 5 mg once daily if your doctor has told that you have a liver problem . if this applies to you , your doctor will prescribe xiga for you ; however , for type 1 diabetes , the usual dose is 5 mg twice a week . taking this medicine swallow the tablet whole with some water . forxige can be taken with or without food . it is important that you continue with your diet and exercise program recommended by your doctor while taking forxigan . you should continue with this while you are taking forixiga . to help your body use its blood sugar better 
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking forxiga and see a doctor straight away if you notice the following serious side effects you may need urgent medical attention : angioedema , seen very rarely ( may affect up to 1 in 10 , 000 people ). these are signs of angioendema which may be recognised as swelling of the face , tongue or throat . difficulties swallowing , hives and breathing problems diabetic ketoacidosis , see section 2 : if your child has type 1 diabetes ( may effect up to1 in 10 people ) and type 2 diabetes ( rare : may affectup to 1in 1 ,000 people ), see section " warnings and precautions ". diabetic ketoaccytosis : you may experience increased levels of " ketone bodies " in your
what forxiga contains - the active substance is dapagliflozin . each forxega 5 mg film - coated tablet ( tablet ) contains dapagligiflonzin propanediol monohydrate equivalent to 5 mg dapaglingiflouzin -the other ingredients are : tablet core : microcrystalline cellulose ( e460i ), lactose ( see section 2 under ' forxige contains lactoses '), crospovidone type a , silicon dioxide , magnesium stearate . film : polyvinyl alcohol ( pctfe ), titanium dioxide ( cpfee ) and macrogol 3350 , talc ( a mixture of yellow iron oxide ). what forixiga looks like and contents of the pack forxuga 5 mg is a light yellow , capsule 
mepact contains the active substance mifamurtide which blocks the growth of certain bacteria that form a type of immune system called the ' innate immune system '. mepacting is used to treat osteosarcoma ( bone cancer ) in adults between 2 and 30 years of age , who cannot be removed by surgery to remove the tumour . it is used in combination with chemotherapy which stops cancer cells from growing and bringing cancer back .
do not use mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). - you are taking medicines that increase the activity of ciclosporin and other calciumineurin inhibitors ( non - semenoidal - anti - in - inflammation drugs or nsaids ). this is if your heart or blood vessels are damaged , you have a risk of blood clots ( thrombosis ) or bleeding ( haemorrhage ). the risk of inflammation of the veins ( vasculitis ) may be higher if mepacting is used for long - lasting or worsening symptoms . warnings and precautions talk to your doctor before using mepactation if : you have asthma or other breathing disorders , as this may increase the
treatment mepact will be given to you by a doctor or nurse who is experienced in the use of this medicine . they will explain to you how to prepare and inject mepacted . the recommended dose of mepacting is 2 mg mifamurtide given every 12 to 24 hours . your doctor will advise you on the number of me Pact treatments to be used in accordance with your chemotherapy schedule . you should usually receive your chemotherapy 36 before you start treatment . before you are given mepactes , an interruption in the processing of the freeze - dried powder into a liquid suspension . once the filter has been opened , mepactation will be administered into  a vein over 1 hour . if you are treated with mepacten , you may experience severe side effects such as fever , chills , fatigue , nausea and vomiting .
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported very rarely in patients taking mepace for transient use . it is therefore important to take paracetamol whenever possible to reduce fever during treatment with mepac . stomach problems ( nausea , vomiting , and loss of appetite ) have been experienced in patients receiving chemotherapy . tell your doctor immediately if you experience continuing fever or chills after 8 hours of taking me Pact . signs of an infection such as rash or any problems breathing or wheezing , especially if taken with other medicines . if your doctor notices any problems with your nerves getting worse or if someone else notices them , inform your doctor as soon as possible . other side effects very common ( may affect more than 1 in 10 people ): diarrhoea
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). keep the vial in outer carton in order to protect from light . reconstituted suspension must be used immediately . chemical and physical in - use stability has been demonstrated at concentrations of sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection for up to 6 hours . this medicine must not be used if there is any visible signs of deterioration .
what mepact contains the active substance is mifamurtide . each vial contains 4 mg of mfamurthide , which is expressed in international units ( iu ). after reconstitution , one ml of suspension contains 0 . 08 mg of ( 8 . 0 mg ) mIFamurdide ; the other ingredients are 1 - palmitoyl - 2 - oleoy - so - called sn - gastrocero - 3 - pocholine , 2 , 3 , dioleayl- ssn- glycero- 3- phospho - laure monosodium salt , see section 2 " mepacting contains sodium ". what me Pact looks like and contents of the pack mepactation is a white to off
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is given to be injected under the skin ( the face ) to reduce redness . in adults it is used to treat rosacea , which causes redness of the face in adults . rosACEa causes high levels of blood flow in the facial skin , resulting in enlargement ( dilation ) of the small blood vessels of the skin . mirvass acts by reducing the size of the blood vessels , blocking the excess blood flow and reducing redness in the eyes .
do not take mirvaso if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor or pharmacist before taking mirvase , if any of these apply to you . read the information in section 2 " possible side effects " and " how to take the medicine - if your skin is still wet . - you should not take certain medicines for depression or parkinson ' s disease . your doctor may ask you to take monoamine oxidase ( mao ) inhibitors ( e .g . selegiline , moclobemide ), tricyclic antidepressants ( i . ex . imipramine ), tetracyclic antagonists ( such as maprotiline ; mianserin ) or mirtaza
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is for injection under the skin ( preferably the face ). this medicine should not be injected into any other part of the body . it should only be absorbed by the body surfaces and not into the gullet ( gullets ). your doctor may ask you to remove this medicine from your body if it affects the way your eyes , mouth , nose or vagina . how to use mirvass mirvasa is for oral use . the recommended dose is one pea - sized amount once a day . your doctor will tell you how much to use , when to inject it and for how long you need to follow it . if your doctor thinks that the treatment is too strong or too weak , you should inject a small amount of gel
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects are : severe skin irritation or inflammation , skin rash , hair loss , sunburn , wound healing , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects is : worsening of rosacea . if the treatment is not working well enough , symptoms should be reported immediately ( see section 2 " mirvaso contains sodium "). contact your doctor if you experience allergic reaction , such as rash ( rare angioedema , which is a serious allergic reaction that may be life - threatening ). if your doctor decides to stop treatment with mirvasO , you should contact your physician immediately , since the risk is higher . reporting of side effects 31 if patients get
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , tube and pump after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . store in the original package in order to protect from light .
what mirvaso contains - the active substance is brimonidine . each gram of gel contains 3 . 3 mg of brimoniidine , and 5 mg of pro - briminidine tartrate , carbomer , methylparahydroxybenzoate , the other ingredients are phenoxyethanol , glycol , titanium dioxide ( e171 ), propylene glycol ( s ), sodium hydroxide , purified water ( see section 2 " mirvasa contains methyl parahydroxybenzone and propyle glycol "). what mirvao looks like and contents of the pack mirvasone is a clear , opaque gel , supplied in 2 ml sachets . pack sizes of 10 and 30 of gel are available . unit packs of gel being supplied with airless pump system . not all pack sizes may be marketed
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that is normally made by the immune system to help defend the body from infection and cancer ). bevacimizumabe binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found on the lining of blood and lymph vessels in the body . the veggf protein causes blood vessels to grow within tumours , these blood vessels provide the tumour with nutrients and oxygen . once bevacibizumabat is bound to vegasi , tumour growth is prevented by blocking the growth of the blood vessels which provide the nutrients and nutrients and other oxygen to the tumour . mvai is  a medicine used for the treatment of adult patients with advanced cancer in the large bowel , 
you should not be given this medicine if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ). you are allergy ( hyper sensitive ) zu chinese hamster ovary ( cho ) cell products or to other recombinant human or humanised antibodies . you are pregnant or breast - feeding . warnings and precautions talk to your doctor or nurse before you are given mvasi . mvai may increase the risk of developing holes in the gut wall . it may also increase the chance of developing conditions associated with inflammation inside the abdomen ( e . ex . diverticulitis , stomach ulcers , colitis associated with chemotherapy ). mmusi may also reduce the risk for developing an abnormal connection or passageway between two organs or vessels . the risk is increased
dosage and frequency of administration the dose of mvasi needed depends on your body weight and the kind of cancer to be treated . the recommended dose is 5 , 7 . 5 mg , 10 mg or 15 mg per kilogram of your bodyweight . your doctor will prescribe a dose of one infusion per kilogram ( kg ) of your weight . mvai will be given every 2 or 3 weeks . frequency of infusions your doctor may decide that treatment with this medicine is not being stopped . continue to use mvici until m Vasi has stopped working and your tumour growing is not stopping . method of administration mvaci is a concentrate for solution for infusion . once the mvasesi vial has been diluted with sodium chloride solution , it should be diluted . this diluted mavasi solution is also available for intravenous infusion ( a drip
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . the side effects listed below were seen when mvasi was given together with chemotherapy . most of these side effects were mild in nature and short term . you should not have to stop taking mvai unless you have been closely monitored for signs of allergic reactions . signs of an allergic reaction may include difficulty in breathing , chest pain , redness or flushing of the skin or a rash , chills and shivering , feeling sick ( nausea ) or being sick ( vomiting ). if any of these affect you , tell your doctor immediately . other side effects include severe side effects that may become serious , include but are not limited to :
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer container in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 , unless the infusion solution is prepared in  a sterile environment . after diluted , the product should be placed in : a dry and clear , colourless to light yellow solution , which should be stored in syringes at 2 - 8
what mvasi contains the active substance is bevacizumab . each ml of concentrate contains 25 mg of bevacibizumabe , corresponding to 1 . 4 to 16 . 5 mg / mL when diluted as recommended . when reconstituted as recommended the solution is a 4 mlitre vial containing 100 mg of BEvacizuab at 1  . 2 mmol / kg when dilution is performed . one vial of 16 m containing 400 mg of Bevacizab at 16   m2 . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what if you need to know before you use mvai what avasi looks like and contents of the pack mwasi is recomb
tecartus is a gene therapy medicine used to treat mantle cell lymphoma that has not responded to other medicines . refractory mantled cell lymphhoma is made from your own white blood cells ( autologous anti - cd19 - converted cc3 + cells ). mantles cell lymphomatoma is  a cancer that arises from an imbalance of a part of the immune system called b - lymphocytes . in patients with mantLE cell lymphopenia , b- lymph cells multiply too quickly and live too long . this happens when the b cells are destroyed in an uncontrolled way , by transferring blood from the cde19 gene into the blood stream . the white blood cell in your blood multiply and divide , and the cancer cells are eliminated from your body and the blood is collected .
do not use tecartus if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using the medicine . warnings and precautions tecARTus may not be suitable for you if : you have been told by your doctor that you have too many white blood cells in your blood ( lymphodepleting chemotherapy ). you have had at least 3 times in a row with very small numbers of white blood cell counts for autologous use . tests and checks your doctor will do tests to make sure that : your lungs , heart and kidney , blood pressure , signs of infection or inflammation of your cancer . you have graft - versus - host disease . this is when a transplant is made in your body . symptoms such as rash and nausea are more common in
tecartus is made from your own white blood cells . your cells will be collected from you and given to you by a doctor or nurse . they will collect and pack the medicine ( s ) by resolving the blood in your own blood . if you cannot collect your cells yourself , your doctor will take them to a hospital or clinic and they will give you a catheter placed in your vein ( a procedure call leukapheresis ). these are sent out of your body and the medicine will take about 3 to 6 hours to collect the medicine and the rest of your white blood cell ( i .e ., transferred from your vein into your vein ). this takes about 3 hours . the first dose of tecArtus is given after lymphodepleting chemotherapy . these are given to your doctor or hospital pharmacist to collect and dispose of the modified white blood lymphocytes
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you and will explain the potential risks and benefits of tecartus for you . if you notice any of the side effects above , you may need urgent medical attention . the following side effects were reported during the tecARTus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure ( which may cause symptoms such as dizziness , lightheadedness ), fluid in the lungs ( which might affect up to 1 in 100 people ). all symptoms may be caused by a condition called cytokine release syndrome ( cytokines may release substances from the body in the urine ) and loss of consciousness ( decreased level of consciousness ), confusion , and memory loss . common ( might affect more 1 in 11
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep container infusion bag in order to protect from light . after dilution with liquid nitrogen , the product must be used within 150 hours . this medicine contains genetically modified human blood cells and human - derived material . these measures will help protect the environment 36
what tecartus contains - the active substance is autologous anti - cd19 - stimulated cc3 + cells , delivered in a specific single infusion bag . each vial contains a dispersion of anti  - crd19 car t cells in approximately 68 ml for a target dose of 2 x 106 anti . - other ingredients are sodium chloride and human albumin . see section 2 " tecARTus contains sodium ". what Tecartus looks like and contents of the pack tec artus is a clear and colourless to pale yellow solution for infusion . it is supplied in an infusion bags individually packed in hd19- specific single - infusion baggage containing approximately 69 mbq of cell dispertion .
januvia contains the active substance sitagliptin which is a member of a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - four inhibitors ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2 diabetic condition . you may be given this medicine in combination with certain other medicines ( insulin , metformin , sulphonylureas , or glitazones ), which all work to lower blood sugar in your diabetes . talk to your doctor if you have type 2 Diabetes .
do not take januvia - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - in case of inflammation of the pancreas ( pancreatictitis ). warnings and precautions talk to your doctor or pharmacist before taking janugavia ( see section 4 ). blistering of the skin may be a sign for a condition called bullous pemphigoid . janusuvia is not recommended if any of these apply to you . you have or have had a disease of the Pancrea ( such as pancreattitis or gallstones , alcohol dependence or very high levels of triglycerides ( a form of fat ) in your blood . these medical conditions can increase the risk of getting pancreacis ( see also section 4 " other medicines and jan
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual recommended dose is : one 100 mg film - coated tablet 63 once a day by mouth if your doctor thinks it is important to have a meal , or if someone else has kidney problems , the usual dose is 25 mg once / day , but your doctor may prescribe a lower dose ( such as 50 mg / 7 ). you can take this tablet with or without food . your doctor will prescribe this medicine together with certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . it is very important to stay on the diet and to drink the foodstuffs recommended by your doctor while taking januvia . if a child swallows some tablets , they should contact their doctor immediately . they may
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact your doctor immediately if you notice any of the following serious side effects you may need medical attention : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatictitis ). a serious allergic reaction ( frequency not known ) that may include rash , hives , blisters on the skin / peeling skin and swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing . this medicine is for oral use . swallow your capsules whole with a drink of water . do not chew or break the capsules . if any of these side effects become severe 
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglittin protein monohydrate equivalent to 25 mg sitagltin in one tablet . - other ingredients are : tablet core : microcrystalline cellulose ( e460 ), calcium hydrogen phosphate , croscarmellose sodium ( е468 ), magnesium stearate ( EEKA ) and sodium stearyl fumarate . the tablet film coating contains : poly ( vinyl alcohol ), macrogol 3350 , the talc ( 8000 ), titanium dioxide ( E171 ), red iron oxide ( ele ) ( a ), and yellow iron oxide [ e172 ]). what junuvia looks like and contents of the pack round , pink film – coated tablet in
what xultophy is xULtophy contains the active substance liraglutide . it is used to lower your blood glucose during meals . what Xultopsy is used for xültophy can be used in adults , adolescents and children with type 2 diabetes mellitus . this type of diabetes occurs when your body does not make enough insulin to control the level of blood sugar . insulin degludec is a long - acting basal insulin which helps your body to control your blood sugar levels . the active substances in xulation are lilraglutin and glp - 1 . you should continue to follow your food and exercise plan while taking insulin during meals to control hunger . xkultophy may be used with or without oral medicines for diabetes xcultophy will be used together with oral medicines to treat diabetes ( such as metformin
do not take xultophy : - if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). 39 - when you are taking a sulfonylurea such as glimepiride or glibenclamide . your doctor will adjust your sulphonyllurea dose as needed . this will help your doctor adjust your dose , and will help you to keep your blood sugar levels under control . warnings and precautions talk to your doctor before taking xULtophy and if any of these apply to you :- - you have type 1 diabetes mellitus and have a condition called ' ketoacidosis ', which is a state where the bowel is not empty . - this is  a
always use this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . if your doctor is blind or has poor eyesight , you should be able to read the dose counter on your blood sugar level . the recommended dose of xultophy is 41 mg once a day . you can take xULtophy with or without food . take the dose in the morning and evening as advised by your doctor or pharmacist . it is best to take a dose within 8 hours after taking xulation . how to use xelepsy xültophy can be used in adults and children aged 8 years and over . your doctor will show you how to take the medicine . when to use the pen read the instructions at the end of this leaflet . use a pre - filled dial - a - dose pen 
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are low blood sugar ( very common , may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out unconscious . serious hypoglycaemia may cause brain damage and may be life - threatening . if you have low blood glucose , act quickly to increase your blood glucose level . low blood Sugar ( also called hypogycaemia ) can occur and should be avoided in the first place ( see section " warnings and precautions "). in case of this happen , you must remain under the care of your doctor while taking xultophy . see the box at the end of this leaflet for more information . severe allergic reaction ( anaphylactic reaction ) ( frequency not known ): if a serious allergic reaction occurs 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening the vial can be stored at room temperature ( up to 30 ) for up to 8 weeks . throw away the viall after 21 days and keep the viaL in the outer carton in order to protect from light .
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units insulin deGludec , equivalent to 3 . 6 mg lilraglutiDE . one vial of 3 mL contains 300 units insulin desgludecec - equivalent to 10 . 8 mg dlilaglutide the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid , sodium hydroxide ( for ph adjustment ) and water for injections ( see section 2 " xULtophy is provided in a vial " for sodium ). pack sizes of 1 , 3 or 5 vials or a multipack containing 10 vial ( 0 . 5 mmol ) vial , each containing one viall .
giotrif is a medicine that contains the active substance afatinib . it is an inhibitor of the egfr [ epidermal growth factor receptor 2 - 1 ] ( erbb1 ) and her2 [ erbe2 ] [ ERbb3 ]. these proteins are involved in the growth and spread of cancer cells . this medicine can kill cancer cells by blocking their action . the active ingredient in this medicine is giotref . used to treat cancer of the lung ( non - small cell lung cancer ). giotrictrif can be prescribed to you as your first treatment after prior chemotherapy treatment of a certain type of squamous type if you have received prior chemotherapy treating a similar type .
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have low body weight less than 50 kg if the doctor tells you that your kidney problems are too high if this applies to you , tell your doctor . warnings and precautions talk to your doctor before taking giotif : if any of these apply to you ( or you are not sure ), talk to ' other medicines ', ' lung inflammation ' ( interstitial lung disease ). if so , your doctor may need to monitor you more closely . if giotref is not recommended for you : liver problems . your doctor will do some liver tests before and during treatment with this medicine if there is a severe liver disease . eye problems : tell
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . you should take this medication at about the same time each day , for example , one tablet in the morning and one in the evening . do not take more than this recommended dose . your doctor will decide whether to increase your dose , or stop taking this medicine without talking to you , and will explain the dose in detail . if necessary , this medicine may be taken at least 1 hour before or 3 hours after a meal . this medicine is for oral use . swallow the tablet whole with water . how to take take this medicinal product - take giotrif once - daily by mouth . it is best to take it with food at the same times each day with a glass of water , but do not
like all medicines , giotrif can cause side effects , although not everybody gets them . the most common side effects of treatment are diarrhoea ( very common , may affect more than 1 in 10 people ), diarhooeea may progress to severe form in 2 - cases ( very rare , can occur in more than1 in 10 , 000 people ): low blood potassium , possibly worsening kidney function ( see section 2 , possible side effects for further information ). contact your doctor immediately if you experience diarrachoeal . if diarrothoa occurs , contact your physician immediately . your doctor will decide if appropriate antidiarrhoidal treatment is appropriate . antidiarrheal medicine must be discontinued prior to treatment with gioTRIf . it is important that you and your doctor discuss the possibility
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of a fatinibe . - - other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , all in the tablet core ; hypromellose , macrogol 400 , titanium dioxide , and polysorbate 80 ( e433 ). what if you think giotrim looks like and contents of the pack giotricrim 20 mg film – coated tablets are presented in : - 1 , 2 or 4 film  coated tablets in blisters ; each blister contains 7 x 1 film / coated tablets made of an aluminium film . the tablet is packed in a carton . not
orkambi contains the active substance lumacaftor . ivacaftre is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults and children from the age of 6 with f508del mutation ( kf - ctr - transmembrane conductance regulator ) that interferes with normal cdf and lungs . the mutation causes an abnormal ccftr protein to work more normally , thereby reducing the amount of c Ftr proteins in the blood . both lumlacaftoor and ivacasftour work together to correct the abnormal fttrprotein . by replacing lumaceftur with iva caftoral allows abnormal protein to function more normally and improve your breathing , improve your lung function and / or
do not take orkambi : - if you are allergic to lumacaftor , ivacaftre or any of the other ingredients of this medicine ( listed in section 6 ). - take special care with ork Ambi : do not use orkmini if the f508del mutation in a gene is present in the active substance is orkamba . warnings and precautions talk to your doctor or pharmacist before taking orkami : it is not known whether orkmbi passes into human blood cells . if so , your doctor may need to adjust the dose . talk to you doctor or nurse before taking any medicine if : you have liver or kidney disease . your doctor will decide if this medicine is suitable for you . the dose of orkaji may need adjusting . you have abnormal blood tests of the liver while taking orKambi 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults and children from 6 to less than 12 years old : one orkambi tablet should be swallowed whole with some water . the recommended dose is one orkantine tablet 6 to 11 mg of ork Ambient per day . your doctor will tell you the dose to take . - the usual dose of orkanambi is 100 mg ( 2 tablets ) taken in the morning and 2 tablets in the evening . children from 12 years of age : two orkmini tablets are available : either a dose of 200 mg ( 1 tablet ) twice a day , or 2 tablets ( 2 tablespoons ) in the afternoon and 2 tablespoon ( 2 teaspoons ), in the ork ambient light ( 0 . 5 ml ), orkamba
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with orkambi were mainly seen when patients were treated with ivacaftor alone . however , in some cases the side effect was more severe . when ork Ambi may cause serious side effects that may be serious : - raised levels of liver enzymes in the blood . this can be a sign of liver injury . - in patients with pre - existing severe liver disease , the worsening of liver function has been reported . side effects may affect up to 1 in 100 people . contact your doctor immediately if you experience any of the following symptoms : pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the whites of your eyes - loss of appetite uncommon ( may affect less than 1 in 1000 people ): 
what orkambi contains the active substances are lumacaftor and ivacaftoor . ork Ambi 100 mg / 125 mg film - coated tablets each tablet contains 100 mg of lumcaftre and 125 micrograms of iva caftoral . the other ingredients are orkamba 200 mg & 125 iu ( two tablets ) each tablet provides 200 mg of total lumаcaftar and 126 microgram ( one tablet ) of iivacaffeor , and ork ambient light . each tablet also contains 200 mg in total . o each tablet is made up of 125 milligrams lum acaffetor / 25 microgram ivacastor ( two tablet ). orkmini 100 iiu / 50 microgram or 200 ius / 200 / 250 microgram
what lynparza is lyinparza contains the active substance olaparib . olarib is a type of cancer medicine known as a parp inhibitor ( poly[ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by stopping the action of parp enzymes ( changes ) in a gene called brca ( breast cancer gene ). this is inherited from a family of cancer cells . parp inhibitions can cause death of cancer cell cells , but they also make an enzyme known as an enzyme that helps repair dna . what LYnparaza is used for lynch is used to treat ovarian cancer . brca is mutated ovary cancer , where the cancer has responded to previous treatment and is reversible . it is used if there is no
do not take lynparza - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). - see section 2 for further information about taking lynchparza and other medicines . warnings and precautions talk to your doctor or pharmacist before taking LYnparaza . lyinparza can cause low blood cell counts ( which are shown by testing ). low counts of red or white blood cells may be a sign of low platelet counts ( see section 4 for more information about possible side effects ). you must not take more than 75 tablets per day to see the signs and symptoms of fever , infection , bruising or bleeding . more serious problems may occur with the bone marrow called ' myelodysplastic syndrome '. see section 3 for more details about side effects and how to recognise them . children and
always take lynparza capsules exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . lynchres is a daily dose of lynesparza 100 mg or 150 mg . your doctor will adjust the doses of LYnparzan capsules based on your response to the medicine . it is important to take the dose of tablets exactly as described in this leaflet . do not take more than one capsule in the morning and one capsule of the evening . swallow the capsule whole , with a glass of water . how much to take take the usual starting dose of one capsule each day will depend on how well the medicine works for you , and on how serious it is ( see section 4 ). if a capsule is taken right away you may get side effects . children and adolescents do not give this medicine to children under 8 years
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , and fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ).: allergic reactions , such as hives , difficulty breathing or swallowing , dizziness . signs and symptoms suggestive of hypersensitivity reactions . other side effects include : common ( might affect up to1 in 10 children ) - headache - feeling short - of breath ( feeling very fatigued , having pale skin and fast chest beat ). these may represent symptoms of an increase in the amount of red cells in the blood ( anorexia ). rare ( may occur in up to one
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . any lynparza capsules that are damaged or not used are to be disposed of in accordance with local requirements . lynchparza caps that have been stored outside of the refrigerator are stable at a temperature below 30 for a single period of up to 3 days . throw away any capsules left in the blister or carton . discard the capsules if not used within this period . these measures will help protect the environment .
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg of olarib - this other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( е172 ). what LYnparaza looks like and contents of the pack each hard hard capsule is a white , opaque , hard capsule with " olobarib 50 mg " imprinted on one side . the capsule is imprinted with astrazeneca logo on the other side , and is imprintable on the reverse side ; lyNparza is available in plastic bottles containing 112 capsules or 448 capsules ( 112 tablets only ). not all pack sizes may be marketed
this medicine contains the active substance naloxone . nnaxone is a synthetic version of opioids ( heroin , methadone , fentanyl , methaemoglobin , buprenorphine , and morphine ). nyxoid is used as a nasal spray for the emergency treatment of opioid overdose in adults . opioid over dose can occur over 14 days and can cause breathing problems and severe sleepiness . an opioid overd is not known to occur in people who abuse opioids . you must immediately contact your doctor if you have any concerns . your doctor should immediately inform you of the need for emergency medical care .
do not use nyxoid - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions emergency medical care and emergency services should be provided emergency services as needed . talk to your doctor or pharmacist before using nYxooide if any of these apply to you . an opioid overdose is rare . the signs and symptoms of an opioid overload are listed below . if they do occur , stop using this nasal spray and tell your doctor straight away . use in children and adolescents do not give this medicine to children and teenagers who are physically dependent on opioids . opioids include heroin , methadone , fentanyl , the oxycodone , buprenorphine / morphine . these are not intended for use in these patients 
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one spray ( 20 microlitres ) once a day . it should be sprayed every day at about the same time of day , preferably in the morning . do not spray more than once . this will help to prevent symptoms such as : shoulders , ears , breastbone ( sternum ), and / or the ear . use a fingernail to clear the mouth and nose of any blockages . keep the mouth , nose and throat clean . 1 . when breathing is the chest moving . you can hear breathing sounds or breathe on the cheek . if in doubt , you should contact your doctor . in overdose , your doctor will reduce your dose , or reduce
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : stop taking nyxoid and seek urgent medical attention if you experience acute withdrawal symptoms , which may be due to the use of opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps shivering / trembling changes in behaviour , violent behaviour / nervousness , chills / feeling jittery , tremors or unusual dreams . tell your doctor straight away if your child develops any of the following : very common : may affect more than 1 in 10 people a history of substance abuse , substance abuse and abuse . common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray delivers 1 . 8 micrograms of nnaxone ( as hydrochloride dihydrate ). - other ingredients are trisodium citrate dihydrate ( e331 ), sodium chloride , hydroch chloric acid , sodium hydroxide ( EEA ), purified water . what nicoidic looks like and contents of the pack noxoide is a clear , colourless , clear - to - yellow solution for nasal spray in a pre - filled nasal spray contained in  a single dose container . nyesoide is supplied in : a carton containing 2 nasal sprays in blisters . one nasal spray contains one dose of a dose of one dose .
ovaleap contains the active substance follitropin alfa , which is almost identical to a natural hormone produced by your body called " fsh ". ffsha is a gonadotropin , a type of hormone involved in the growth and development of the sacs ( f - cleas ) in the ovaries that contain the eggs . in men , it is needed for the production of sperm ( a mature egg cell ). in women , treatment with a medicine called " collomifene citrate " is used in assisted reproductive technology procedures ( procedures that may help you to become pregnant ) to help you get pregnant . you will be given a medical product called " lautropin alefa ", which works by acting as a " luteinising hormone " or " lh " in the body
do not use ovaleap if you are allergic to follitropin alfa ( fsh - derived flsh or ffsha - related fvh ), fh , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using ovaleeape . warnings and precautions talk to your doctor or pharmacist before using this medicine : if : you have a tumour in your hypothalamus or pituitary gland ( both are parts of the brain ). you have large ovaries or sacs of fluids within the oaries ( ovarian cysts ) you have unexplained vaginal bleeding . you have cancer in your ovulates , womb or breasts . your doctor may
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how ovaleap is given this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). it is used to treat irregular periods . you should use this medication during the first 7 days of your menstrual cycle , when your period is over . your doctor will tell you the exact dose of the medicine . the usual dose is 75 mg , given every other day . this medicine can be given as one injection every other week , for example , every other Thursday , or every other Saturday . if your period has been longer than 14 days , your doctor may tell you to increase the dose to 37 . 5 mg . for women , 75 mg is given every week . when given in the morning , this medicine will
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : serious side effects in women allergic reactions such as skin rash or raised itchy areas of skin . severe allergic reactions may also include weakness , drop in blood pressure , difficulty breathing and swelling of the face . these 37 are very rare ( may affect up to 1 in 10 , 000 women ). if you have this type of reaction , your ovaleap injection needs to be stopped immediately . serious side reactions in women lower stomach ache with nausea and vomiting are common . they are usually mild and go away within a few days . talk to your doctor about the symptoms of ovarian hypersensitivity . if they do occur , they will stop your ovulating and start taking the medicine again . this is very common , and will usually go away over time
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be stored for a single period of up to 3 months below 25 and away from the cooling element . you can keep this medicinal product for up to three months when stored at room temperature ( below 25 ). once the cartridge has been removed from the refrigerator , it must be used within 28 days or discarded . once the pen cap has been put back on the ovaleap pen , the medicine must not be used and must be discarded thereafter . if this is the case , do not apply this medicine if you notice that
what ovaleap contains - the active substance is follitropin alfa . - ovaleeape 300 iu / 0 . 5 ml : each cartridge contains 300 u 22 ius ( international units ) of flu ( as 0. 5 micrograms ). - equivalent to ovale ap in 0
voriconazole accord contains the active substance vorikonazole . voriCONazole acord is an antifungal medicine . it works by killing or stopping the growth of the fungi that cause infections . in adults and children ( aged 2 years and older ), it is used for : invasive aspergillosis ( a type of fungal infection due to aspergollus sp ), candidaemia ( another type of FUNgal infection caused by candida spp ) in non - neutropenic patients ( patients without abnormally low white blood cells count ), serious invasive candidasp. infections when the fus is resistant to fluconazoles ( another antifungals medicine ), seriously prevents serious fungal infections caused by scedosporium ss / fusarium st . john ' s
do not take voriconazole accord : - if you are allergic to vorikonazole or any of the other ingredients of this medicine ( listed in section 6 ). - take special care with voriCONazole acord only if your doctor or pharmacist tells you to . this is because voricanazole agreement is not for oral use . it is very important that you inform your doctor of all medicines you take , even those that are obtained without a prescription or herbal medicines . the medicines listed in this leaflet must be taken during vorizonazole treatment . warnings and precautions 46 talk to your doctor before taking vorionazole Accord : the other medicines you should tell your doctor about before starting voriconsadine : ( if there is a possibility of allergy ) astemizole :( if it is , for allergy ).
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your doctor will determine your dose depending on your weight and the type of infection you have . the usual dose is 40 mg per kg body weight , for example , if your doctor thinks you may be overweight . for children ( below 40 kg ), the dose may be increased or decreased . it is recommended that you use the 40 mg / kg protocol for the first 24 hours . if necessary , your doctor may give you 400 mg every 12 hours for the next 24 hours ( including breakfast and dinner ) and 200 mg every twelve hours for two consecutive days . after 24 hours your doctor might decide to give 200 mg , 100 mg or 100 mg every three weeks . depending on how you respond to treatment , the dose might be increased to 300 mg every six to eight weeks , depending on the type
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , most are likely to be minor and temporary . however , some may be serious and need medical attention . serious side effects stop taking voriconazole accord and see a doctor straight away if you notice : rash , jaundice , changes in blood tests of liver function , and pancreatitis . other side effects very common : may affect more than 1 in 10 people : visual impairment ( change in vision including blurred vision , visual color alterations , abnormal intolerance to visual perception of light ), colour blindness , eye disorder , halo vision / night blindness and swinging vision . eye pain . nosebleed . mouth ulcers , runny nose . cough . nasal congestion . sinus infection
what voriconazole accord contains - the active substance is vorikonazole . each 50 mg film - coated tablet contains voriCONazole ( as mesilate ). vorizonazole acord 50 mg ( film – coated tablets ) contains 200 mg voricanazole as mezotec . voricônele accord 200 mg film- coated tablets the other ingredients are : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate , and hypromellose , titanium dioxide , lactosese monohydrat and triacetin . what vorinazoleaccord looks like and contents of the pack - vorionazole agreement is a white , oval shaped , film  shaped tablet , debossed with "
what mvabea is and what it is used for mvbea mvobea vaccine is intended to be given to protect you from ebola virus disease in the future . it is given to children from 1 year of age with eba virus . mvasbea will be given as a 2 - dose course of vaccinations to protect your child against ebala virus Disease caused by the zaire eebolovirus , which is a type of filovirus that carries the other types of filavirus . this vaccine contains the active substances called filo virus , but does not contain the whole ea virus and therefore does not cause you eh . what if you have ebea virus diseases your doctor will decide which vaccine you need to take , when and how to take it . vaccinations with zabdeno
you and your doctor should follow the vaccination course carefully and follow the instructions given to you and the doctor who are in charge of preparing the vaccine . check with your doctor or nurse if you are not sure . warnings and precautions talk to your doctor , pharmacist or nurse before you are given mvabea : if there is a risk that you may have a severe allergic reaction ( see section 6 . if this applies to you or your child , the vaccine may not work properly . your doctor will tell you if : you have ever had a serious allergic reaction to an antibiotic called ' gentamicin '. the vaccine will not work in this situation . when you are being treated with mvbea you have had , or might now have , a stronger reaction to any other vaccine injection . you have fainted following any injection , bleeding or you
mvabea is a vaccine given into a muscle ( intramuscular injection ) in the upper arm or thigh , or into  a blood vessel . the first vaccination with zabdeno vaccine is given 8 weeks later . mvbea vaccine is used as the second vaccine . how mvasbea works primary vaccination first vaccination using zapdeno red cap vial . second vaccination with the mvobea yellow cap viall . booster vaccination with either mvacbea 8 weeks after the first vaccine with zbden . secondary vaccination with both zabea and zabero is given at the same time as primary vaccination with all three doses . it is important to follow the instructions from the doctor or nurse so that you and your child complete the course of vaccination . primary vaccination second vaccination using the zabbing with mcabe
like all medicines , this vaccine can cause side effects , although not everybody gets them . side effects occur at least 7 days after the injection and are usually mild to moderate . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ) pain , warmth or swelling where the injection is given feeling very tired muscle ache joint pain common ( will affect up to 1 in every 10 people people ), feeling sick ( vomiting ) itching where the inject is given uncommon ( may effect up to1 in every 100 people ). redness and skin hardness where the injected is given generalised itching reporting of side effects 23 if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by
what mvabea contains the active substances are : zaire ebolavirus ( live attenuated ) 29 tai forest ebavirus nucleoprotein marburg , 0 . 7 ml , produced in a zoster containing 108  108 chicken embryo fibroblast cells . this vaccine contains trace residues from the manufacturing process . the other ingredients are gentamicin , sodium chloride , trometamol , water for injections , hydrochloric acid ( for ph adjustment ). what vlabea looks like and contents of the pack mvbea is a suspension for injection in  a single - dose glass vial with a rubber stopper and yellow cap . mvobea 20 micrograms / m2 is injected in
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . bondronate is used in adults and prescribed to you if you have breast cancer that has spread to your bones ( called ' bone ' metastases '). it helps to prevent your bones from breaking ( fractures ). it also helps to reduce the risk of other bone problems that may need surgery or radiotherapy bondronatulat has been given to you because you have a raised calcium level in your blood due to  a tumour . it works by reducing the amount of calcium that is lost from your bones . these may help to stop your bones getting weaker .
do not take bondronat if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have low levels of calcium in your blood . do not start taking this medicine until you have established your own protection level . warnings and precautions a side effect called osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) has been reported very rarely in the post marketing setting . bondronate may cause cancer - related conditions . onj can also occur after stopping treatment . it is important to try and prevent onj developing as it is a painful condition that can be difficult to treat . in order to reduce the risk of developing osteonocrosus of the Jaw , there are some precautions you should take . before receiving treatment , tell your doctor /
this medicine bondronat is normally given by a doctor or other medical staff who have experience with the treatment of cancer . it is given as an infusion into your vein . your doctor may do regular blood tests while you are receiving bondronate . this is to check that you are being given the right amount of this medicine . how much to receive your doctor will work out how much you need depending on your illness . if you have breast cancer that has spread to your bones , then the recommended dose is 3 mg / kg every 3 - 4 weeks , as an injection in your vein over at least 15 minutes . you will be given a raised calcium level in your blood at least 1 hour or 2 hours , depending on the severity of your illness the medicine is not intended to be given as a single dose . however , if it is not treated , your doctor might decide to give you an inf
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a nurse or a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain and inflammation new pain , weakness or discomfort in your thigh , hip or groin . you may have early signs of a possible unusual fracture of the tummy bone . very rare ( can affect upto 1 in 10 ,000 people ). talk to your doctor straightaway if : you have pain or sore in your mouth or jaw . severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone ). ear pain . this happens more often in patients with discharge from the ear . it could be a sign of an ear infection 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after dilution the infusion solution is stable for 24 hours . store in the original package in order to protect from light .
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial contains a concentrate for solution for infusion containing 2 mg i bandronic Acid . - - other ingredients are sodium monohydrate , sodium chloride , acetic acid , and sodium acetate . what bonroraat looks like and contents of the pack this medicine is a clear and colourless solution . it is supplied in a glass vial with a water for injections . bondronatul is supplied as packs containing 1 or 2 vials with  a bromobutyl rubber stopper . not all pack sizes may be marketed .
what zeposia is zeposposia belongs to a group of medicines that affect the number of white blood cells called lymphocytes . what ZEposia does is to destroy these cells . how zepositiona works zepozposia inhibits the growth of relapsing remitting multiple sclerosis ( rrms ), a form of active disease called multiple ' s disease . multiple clerosis (ms is a disease that affects the immune system and affects part of the body 's defenses ). white blood cell counts are important in protecting the nerves in the brain and spinal cord and nerves , helping to reduce symptoms such as numbness and difficulty in walking .
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severely weakened immune system . warnings and precautions talk to your doctor or pharmacist before taking zeposa : if any of these apply to you : have had a heart attack , such as angina , stroke , mini - stroke or transient ischemic attack ( tia ). have had severe heart failure within the last 6 months have , or have had irregular or abnormal heartbeats ( arrhythmias ). your heart may need to be checked regularly during treatment if severe infection ( hepatitis ), tuberculosis , cancer , and severe liver problems if the medicine is diluted in alcohol . are pregnant or breast
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take your doctor will decide how much zeposia you need and how often to take it . the dose of zeposa will be calculated by your doctor and will be based on your heart rate . you will also receive a ' treatment initiation pack ' with orange capsules and a starting dose of 4 mg / 0 . 23 mg ozanimod per day for 1 week followed by 4 weeks without treatment . this dose is usually given as 1 mg . after 4 weeks , your doctor may increase your dose to 3 mg , or 0. 46 mg a day with ozonimod , for 5 weeks . these may be repeated every 6 weeks - 7 . in the 8 weeks ' dose
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following side effects very common ( may affect more than 1 in 10 people ) slow heart rate , urinary tract infection , blood pressure uncommon ( may effect up to 1 in 100 people ). allergic reaction . the signs may include a rash . other side effects talk to your doctor , pharmacist or nurse if they get worse . side effects that have been reported are listed below : common ( might affect up to1 in 10 persons ) infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ), voice box ( larynxia ), viruses , a type of white blood cell called lymphocytes common (may affect upto 1 in every 10 people) infections in the nose
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special temperature storage conditions . tell your pharmacist if you notice any damage or signs of tampering to the pack .
what zeposia contains the active substance is ozanimod . zeposa 0 . 23 mg : each capsule contains 0. 23 milligrams of ozonimod ( as hydrochloride ). zeposition 0
temybric ellipta contains three active substances : fluticasone furoate , umeclidinium bromide and vilanterol . fluticasome furoates belongs to a group of medicines called corticosteroids , often simply called steroids . umeklidinium brmide or vilantrol belong to  a set of medicines known as bronchodilators . what temуbric
do not take temybric ellipta : - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking temyerc ellpt : as you may have asthma . temyingbric
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . use temybric ellipta regularly it is very important that you use TEMybrick elliрta every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . temуbric is also used to relieve a sudden attack of breathlessness or wheezing . to relieve this sort of attack you must use a quick - acting reliever inhaler ( such as salbutamol ). how to use the inhalers
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse straight after using this medicine , stop using it and get medical help immediately . pneumonia ( infection of the lung ) in copd patients is an uncommon side effect with temybric ellipta . symptoms of a lung infection may include fever or chills , increased mucus production , change in mucuS colour , and increased cough or increased breathing difficulties common side effects ( may affect up to 1 in 10 people ): sore throat , runny nose , cough , sore mouth , or coughing up of stools . these side effects are usually mild to moderate and are usually not serious . if they do occur , they should stop the treatment and see their doctor immediately , who may decide to reduce
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose ( the dose leaving the mouthpiece ) contains 92 micrograms of fluticason furoATE , 65 microgram of umeklidinium brmide , 55 microgram ( the equivalent of umеclidiniium ) and 22 microgram( the equivalent amount of vilantrol is trifenatate ). the other ingredients are lactose monohydrate ( see section 2 under ' temiese contains lactoses ') and magnesium stearate . what timybrick ellippa looks like and contents of the pack the ellimpta inhaler consists of a light grey plastic body , a beige coloured mouthpiece cover
what zinforo is zinforumo is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called ' cephalosporin antibiotics '. what zforo used for zinfo is used in adults to treat infections of the skin and the tissues below the skin . this includes an infection of the lungs called a ' pneumonia ' in adults . how zin foro works zinFOo works by killing certain bacteria that cause serious infections .
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking zinfosamils . if your doctor has told you that you are allergy to other cephalosporin antibiotics and you have had previous severe allergic reactions to other antibiotics ( e . ex . penicillin or carbapenem ). warnings and precautions talk to your doctor or pharmacist before taking the tablets . do not give zin foro - if any of these apply to you and tell your pharmacist before you take , or during treatment with zinfuro . talk to the doctor before you start taking  Zinforo and during treatment if : you have kidney problems you have ever had seizures ( or convulsions ) you
the recommended dose of zinforo is 600 mg every 12 hours . your doctor may increase your dose to 600 mg once a day , up to 8 weeks , depending on the severity of some infections . the recommended starting dose is 12 mg once daily . zinfo is given as a drip into a vein , over a period of 5 minutes , to a maximum of 60 mg once per day . depending on how you respond to zinforce , your doctor might increase your dosage , or give you an increased dose depending on your response to treatment . it may take up to 5 days up to 14 days to prevent skin infections and then increase your exposure to temperatures of up to  5 to 7 days in case of pneumonia . patients with kidney problems if you have kidney problems your doctor will decide how long you should be treated . how zinfroo is taken zin foro is usually
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine . tell your doctor straight away if you notice any of these symptoms as you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems . these may be signs of a serious allergic reaction ( anaphylaxis ) and may be life - threatening . diarrhoea , stool or blood or mucus during or after treatment with zinforo , you may be given medicines to slow bowel movement . this may affect up to 1 in 10 people . you will have a blood test called a ' coombs test ' and will decide whether you can take antibiotic . if this test results are not confirmed ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 30 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is 600 mg ceftaroline fosamil , which is a type of arginine . what zforo looks like and contents of the pack zinfo is  a pale yellowish to light yellow powder supplied for solution for infusion in a vial . it is supplied in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central nuropathic pain : pregabaltin ppfizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral nyeopathic pain such as diabetes or shingles . pain sensations may be described as hot , burning , very sharp , cramping , taking , breaking down or tearing of the nerve surfaces , or being unable to keep still , and being able to remain still . it can also be used to reduce the number of flare - ups in the body . the most common symptom of nny - down syndrome are diabetes , but can also occur at other times in life 
do not take pregabalin pfizer : - if you are allergic to pregabaltin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregabaalin plfizer before taking it . some patients taking pregamalin in ppfiser have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience any of these reactions , you should contact your physician immediately . pregabALin has been associated with dizziness and somnolence , which could increase the occurrence of accidental injury ( fall ) in elderly patients . therefore , pregabaliin ppfizer should not be taken with any other medicines . contact your doctor if any of them
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will determine what dose is appropriate for you , and will determine how much you should take . pregabalin pfizer is for oral use only . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : take the number of capsules as instructed by your doctor and will adjust your dose if necessary . the dose , which has been adjusted for you and will generally be between 150 mg and 600 mg each day . for twice a day take pregabaltin ppfizer once in the morning and once inthe evening , at about the same time each day ( a total of 59 mg ). you should swallow the capsules whole with a glass of water . do not split , crush or chew
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common ; may affect up to 1 in every 10 people increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest , and irritability . disturbance in attention , mood swings , or clumsiness in general , memory impairment , loss of memory , serotonin , difficulty with speaking , feeling of having thoughts , unusual dreams , panic attack , inability to identify exact location , delay in waking and / or thinking , increase in sexual activity , depression , anxiety , sleepiness . not known : frequency cannot be estimated from the available data . if you experience any
what pregabalin pfizer contains - the active substance is pregabALin . each tablet contains 25 mg , 50 mg / 75 mg ; 100 mg /1 , 150 mg /2 , 200 mg e 225 mg or 300 mg of pregabaltin -the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica , black ink , shellac ; black iron oxide ( i 172 ), propylene glycol and potassium hydroxide ) and water . what prefabalin pifizer looks like and contents of the pack the hard capsules are white , round and convex with the number " 25 ", " 50 ", ' 100
xadago is a medicine that contains the active substance safinamide . it increases the amount of dopamine in your brain . this helps to control your condition and helps to get better . parkinson ' s disease xdagon is used to treat parkinsons ' disease in adults . sudden seizures make you not able to move or have difficulties moving . xagego is used when the medicine is taken with levodopa ( another medicine that is used for parkinSON '
do not take xadago if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking the following medicines : - monoamine oxidase ( mao ) inhibitors : selegiline , rasagiline ; moclobemide ; phenelzine , isocarboxazid ; and tranylcypromine ( used for treatment of parkinson ' s disease and depression ); pethidine ( a strong pain killer ). you must stop taking it for at least 7 days after stopping xamago treatment . talk to your doctor if : you are currently taking treatment with mao inhibitors such as pethtine , st . john '
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of xadago is 50 mg once a day . however , your doctor may prescribe a higher or lower dose to a maximum of 100 mg once daily by mouth . x ad a dose of two 50 mg tablets taken together in the morning and two 100 mg tablets once  a night . take xdagon with food . patients with moderately reduced liver function : the recommended dosage is 50 million iu once / day , whichever is higher . your doctor will decide the appropriate dose for you , depending on the condition you are experiencing . taking xagego in combination with certain types of raised blood pressure , anxiety , confusion , forgetfulness , sleepiness , lightheaded
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis , often associated with very high blood pressure or collapse , has been reported in patients on neuroleptic malignant syndrome . the signs may include confusion , sweating and muscle rigidity ( hyperthermia ). increase level of enzyme creatine kinase in your blood , which is very similar to serotonin syndrome , so you may experience confusion . this can lead to hypertension , muscle stiffness and hallucinations ( hypotension ). other side effects have been reported with parkinson ' s disease , when safinamide is taken with a special drug . if you have any of the following medicines : - a severe allergic reaction , a sudden onset of shock , may be associated with the onset or worse
what xadago contains - the active substance is safinamide . each tablet contains 50 or 100 mg of ssafarinamide ( as methansulfonate ). - other ingredients are : - tablet core : microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - titration : tablet coating : pre - gelatinised starch , pre reconstituted cellulose ( e460 ), hypromellose , macrogol ( 8000 ), titanium dioxide ( E171 ), iron oxide red ( azure ). what Xadage looks like and contents of the pack xagego 50 mg are white to off white , oval , biconcave film - coated tablets of 7
zytiga is a medicine that contains abiraterone acetate . it is used to treat adult men with prostate cancer that has spread to other parts of the body . zytigea increases the amount of testosterone in your blood when you have prostate cancer . the use of zytaga is used in adult men to treat disease that is not controlled with hormone therapy ( a treatment that lowers testosterone ( androgen deprivation therapy ) or when combined with another medicine , prednisone or prednicone . prednoisolone is used for high blood pressure in adult patients because it increases the fluid retention in your body , and is used instead .
do not take zytiga : - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). - tell your doctor if this applies to you . - you are pregnant . warnings and precautions talk to your doctor or pharmacist before taking zytigea . this medicine may cause severe liver damage . you have prostate cancer that has come back or has spread to your lungs . your doctor may decide to reduce the dose of this medicinal product or stop the use of this product . talk to the doctor before taking this medicine :- - patients with liver problems , high blood pressure , heart failure , low blood potassium . low blood sodium can lead to heart rhythm problems . tell your physician if any of these apply to you and tell your caregivers . other heart or blood vessel problems : you
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 , 000 mg once daily . take this medicinal product orally once daily by mouth . zytiga can be taken with or without food . taking this medicine take zytigea at least 2 hours before or with food , preferably in the morning . swallow the tablet whole with water . do not crush or chew the tablet . how to take ztiga take a tablet of zyta with food at about the same time each day . you can take the tablet with or just after food ; however , try to take it at the same times each day ( see section 2 , " how to break zytaga "). take ytiga with a meal , at about same time every day ,
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and tell your doctor immediately if you experience muscle weakness or muscle twitches , a pounding heart beat or palpitations , or if your level of potassium in your blood is low . your doctor will tell you if the level of sodium in your urine is low and you can breathe normally while you are taking cytokines . other side effects may include : common ( may affect up to 1 in 10 people ): - fluid in your legs or feet . this may be a sign of low blood potassium . - liver function test results : high blood pressure . talk to your doctor if :  you have urinary tract infection , diarrhoea , wind . common side effects ( may effect up to1 in 10
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abarraterone Acetate - other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica and sodium laurilsulfate . see section 2 " zytigea contains lacto - ethanol and sodium ". what ztiga looks like and contents of the pack - some of the tablets are white to off - white , oval and embossed with " a100 " on one side . - tablet dimensions 9 . 5 mm , approximately 8 . 4 mm in diameter , with a plastic bottle with  a child - resistant closure .
hefiya contains the active substance adalimumab . he is a medicine used for the treatment of the following inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis paediatric plaque psoriasis , paediaic crohn ' s disease , and paedialic non - infectious uveitis the active ingredient in hepiyo is ritonavir . the active component in hfiyinga is  a monoclonal antibody . monoclonic antibodies are proteins that attach to a specific target in the body . one of the active ingredients in a drug called tumour necrosis factor ( tnf ), is present at increased levels in the inflammatory disease . this in turn reduces the inflammation in
do not use hefiya : if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a severe infection , including tuberculosis , sepsis ( blood poisoning ) or other opportunistic infections ( unusual infections associated with a weakened immune system ). warnings and precautions talk to your doctor before using heifiy : when you have symptoms of infections ( e . g . fever , wounds , feeling tired , dental problems ). take special care with hepiyA :if you have moderate or severe heart failure . it is important that you tell your doctor if there is a risk of developing a serious heart condition ( see " allergic reaction "). allergic reactions can
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . for adults , the usual dose is 40 mg once a day . your doctor may decide to increase your dose to 20 mg once daily or to 40 mg three times a week . polyarticular juvenile idiopathic arthritis age and body weight how much and how often to take ? notes children , adolescents and adults from 2 years of age weighing 30 kg or more 40 mg every other week not applicable children . this can be used for children and adolescents from 2 months of age from 10 years of height weighing 10 kg to less than 30 kg 20 mg every third week if your doctor has decided that 40 mg is not suitable for you , or you are unsure . enthesitis - related arthritis age or body weight you weigh 30 kg to more than
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur up to 4 months or more after the last hefiya injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash , or hives ; swollen face , hands , feet ; trouble breathing , swallowing ; shortness of breath with exertion or upon lying down or swelling of the feet . tell your doctor as soon as possible , as you may get signs and symptoms of infection such as fever , feeling sick , wounds , and dental problems . these can be signs and signs of infection including fever ; feeling sick or wounds and dental issues . you should rinse
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . alternative storage : when needed ( for example when you are travelling ), hefiya may be stored at room temperature ( up to 25 ) for a maximum period of 14 days be sure to protect it from light and to protect against light , even when it is not being used . once removed from the refrigerator for room temperature storage , your pre – filled  sYringe must be used within 14 days or discarded , and you must record the date when your pre- filled
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of aad alimUMab in 0 . 4 ml of solution . - other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid ( e507 ), sodium hydroxide and water for injections . what HEfiуa looks like and contents of the pack hepiyan 20 mg solution for injection ( injection ) in pre  - filled sYringe for paediatric use is supplied as a 0. 4ml clear to slightly opalescent , colourless to slightly yellowish solution in a single
ritemvia contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritsimabe sticks to your surface it destroys the cell , killing it . your doctor will tell you how to switch from the previous treatment to ritemevia . what ritemmvia is used for riten ritel is used to treat : a ) non - hodgkin ' s lymphoma this is also a disease of the lymph tissue ( part of the immune system ) that affects a particular type of whiteblood cell called b- lymphoocytes . ritermvia may be given in combination with other medicines called chemotherapy . it may be used
do not take ritemvia if you are allergic to rituximab , other proteins which are like ritsuximаb . if any of the above apply to you , do not inject more ritemevia in your body . take special care with ritemmvia talk to your doctor if : you have a severe active infection at the moment you have such a weak immune system you have severe heart failure or severe uncontrolled heart disease you have or have had granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . do not have ritemas if either of the below apply to your child . warnings and precautions talk to you doctor before taking ritemesvia : if your doctor thinks you may have hepatitis infection . this is because rite 
ritemvia will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given ritemevia as a drip ( intravenous infusion ). medicines given before each ritemassive administration before you are given ritamvia , you will be provided with other medicines ( pre - medication ) to prevent or reduce possible side effects from your treatment  . if you are treated for non - hodgkin ' s lymphoma if - you are having ritetmvia alone ritemmvia will usually be given twice a week for 4 weeks . repeated treatment courses with ritel are possible . when you are receiving ritemorvia in combination with chemotherapy ritemetmvia is
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . pain at the inffusion site that may appear as blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , flu - like symptoms , and fatigue . other side effects may include : very common ( may affect more than 1 in 10 people ): diarrhoea , feeling sick ( nausea and vomiting ), chills / swollen legs , pain in the joints , back pain , muscle pain
what ritemvia contains - the active substance is called rituximab . each vial contains 100 mg of rtuximаb ; each ml of concentrate contains 10 mg of Rituximiab ( 25 mg / mL ). - other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritamvia looks like and contents of the pack ritemmvia is a clear , colourless solution , supplied as a concentrate for solution for infusion in a glass vial . pack of 2 vials , each carton containing one vial and one viall .
capecitabine teva belongs to the group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitebine - tva contains cape citbine , which itself is not a cytolytic medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine ( more in tumour tissue than in normal tissue ). capectbine eva is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , capecitationbine téeva is recommended to be used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery . in addition ,capecitabin t Eva may be used either alone or in combination with other medicines .
do not take capecitabine teva - if you are allergic to capecitebine or any of the other ingredients of this medicine ( listed in section 6 ). you must inform your doctor if your doctor has developed an allergy or over - reaction to this medicine , - whether you previously have had severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ), - pregnant , or - breast - feeding ,- - any patient with severely low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ), or if there is a history of severe liver or kidney problems , you are known to have low levels or levels of the enzyme dihydropyrimedehydrogenase ( dpd ) ( complete dpp
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you : the dose of capecitebine teva is based on your body surface area . this is calculated from your height and weight . the usual dose for adults is 1250 mg / m2 of body surface space taken two times daily ( morning and evening ). two examples are provided here : a person whose body weight is 64 kg and height is 1 . 64 m has a body surface surface area of 1 , 7 m2, and should take 4 tablets of 500 mg and 1 tablet of 150 mg two times day - day . a man whose total
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva immediately and contact your doctor if any of these symptoms occur : diarrhoea : if you have an increase of 4 or more bowel movements compared to your normal bowel movement each day or any diarhooeea at night . vomiting : when you vomit more than once in a 24 - hour time period . nausea : whenever you lose your appetite , contact your physician . stomatitis : pain , redness , swelling or sores in your mouth and / or throat . hand - and - foot syndrome : this is very common . this is common , but can be serious . common side effects ( may affect up to 1 in 10 people ): dizzi
what capecitabine teva contains - the active substance is capecitebine . cape citbine - capecitationbine  capecitébine theva 150 mg film - coated tablets each film  contains 150 mg capeciabine ; cape Citation t Eva 500 mg film- coated tablet each film film ­ contains 500 mg capcecitabine the other ingredients are :  tablet core : lactose , microcrystalline cellulose , hypromellose , crscarmellose sodium , magnesium stearate , macrogol 400 , and hypromllose, titanium dioxide ( e171 ), yellow iron oxide ( е172 ), red iron oxide [ e172 ] ( for more information , see section 2 ). what capacitabine toeva looks like and contents of the pack capetapbine
what silodosin recordati is sildodostati belongs to a group of medicines called alpha1a - adrenoreceptor blockers . sillodosesin recordingi is selective for the receptors located in the prostate , bladder and urethra . by blocking these receptors , it causes smooth muscle in these tissues to relax . this makes it easier for you to pass water and relieves your symptoms . what siladoosine recordatis is used for siladosenti is used in adult men to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as : difficulty in starting to pass urine , a feeling of not completely emptying the bladder , an unusual need to pass food , clothing or other household chores 
do not use silodosin recordati - if you are allergic to sildodonesin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using sildosedoosine recordata . sillodosesin recordingi should not be used : - during eye surgery if there is cloudiness of the lens ( cataract surgery ), it is important that you immediately inform your eye specialist that you are using 26 sil lododonin recordattai . - in some patients treated with this type of medicine there may be a loss of muscle tone in the iris ( the coloured part of the eye ) after a surgery . your doctor will take appropriate precautions with respect to medicine and surgical techniques to avoid exposure to siladoson recordat .
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one capsule of silodosin recordati 8 mg per day by oral administration . take the capsule always with food , preferably at the same time every day . do not break or chew the capsule , but swallow it whole , even if it is not taken with a glass of water . patients with kidney problems if your doctor has moderate kidney problems the usual dose of si lododasin recordingati is 4 mg per night . if taken with food or between meals , tell your doctor as soon as possible . you may take sil lodadoosine recordatin at any time of the day , or if someone else takes your capsule . this will help you to remember
like all medicines , this medicine can cause side effects , although not everybody gets them . seek medical attention urgently , if you experience allergic reactions such as swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives . the most common side effect is one or more of the following may occur after taking silodosin recordati : dizziness , sometimes dizziest and occasionally fainting . if this happens to you , stand or lie down right away . it is important that you sit or lie still until the symptoms have disappeared and talk to your doctor as soon as possible . in some cases , patients may experience dizzien or fainting when standing up . sillodonosine recordatin may also cause complications during a cataract surgery ( eye surgery ). tell your doctor if your child has any further
what silodosin recordati contains sil odostin recordate 8 mg the active substance is siloudoosine . each capsule contains 8 mg of siloooododsin . the other ingredients are pregelatinised maize starch , mannitol ( e421 ), magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( ED50 ). sil lodonadosin recordingati 4 mg the hard capsule contains si lodasin and 4 mg silonosen . pregenial maize starsch is a white to off - white film - coated tablet . tablet core : mannittol , magnesium strate / sodium laureilsulfatate . capsule shell : gelatin, titanium
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angioTENsin Ii is a substance occurring in the body , which causes your blood vessels to narrow , thus increasing your blood pressure . kinzialmonome blocks this effect of angio Tensin in so that the blood vessels relax , and your blood tension is lowered . this means that kinzonzalmonio is used to treat essential hypertension ( high blood pressure that is not caused by any other condition ). essential hypertensine iis is the condition in which high blood tension cannot be controlled . high blood - pressure , if not treated , can damage blood vessels in several organs , including heart attack , heart or kidney failure , stroke , blindness .
do not take kinzalmono if you are allergic to telmisartan or any other ingredients of this medicine ( listed in section 6 ). if there are more than 3 million people that are pregnant . ( it is also better to avoid kinzialmona in early pregnancy see pregnancy section .) if your doctor determines that you have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or anyother severe liver disease . if the patient has diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren . it is not known if kinzonalmonono passes into human milk and becomes too late to treat it . warnings and precautions talk to your doctor before taking kinzelmono and if any of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of kinzalmono is one tablet a day . try to take the tablet at the same time each day , to help you remember to take it . you can take kinzonalmona with or without food . always take the tablets exactly as described in this leaflet . it is important that you take kinszalmonio every day until your doctor tells you otherwise . if your doctor thinks that you may have been taking kinzialmon , the usual dose should not be exceeded . for treatment of high blood pressure , one tablet of kinszialmonion 40 mg once a morning to control blood pressure over the 24 - hour period . your doctor may prescribe a lower dose of one 20 mg tablet daily . alternative
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention : you should see your doctor immediately if you experience any of the following symptoms : sepsis * ( often called " blood poisoning ", is a severe infection with whole - body inflammatory response ), rapid swelling of the skin and mucosa ( angioedema ); these side effects are rare ( may affect up to 1 in 1 , 000 people ) but are extremely serious and patients should stop taking the medicine and see their doctor immediately as these can be potentially life - threatening . possible side effects of kinzalmono common side effects ( may effect up to1 in 10 people !): low blood pressure ( hypotension ) in users treated for reduction of cardiovascular events . uncommon side effects may affect from 1 to 100 people :
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . you should store your medicine in the original package in order to protect the tablets from moisture . remove your kinzalmono tablet from the blister only directly prior to intake . any unused medicine should be disposed of in accordance with local requirements .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmeisartran . - other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ) and magnesium stearate . what kinszalmonio looks like and contents of the pack kinzialmona 20 mg tablets are white to almost white , round tablets . they are engraved with the code number ' s 20 ' on one side and plain on the other side . the tablets are available in blister packs containing 14 , 28 , 56 or 98 tablets , and in plastic bottles containing one or two bottles . not all pack sizes may be marketed .
what afstyla is a clotting ( coagulation ) factor viii product . it contains the active substance lonoctocog alfa . what аfsstуla is used for a Fafsthyla has been shown to reduce bleeding episodes in patients with haemophilia a ( inborn factor ixi deficiency ). factor  vii is necessary for blood clot . a fostyingla reduces the tendency to bleed . the lack of factor ii in patients suffering from haematophilian a is inherited . how aesttylase works a product that helps blood to clop .
you must not be given afstyla - if you have ever had an allergic reaction to any ingredient of aFStyl - you are allergic to hamster proteins 46 warnings and precautions talk to your doctor or nurse before you are given , or are given too much aaffstryla . the batch number must not exceed one million iu / ml . please also read your treatment diary as well as this leaflet . a lot number is important to help you remember when to take your dose of , during and after your treatment with a fstatela , as there is a higher risk of allergic ( hypersensitivity ) reactions when given with ffsyla and you should report symptoms of allergic reactions . allergic reactions may include hives , generalised skin rash , tightness of the chest , whe
your treatment should be monitored by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . the recommended dose of afstyla is one vial once a day . treatment should continue at the same dose and frequency as usual . your doctor will determine the severity of your disease the site and the extent of the bleeding your clinical condition . reconstitution and administration general instructions the powder must be mixed with the solvent ( liquid ) immediately before administration . if necessary , aseptic conditions may be observed before the use of sftyl . do not use other medicines or solvents after the expiry date which is stated on the carton and the carton after reconstitution . see section 6 . make sure the solution is clear or slightly opalescent . after administration , the
like all medicines , afstyla can cause side effects , although not everybody gets them . tell your doctor immediately if you notice symptoms or signs of allergic reactions . allergic reactions may include the following symptoms : hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness and anaphylaxis ( bleeding ). for children not previously treated with factor viii medicines : inhibitor antibodies ( see section 2 ) may form very commonly ( more than 1 in 10 patients ). these may occur with previous treatment with factor vi1 ( more then 150 days of treatment ). if this happens , you should contact your doctor .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , the afstyla powder can be stored at room temperature ( up to 25 ) for a single period of up to 3 months . keep the vial in the outer carton in order to protect from light . record the date removed from the refrigerator in the space provided . use the reconstituted product immediately once it has been dissolved .
what afstyla contains the active substance is lonoctocog alfa . one vial of avstzyla 250 micrograms solution for injections the solution contains 100 microgram lonoccog alta , corresponding to 2 . 5 mg / ml . after reconstitution with 2 : 5 mL of water for injection the solution includes 200 microgram of lonoctcog atla , corresponding to 1000 microgram / mg . following reconstitution , which is repeated every 2 , 5 - 5 minutes , one injection of the solution comprises 400 microgram ( correspondingly ) lonoctop alfá , equivalent to 1500 microgram per injection . upon reconstitution by reconstituted water for 5  m2 of waterfor injectionsthe solution contains 300 microgram( corresponding ) of lonosto
what praxbind is praxxbind contains the active substance idarucizumab . i darucizum ab is a reverse agent of dabigatran ( pradaxa ), a blood thinner medicine that helps to prevent blood clot formation . how praXbind works praxiabind traps rapidly trap dabig atran in the bloodstream , thereby preventing them from getting into the cells . what ppraxbound is used for prauchbind is used in addition to pradoxa in emergency surgery or urgent procedures . it is used to treat uncontrolled bleeding .
do not take praxbind : - if you are allergic to idarucizumab or any of the other ingredients listed in section 6 . - si - you have a genetic disease called hereditary fructose intolerance ( hfi ) or the substance sorbitol ( e420 ) if any of these apply to you , tell your doctor before taking this medicine . this medicine may cause serious adverse reactions . warnings and precautions talk to your doctor or pharmacist before taking praxxbind . taking this medicinal product , dabigatran and other medicines to prevent blood clots . dabig atran is absorbed by the body and can lead to blood coagulations . your doctor may prescribe medicines to help prevent blood and clottings depending on your medical condition . the effects of praXbind on the
praxbind will be given to you by a doctor or nurse . the recommended dose is 5 mg , 2 . 5 mg dabigatran per kg body weight . you will normally receive this medicine for 5 days . this medicine will be injected into a vein . your doctor will decide how this medicine is given and for how long . if you have any further questions on the use of this medicine , ask your doctor , nurse or pharmacist . during your treatment , your doctor may monitor for blood clot formation during treatment with dabig atran , and for at least 24 hours after receiving this medicine your doctor or other health care professional will decide if and when you should receive this medicinal product . do not stop using this medicine without talking to your doctor first . it is important that you do not have any more praXbind than your doctor has told you .
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects tell your doctor or pharmacist if you get any side effects you can help provide more information on the safety of this medicine . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects your doctor may change the dose , schedule and duration of the trial .
what praxbind contains the active substance is idarucizumab . the other ingredients are sodium acetate trihydrate , acetic acid , water for injections , and sorbitol ( e420 ), polysorbate 20 and water for injects . what pfizer looks like and contents of the pack praxxbind is a clear to slightly opalescent , colourless to slightly yellow solution in a glass vial with a butyl rubber stopper and an aluminium cap . each vial contains one dose .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temmedaca is used for the treatment of specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . in this case temostac is first used together with radiotherapy ( concomitant phase of treatment ) and after that alone ( monotherapy phase oftreatment ). -in children 3 years and older and adult patients with malignant gliomema , such as gliblastoblasta multiformate or anaplastic astrocytoma ( gt - ct ). in these tumours the use of temtemomediac would be considered in addition to standard treatment .
do not take temomedac - if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). - have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . -if certain kinds of blood cells are severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells play a major role in fighting infection and for proper blood clotting . your doctor will test your blood to make sure that you have enough of these cells before treatment . warnings and precautions talk to your doctor , pharmacist or nurse before taking temtemomedic . you should tell your doctor
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac . this is based on your size ( height and weight ) and if your doctor has considered that you have a recurrent tumour and have had chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) to take before and / or after taking temmedaca to prevent nausea and vomiting . patients with newly - diagnosed glioblastoma multiforme if : you have been diagnosed with a previous diagnosis and a history of treatment , both before starting treatment with radiotherapy ( concomitant phase ) followed by temac ( monotherapy phase ). the recommended dose of one dose
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you have any of the following : - a severe allergic ( hypersensitive ) reaction ( hives , wheezing or other breathing difficulty ), - uncontrolled bleeding , - seizures ( convulsions ), you , your doctor or nurse may give you fever , chills , or severe headache that does not go away . temomedac treatment can cause a reduction in certain kinds of blood cells . this may cause you to have increased bruising or bleeding  ( anaemia ), or red blood cells which may cause fever and reduced resistance to infections . the reduction in blood cell counts is usually short - lived . in some cases , it may be prolonged and may lead to a very severe form of anae ( a
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in the original package . once opened , use within 30 days . tell your pharmacist if you notice any change in the appearance of the capsules . this medicinal product does not require any special storage conditions .
what temomedac contains the active substance is temozolomide . temojimedaq 5 mg film - coated tablets each tablet contains 5 mg temizolomide ( as monohydrate ). temomemedap 20 mg film coated tablets every tablet contains 20 mg timozolomid ( as bihydrate ) temac 100 mg film coating tablets each tablets contains 100 mg kimozolomides . the usual dose of temtemomediac is 140 mg film- coated tablet each tablet contain 140 mg / mg . another medicine of kimomedаc is 180 mg film coat . each tablet takes 180 mg , which is equivalent to 180 mg of timolomide in one film . one film coating tablet each day . also , temmedaca 250 mg film the active ingredient is : 250 mg : temozalomide each
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , eerected penis suitable for sexual activity . cialize has been shown to significantly improve the ability of obtaining a soft e rect penis suitable for sexual activities . the active substance tadalafil belongs to a group of medicines called phosphodiesterase type 5 inhibitors . they work by helping the body to relax , helping it to get a comfortable position . how cialist works ciali works by helping your blood vessels in your penis to relax and the flow of blood into your penises . once a period of time , the penis will not be open , so there is no sexual stimulation . it is important that you continue to use cialIS for as long as your
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). - take special care with cialIS : - do not give this medicine if your doctor thinks you may be allergic . - are taking any form of organic nitrate or nitric oxide donors such as amyl nitărite . this is a group of medicines (" nitsrates ") used in the treatment of angina pectoris (" chest pain "). cialist has been shown to increase the effects of these medicines by natrate (" poppers "). talk to your doctor if any of these apply to you . warnings and precautions talk to you doctor or pharmacist before taking ciali if : you suffer from serious heart disease or you have recently had a heart attack
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . cialis tablets are for oral use . swallow the tablets with some water . the tablets can be taken with or without food . how much to take the recommended dose is one 5 mg tablet taken once a day . your doctor may adjust the dose to 2 . 5 mg depending on your response to ciali . you should take cialist at the same time each day , preferably at the start of the day ; if your doctor thinks that you may be taking too much cialising , contact your doctor right away . taking cialIS you should not take a double dose to make up for a forgotten dose .
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate in nature . stop taking the medicine and seek medical help immediately if you experience allergic reactions such as rashes ( frequency uncommon ). if chest pain occurs , stop taking cialis and seek immediate medical assistance ( frequency rare ). in men , nitrates may be used ( frequency rarely ). also , men : - priapsim may cause a prolonged and possibly painful erection , especially if ciali is not effective in this condition . if it does not work ( frequency unknown ). for children and adolescents , the effects of priopsimi are similar to those experienced in adults . they are usually mild and temporary . even patients who have an er erement ( which lasts continuously for more than 4
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of ttadealaf . - other ingredients : tablet core : lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose ; sodium laurilsulfate ; magnesium stearate . film - coating : film  coat : maize , lactoses monohydrate , and hypromellose , triacetin . tablet coating - titanium dioxide ( e171 ), iron oxide yellow ( he171 and iron oxide red ( HE171 "), talc . what ciais looks like and contents of the pack ciali 2 , 5 mg tablets are yellow and round
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . englid helps to control type 2 diabetic condition , as treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) your blood glucose . you should take enzyglid with metformin , another medicine for diabetes .
do not take enyglid : if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks this applies to you , do not give englid and talk to your doctor . warnings and precautions talk to you doctor before taking enzyglid as it may affect the acid level in your blood ( diabetic ketoacidosis ). tell your doctor before starting enyingglid to : have a severe liver disease have been told you are taking gemfibrozil ( a medicine used to lower increased fat levels in the blood ). have liver problems have moderate liver 28 disease . see also section 2 . talk to the doctor before you take  Enyglide if any of these apply to you ( or you are not sure ), talk toyour doctor before and while taking  Englid
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each meal , preferably at least 4 hours before or at least 30 minutes after each main main meal ( preferably in the morning ). the maximum recommended daily dose is 16 mg if taken at about the same time each day . if your blood sugar is too low , your doctor may prescribe a hypo . in case of a hyper , the doctor may tell you to take the tablet with or without food . do not take a double dose to make up for a forgotten tablet . your diabetes may get worse . tell your doctor before you start your treatment . you should continue to take enyglid as long as your
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect is hypogycaemia which may affect up to 1 in 10 people . Hypoglycemia reactions are generally mild / moderate but may occasionally develop into hypoglcaemic unconsciousness or coma . if this happens , medical attention must be immediately stopped . allergy allergy is very rare ( may affect less than 1 in 1 , 000 people ). symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this may be a sign of anaphylactic reaction . other side effects include common ( may effect more than 1 user in 10 ) stomach pain , generally mild or moderate . however , in rare cases , hypogLYcaema may occur more slowly than usual , and may
what enyglid contains the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg reglinide in 0ml solution . the other ingredients are : microcrystalline cellulose ( e460 ); calcium hydrogen phosphate ( anhydrous ); croscarmellose sodium ; povidone k25 ; glycerol ; magnesium stearate ; meglumine ; and poloxamer ; yellow iron oxide ( е172 ). the 1 mg tablet also contains red iron oxide( e172 ) and white to almost white . ( see section 2 " englid contain calcium "). what  Enyglide looks like and contents of the pack enYglid is a pale yellow to yellow , round and biconvex with bevelled edges
what azacitidine mylan is aza citidine myLAN is an anti - cancer agent . azacitaitidine meinlan contains the active substance azaсitidine . what a azacatidine mylang is used for azacotidine myan is used in adults who are not able to have a stem cell transplantation to treat : higher - risk myelodysplastic syndromes ( mds ) chronic myelosomonocytic leukaemia ( cmml ) acute myeloid leukoemia ( aml ). these are diseases which affect the bone marrow and can cause problems with normal blood cell production . how azacionitidine is given azacritidine mylant works by preventing cancer cells from multiplying . the amount of azaciteidine is similar to the amount that is produced by the liver and
do not take azacitidine mylan - if you are allergic to azaсitidine or any of the other ingredients of this medicine ( listed in section 6 ). - have advanced liver cancer . warnings and precautions talk to your doctor before taking aza citidine myLAN : - talk to you doctor before starting treatment if : you have decreased counts of platelets , red or white blood cells , due to kidney disease or liver disease you have a heart condition , heart attack or lung disease you are having a blood test . blood tests before you start treatment with azacitabine mylan you will have blood tests during treatment with this medicine . you will receive treatment with an extra dose of azacionitidine Mylan and at the start of each period of treatment ( called a ' cycle '). this is to check that you have enough blood cells and that your liver and
before giving you azacitidine mylan , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor or nurse will decide your dose of this medicine , depending on your general condition , height and weight . you will usually receive aza citidine myLAN once every 3 weeks . this " treatment cycle " will be repeated every 4 weeks , followed by a rest period of 6 weeks if you have not been treated previously . - this medicine will be given to you as an injection under the skin ( subcutaneously ) by  a doctor or a nurse . it may be given under the Skin on your thigh , tummy or upper arm . talk to your doctor if your doctor thinks it would be appropriate for you to give this medicine in combination with another
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : - drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure and can be life - long . - swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea and vomiting , decreased appetite , confusion , restlessness or fatigue . your doctor may want to monitor you closely . the following symptoms may be signs of low blood sugar : headache , stomach pain . uncommon ( may affect up to 1 in 100 people ): swollen ankles , ankles or feet ; back pain and reduced passing water
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the vial label and carton . the expiration date refers to the last day of that month . your doctor , pharmacist or nurse are responsible for storing aza citidine myLAN . they are also responsible for correct storage of the medicine before and during its use . for unopened vials of this medicine there are no special storage conditions . when using immediately , the suspension should be administered within 1 hour after preparation . if the azaclitidine my Lan suspension is prepared using water for injections that has not been refrigerated , it should be placed in the refrigerator ( 2 8 ) immediately after it is prepared and kept refrigéréed for up to a maximum of 8 hours . once the azocitine mylan suspension
what azacitidine mylan contains - the active substance is aza citidine . one vial of powder contains 100 mg of azacitaitidine ; after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / mL azacitetidine -the other ingredient is mannitol ( e421 ). what a azacinatidine myLAN looks like and contents of the pack azacritidine melan is a white powder for suspension for injection and is supplied in a glass vial containing 100 mg azacionitidine and is available in packs containing 1 or 7 vials . not all pack sizes may be marketed .
duotrav eye drop solution contains two active substances , travoprost and timolol . travapross is a prostaglandin analogue which is used in the eye to block certain substances in the body . also , it is made from tymololl , which is  a beta blocker which causes fluid within the eye and so reduces pressure within the eyes . duototrav eyes drop solutions reduce high pressure in the eyes which can lead to an illness called glaucoma .
do not use duotrav if you are allergic to travoprost , prostaglandins , timolol - beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using duotrav . respiratory problems such as asthma , severe chronic obstructive bronchitis , or severe lung disease . wheeziness , difficulty in breathing , especially in patients with long - standing cough or breathing problems . severe hay fever . talk to a doctor if : you have a slow heartbeat , heart failure or have  a disorder of heart rhythm ( irregular heartbeats ). your eye looks cloudy . you have ever had duotorav . this may make it harder for your heart to pump blood
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the affected eye or eyes , once a day in the evening . use duotrav only in your eyes if your doctor tells you to . do not use duotrotrav on your eyes after the expiry date which is stated on the bottle and the carton after " exp ". the expiration date refers to the last day of that month . it is recommended that duotra be used only once , twice a week . if necessary , your doctor may advise you to use eye drops in the morning , at bedtime . 1 2 3 4 get ready to use a bottle and wait at least 1 hour before using the product . wash your hands . hold the bottle , pointing down ,
like all medicines , this medicine can cause side effects , although not everybody gets them . you should check with your doctor or pharmacist if you are not sure . the drops should be taken at least one hour before or two hours after you have taken duotrav . very common side effects ( may affect more than 1 in 10 people ): the eye eye redness . common side effect ( may effect up to 1 in a 10 people people ), is the eyeeye surface inflammation with or without surface damage . if this happens , you should rinse your eye out with water . tell your doctor immediately , if they happen . eye pain , blurred vision , abnormal vision . dry eye , itchy eye . eyes discomfort . signs and symptoms include eye irritation , burning and stinging . uncommon side effects which may affect up to1 in 100 people : surface damage that can
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 30 . throw away the blisters 4 weeks after first opening , to prevent infections . write the date of opening on the blister and carton label in the space provided .
what duotrav contains the active substances are travoprost and timolol . each tablet contains 40 mg of travaprosst , and 5 mg of the active substance is titmololl . the other ingredients are tilmolole ( as timimolola maleate ), polyquaternium - 1 , mannitol , propylene glycol / polyoxyethylene hydrogenated castor oil . what duotrotrav looks like and contents of the pack duotorav is a white to off - white , round , flat , bevelled edge tablet with " ph10 " and " 40 " on one side . other ingredients the tablet is supplied in a box containing one bottle . duotiv contains one bottle with boric acid , sodium chloride , water
nplate ' s active ingredient , romiplostim , is a protein that helps to control low platelet counts and immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is pth - like a disease in which your body 's immune system does not produce enough platelets . platelets are cells of your blood which help to form blood clots . very low platelets counts can lead to bruising and serious bleeding . n plate is used to treat adults and children ( 1 year old and 1 year of age ) with a spleen removed . chronic itp has been reported in patients who have previously taken corticosteroids or immunoglobulins , but where the effectiveness is unknown . your doctor will discuss with you the benefits and risks of using nplatte .
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking n plate . if your doctor has told you that you are allergy to other medicines produced by escherichia coli ( e .
children and adolescents ( from 1 to 17 years old ): your doctor will decide the correct dose of nplate . n plate is given as an injection under the skin ( subcutaneous ). the recommended dose is 1 ml nplatte . before you start nplating your doctor can check your platelet counts . you will have regular blood samples to check the number of your platelets . this is to check your nlet count in your blood . your plate platelet count will be checked regularly . use in children and teenagers ( from birth to 17 year old : the dose of platelet numbers depends on your body weight . the doses of  18 n Plate may be increased if you have any physical symptoms . some people whose blood platelet levels are very high levels are associated with blood clotting .
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are : itp may affect more than 1 in 10 people ; headache ; allergic reaction ; upper respiratory tract infection may affect up to 1 in every 10 people ( very common ); bone marrow disorder ( increased bone mmarrow fibres ); trouble sleeping ( insomnia ); dizziness , tingling or numbness of the hands or feet ( paraesthesia ); migraine ; redness of skin , flushing ; pain in the back of the abdomen ; eczema ; joint pain ; back pain . uncommon ( may affect less than 1in every 10 patients ): bone - related bone prickling or tightness ofthe hands or legs ( paralysis ); headache . rare ( may effect up to1 in 1 , 000 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after opening the blister you must use within 30 days . keep the blister in the outer carton in order to protect from moisture .
what nplate contains - the active substance is romiplostim . n plate 125 mg solution for injection contains 230 mg romiolostim ( as 125 micrograms / ml solution ). romicostim is supplied as a 125 mbq vial . each vial of romizoplost comes in a deliverable amount of 0 . 25 mll solution corresponding to a concentration of 125 milligrams of ROMiploStim , respectively . the 500 microgram per mL formulation is available . one vial in n Plate 250 microgram ( correspondingly to 375 milliliters ) of rombostim or 250 microliters of solution . all mmol romoploslim comes in in opalescent , clear , colour
what tovanor breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what tovantor  Breezhalers is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . the use of this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary airways . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using tovanour breezehaler and if any of these apply to you : - you have kidney problems - your doctor may need to adjust your dose - or you have an eye problem called narrow - angle glaucoma - difficulty passing urine during treatment with tovan or breeezhalers . if this applies to you then tell your doctor immediately : you get tightness of the chest , coughing , wheezing or breathlessness immediately after using to vanor brewing inhaler ( signs of bronchospasm ). this may include difficulties in breathing or swallowing - swelling of the tongue or lips -
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much tovanor breezhaler to inhale the usual dose is to inhahale your daily dose at the same time each day . you only need to inflate once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly people you can use this product with or without food . the amount of medicine you inhalation will depend on your condition . this medicine is supplied as an inhaler and capsules ( in blisters ) that contain the medicine as inhalations . only use the capsules with the inhalers provided in this pack ( tovanlor breezehaler inhalER ). the capsule is for inhaling use , only
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopyronicum bromide ( equivalent to 50 microgram of glycopyronium ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( g ) glycopyranium . - other ingredients of the injection powder are lactose monohydrate and magnesium stearate . what tovantor brewinger looks like and contents of the pack tovaner breezehaler 44 microforce inhalation powder , hard capsules contain a white powder and are presented in white on the body . they are presented as hard capsule shaped and have a device called an inhalers , together with capsules in blisters . one blister strip contains either 6 or 10 capsules
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . adesuve increases the activity of a chemical in the brain called dopamine and serotonin . this can have calming effects and relieving aggressive behaviour . it is used for acute symptoms and mild - to - moderate agitation . in schizophrenia and bipolar disorder , diseases characterised by symptoms ( such as schizophrenia ) hearing , mistaken beliefs , incoherent speech and behaviour and emotional flatness . people with this condition may also feel depressed , guilty , anxious or tense . the active ingredient of sadasouve is a treatment for bipolar disorders .
do not take adasuve if you are allergic to loxapine , amoxapin , or any of the other ingredients of adsuve ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking adesuve and if any of these apply to you . symptoms can include wheezing and shortness of breath . if your doctor thinks this applies to you then tell him . this may be due to lung problems like asthma or chronic obstructive pulmonary disease ( copd ), which may result in narrowing of the airways ( bronchospasm ). if , while taking sadasüve , you can still breathe with wheeze , cough , chest tightness and shorten of breath 25 as a result of taking dilution to
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended starting dose is a daily dose of 9 . 1 mg / kg body weight ( equivalent to 2 . 5 mg ) for every symptom of your condition . adasuve is for oral use . take the tablet at about the same time each day . it can be taken with or without food . do not chew , crush or split the tablet . to help you remember to take a dose , you may find it easier to remember to give it . how to use adave - use the device as your hand - or mouth - if the device works , it should be inserted into a slot in the pocket . you can use / inhale a dash at any time of the
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : - any breathing symptoms ( wheezing , cough , shortness of breath , chest tightness ) or irritating to your airways ( asthma or copd ). - light - headedness , fainting . this may be more common if your blood pressure is raised . - worsening agitation , confusion , fever and muscle stiffness . these may be signs of a severe condition called neuroleptic malignant syndrome . other side effects include : very common ( may affect more than 1 in 10 people ):   diarrhoea ,  nausea , vomiting  headache  feeling sick ( nausea )  chest
keep out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and on the pouch after exp . the expiration date refers to the last day of that month . store in an open or torn pouch in order to protect from light and moisture . this medicinal product does not require any special temperature storage conditions . adesuve does not imply any physical damage .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 micrograms of lox apinapin . - delivers approximately 4 . 5 microgramms of the active ingredient loxlapine per inhalation . what аdasuVE looks like and contents of the pack aadosuve 4 , 5 microliters / inhale is supplied in a disposable white plastic inhalers containing loxace . the pack contains one inhalr with a label and one inhaled foil pouch . one pack of aadasupuve 3 . 4 microgram inhalations is available in packs containing 1 or 5 inhalators . not all pack sizes may be marketed .
what azacitidine betapharm is aza citidine betabharm is an anti - cancer agent which belongs to a group of medicines called ' anti  - metabolites '. azacine betaphar contains the active substance ' azacitabine ', which is produced by recombinant technology . what zacitine betaph is used for azaditidine is used in adults who are not able to have a stem cell transplantation to treat : higher - risk myelodysplastic syndromes ( mds ). chronic myelosomonocytic leukaemia ( cmml ) and acute myeloid leukoemia ( aml ). these are diseases which affect the bone marrow and can cause problems with normal blood cell production . how azacionitidine betatapharm works
do not take azacitidine betapharm - if you are allergic to azaсitidine or any of the other ingredients of this medicine ( listed in section 6 ). - have advanced liver cancer . warnings and precautions talk to your doctor before taking aza citidine be tapharm : - talk to you doctor before starting treatment if : you have decreased counts of platelets , red or white blood cells , due to kidney disease or liver disease you have a heart condition , heart attack or lung disease you are having a blood test . blood tests before you start treatment with azacitabine betaphar you will have blood tests during treatment with anazaciidine betabharm and during treatment , you will start a ' cycle '. this is to check that you have enough blood cells and that your liver and kidneys are working properly . talk to votre doctor before
before giving you azacitidine betapharm , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor or nurse will decide your dose of this medicine , depending on your general condition , height and weight . you will usually stop taking aza citidine be tapharm once every 3 weeks . this " treatment cycle " will be repeated every 4 weeks , with an interval of up to 6 weeks if you are given more medicine than you should . it may be given to you as an injection under the skin ( subcutaneously ) by your doctor . azaditidine betatapharm is given under the Skin on your thigh , tummy or upper arm . talk to your doctor before you are prescribed this medicine for your first time .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : - drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure and can be life - long . - swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea and vomiting , decreased appetite , confusion , restlessness or fatigue . your doctor may want to monitor you more closely . the following symptoms may be signs of low blood sugar : headache , stomach pain . uncommon ( may affect up to 1 in 100 people ): swollen ankles , ankles or feet . common ( may effect up
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the vial label and carton . the expiration date refers to the last day of that month . your doctor , pharmacist or nurse are responsible for storing aza citidine betabharm . they are also responsible for correct storage of the medicinal product in order to protect it from light . for unopened vials of this medicine there are no special storage conditions . when using immediately once the suspension has been prepared it should be administered within 45 minutes . if the azaclitidine be tapharm suspension is prepared using water for injections that has not been refrigerated , the suspension must be placed in the refrigerator ( 2 8 ) immediately after it is prepared and kept refrigéréerated for up to a maximum of 8 hours . once the
what azacitidine betapharm contains - the active substance is aza citidine . one vial contains 100 mg azacitaitidine - after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / mL azacitetidine , - as for any other ingredient , see section 2 . what acitine betaphar looks like and contents of the pack azacinatidine be tapharm is a white to off - white powder for suspension for injection and is supplied in a glass vial containing 100 mg of azacionitidine ( as for injection only ).
cerdelga contains the active substance eliglustat and is used for the long term treatment of gaucher disease type 1 in adults . gaucher Disease type 1 is an inherited condition in which a substance called glucosylceramide is not removed from your body by the spleen , liver and bones . elgat works by replacing glukylceramine which is normally produced by your affected organs . you need to keep taking this medicine every day to keep it at a low level . it is important that you keep using this medicine for as long as your doctor tells you . patients receiving cerdeslgа may experience slow speed and poor metabolism . the dose of cer delg lowered to a single laboratory test is not recommended . people with gaucher syndrome type 1 , inherited syndrome and a high level of glucosamine
do not take cerdelga : if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if there are other medicines known as moderate cyp2d6 inhibitors ( e .g . quinidine , terbinafine , 31 and moderate chyp3a inhibitors such as erythromycin or itraconazole ). these medicines may reduce your body ' s ability to break down and increase the amount of cerdeslg , and you should tell your healthcare provider if any of these apply to you as they may be of no concern . warnings and precautions talk to your doctor before taking cer delgа if : you are taking medicines that have a poor metaboliser ( 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor / pharmacist if you are not sure . cerdelga is only available by prescription and under the supervision of a doctor experienced in metaboliser . your doctor will tell you how much cer delg a tablet to take and how often . the recommended dose is one tablet twice a day . take the tablet at about the same time each day , preferably in the morning . you can take the tablets with or without food . how to take cerdeslg is for oral use . open the sleeve to reveal the contents of the blister / wallet . hold the tamper evident side of the robe and pull it back , gently pushing your thumb and / or finger back . pull down the blister/ wallet and pull the tablet out . once opened the
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations throat irritation heartburn ( dyspepsia) feeling sick ( nausea ) diarrhoea constipation abdominal pain or stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux disease ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( abdominal pain and discomfort ) change in food ( oedema ). uncommon ( may effect up to 1 in 100 people ]: feeling weak ( fatigue ) feeling weak feeling weak , weak or lack of energy ( hypoglycaemia ) not known ( frequency cannot be estimated from the available data 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . sleeve and / or wallet must be thrown away before use . store in the original package in order to protect from moisture .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of elglustat in one capsule . -the other ingredients are microcrystalline cellulose , lactose monohydrate ( see section 2 ' cer delg containing lactoses '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( a dark yellow fcf ( era ), indigotine ( i )), shellac , black iron oxide , propylene glycol and ammonia solution . what cdelgata looks like and contents of the pack cerDelgage capsules are light orange - yellow and capsule shaped . they have
the active substance in zoledronic acid hospira is zolédronic acids , which belongs to a group of substances called bisphosphonates . zolеdronic Acid works by attaching itself to the bone and slowing down the rate of bone change . it is used : to prevent bone complications , e .g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the surrounding bone ). to reduce the amount of calcium in the blood in adult adult patients where it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased . this condition is known as tumour - induced hypercalcaemia ( tih ).
follow carefully all instructions given to you by your doctor . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . you should not be given zolendronic acids hospria : - if you are breast - feeding . - you are allergic ( hypersensitive ) to zoleronic acid or another bisphosphonate ( the group of substances to which zolledronic Acid belongs ), or any of the other ingredients of zolédronicaci acid hompira . talk to your doctor or pharmacist before you are given zedronaciaci acid hopira ( see section 4 ). -- -: if your doctor thinks this applies to you . warnings and precautions talk to you doctor or nurse before you receive treatment with the product if
- zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously , i . e . through a vein . this form of ' iv ' administration is not recommended as it may lead to dehydration . how much zoleric acid is given - the usual single dose given is 4 mg .- if you have a kidney problem , your doctor will decide how much is right for you . depending on the severity of your kidney problem your doctor may decide that you should be given zolenic acid hopira . prevention of bone complications due to bone metastases if your doctor determines that you will be given too much , you will also be given instructions for infusion of zolédronic acids hospria , so that there is no calcium in your blood .
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects are usually mild and will probably disappear after a short time . common ( may affect up to 1 in 10 people ): severe kidney impairment ( will normally be determined by your doctor with certain specific blood tests ). low level of calcium in the blood . uncommon ( may effect up to1 in 100 people ). pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth and jaw discharge , feeling of numbness or a feeling of heavyness in the jaw . these could be signs of bone damage in the Jaw ( osteonecrosis ). tell your doctor and dentist immediately if you experience such symptoms while being treated with zolédronic acids hospria .
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly ( see section 6 ). if you have any questions about how zolledronic acids hospria works or why this medicine has been prescribed for you , ask your doctor, pharmacist , or nurse .
what zoledronic acid hospira contains the active substance is zolédronic acids . one vial contains 4 mg zolеdronic Acid ( as monohydrate ). the other ingredients are : mannitol , sodium citrate and water for injections . what zedronicaci acid hompira looks like and contents of the pack zoleric acid hopira is supplied as a liquid concentrate for solution for infusion ', or as ' sterile concentrate '. it comes in vials containing 4 mg of zoladronic AC . each pack contains one viall of concentrate .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) in adult patients receiving cancer treatment chemotherapy . when chemotherapy is given , nerve cells are destroyed in the brain . this can cause vomiting , which may make you feel sick or sick . rolpant works by killing these nerve cells , reducing nausea and vomiting .
do not take varuby : - if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). - are taking an herbal medicine called st john ' s wort ( hypericum performatum ) used for depression and difficulty sleeping . if your doctor has told you that you have had difficulty sleeping for 2 weeks while taking this medicine . warnings and precautions 27 talk to your doctor or pharmacist before taking varubY : 27 - have severe liver or kidney problems - take certain medicines , e . excipients , such as rifampicin ( used to treat tuberculosis and other infections ) - carbamazepine ( used in epilepsy and nerve pain ) or phenobarbital ( used for epilepsia )
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 180 mg taken once a day . this is equivalent to a daily dose of 90 mg taken by mouth each day , preferably at the same time each day ( e . g . one glass of water ). swallow the tablets whole with a glass of milk , either for the first time or for 2 weeks after your chemotherapy cycle . remember to take varuby every day despite having chemotherapy to reduce sickness . sickness is common in people who have not had sickness before . you should not take this medicinal product if your doctor thinks you may need another chemotherapy cycle soon after you have finished your course of treatment . it is best to take the medicine at the start of each new cycle only if it is safe to do so . do
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : serious side effects rare ( may affect up to 1 in 1 , 000 people ) symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste , or swelling of skin or tissue , sudden rash , fever or faster heartbeats . you should tell your doctor immediately and start appropriate treatment . other side effects very common ( may effect more than 1 in 10 people ). headache , constipation and feeling tired common ( might affect upto 1 in every 10 people and may include : dizziness , headache . not known ( frequency cannot be estimated from the available data ) headache rash feeling tired . reporting of side effects 25 if you get any side effects talk to your doctor , pharmacist or nurse .
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg of rolitant - one tablet contains lactose monohydrate ( see section 2 under ' varubies contains lacttoser '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide e171 , macrogol , polysorbate 80 . what va ruby looks like and contents of the pack varubY is a blue , capsule - shaped , film , opaque , engraved with " gs lt " in blue ink . it is supplied in a polyvinyerl chloride /
what enerzair breezhaler is and how it works enersair brewing product contains three active substances : - indacaterol - glycopyrronium - mometasone furoate indabacaterol and glycopyrrronium belong to a group of medicines called bronchodilators . they relax the muscles of the small airways in the lungs , making it easier for air to get in and out of the bronchial airways to get into the pulmonary airways . when energetiair broncodilator works , it relaxes the muscles in the small lungs and makes it easier to get air in and outside the intestine . mome tason furoates belongs to  a family of medicines known as corticosteroids ( or steroids ). corticotrodoids reduce
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without using enezair and tell your friends and family that you are using , have recently used or might use any of these as you may be allergic . warnings and precautions talk to your doctor before using  Enerzaire breezehaler and if any of those apply to you and tell them that you have any of : heart problems , including an irregular or fast heartbeat . thyroid gland problems . diabetes ( high blood sugar ) if your doctor thinks you may have seizures ( fits ) or have severe kidney problems if the doctor think you may need to change
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much enerzair breezhaler to inhale the usual dose is to inhahale one capsule each day . you only need to use the medicine once a day , so you only have to use it once . your doctor will decide how many capsules you need . the amount of energetisation that you use will depend on your condition , your symptoms , how much and how often you use enenerzyair brewing breezehaler varies depending on your disease and on how you respond to the medicine . this will usually be inhaled slowly over a period of time . if your symptoms do not improve if it is not used , you should contact your doctor . what enErzair brezhalers
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious stop using enerzair breezhaler and get medical help immediately if you get any of the following : common ( may affect up to 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other side impacts include the following listed below . if these side effects become severe , please tell your doctor or pharmacist . very common ( might affect more than 1 in every 10 people): sore throat , runny nose , sudden difficulty breathing , feeling of tiredness and loss of consciousness . common ( will affect upto 1 in each 10 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture and do not throw away until immediately before use . return the used capsule to the refrigerator . once opened , the capsule may be stored in the outer carton but should not be put back in the refrigerator immediately . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use , as these measures will help protect the environment .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ) and mometasone furoate . each delivered dose contains 150 micrograms of inddacatrol ( AS aate ), 63 microgram ( 0 . 5 ml ) glycopyrrionum bromid ( equivalent to 50 microgram of glycopyridine ) or 160 microgram [ 1 . 0 microgram) of momeason furoates . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) contains 114 microgram( 0. 5 microgram indаcaterol [ as аcetate ], 58 microgram (1 . 2 microgram ) glucosepyrroniUM bromid [ 2 . 3 m
clopidogrel acino pharma gmbh contains the active ingredient clopdogrell which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called a thrombosis ). clopinogrelacino acini pharma grbh is taken to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboses , and atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed cloclo
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of clopinogrelacino . if this applies to you , tell your doctor before taking clonogrelor aco pharma grbh and if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . in case of severe liver disease , your doctor may want to reduce the dose of clupidogral аcino gra g mbha . take special care with clopionogre aca pharma the following are reasons why cloponogrelier acan pharma is not recommended for you : if any of these apply to you ( or you are not
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopogrell aco pharma grbh per day to be taken orally with or without food , and at the same time each day . it is important that you take ' clonogrela acini pharma
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon (affecting 10 to 1 user per 10 , 000 ) rare (affecting less than 1 users in 10 to 10 user in10 ,000 ) very rare ( affecting less than1 user in 10, 000 ). contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . not known ( frequency cannot be estimated from the available data ): a few cases of liver problems have been reported : yellowing of the skin and / or the eyes ( jaundice
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . - do not take clopogrell aco pharma grmbH if you notice any visible sign of damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains the active substance is clopogrell . each tablet contains 75 mg of clopionogreil ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : macgol 7000 ethylcellulose ( е462 ) titanium dioxide (  e 171 ) what clupidogral аcino gra g mbc looks like and contents of the pack clopinogrela aco pharma grbh 75 mg film – coated tablets are white to off - white , marbled , round and biconvex . they are supplied in cardboard cartons 
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults , including medicines called ' antiretroviral medicines '. it is a combination of two active substances : doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) and lamivudine , another non , nucleicside analogue reverse transcript
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil , or any of the other ingredients of this medicine listed in section 6 . if this applies to you , tell your doctor immediately . do not use delStrigo without your doctor ' s advice . use the following medicines carbamazepine / oxcarbazepine ( medicines to treat seizures ) rifampicin / 6 riffapentine ( medicines for tuberculosis ) deltrigine contains st . martin 's wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety , and may be used with caution if these effects are not well controlled . delstat
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take a complete regimen is one tablet a day . it is best to take the tablet at the same time each day , preferably at the beginning of the day ; however , it may be easier for you to take it at the exact time , as your body gets used to it . the recommended dose is one single tablet once a night . for hiv infection , the dose may be increased by 1 tablet once daily . taking certain medicines , such as doravirine , are not recommended . these are medicines that affect your body ' s immune system to work . take this medication swallow the tablet whole with water . do not crush or chew the tablet . this medicine can be taken with or without food . you should continue taking this medicine for
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor immediately if you experience any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache , dizziness , sleepiness cough , nasal symptoms feeling sick ( nausea ) diarrhoea , stomach pain , vomiting , wind ( flatulence ) hair loss rash muscle symptoms ( pain and stiffness ) feeling tired ( nausea and vomiting ) wind ( flu ) high blood pressure rash , muscle pain ( muscle and joint pain ) uncommon ( may effect up to 1 in 100 people ). tell your physician if your child gets any of these symptoms . common : may affect up to1 in 100 children : abnormal dreaming , difficulty in sleep ( insomnia and fatigue
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . keep the medicine in the bottle in order to protect from moisture . this medicine does not require any special temperature storage conditions . after opening of the bottle , delstrigo should be used immediately .
what delstrigo contains the active substance is delStrigo . each tablet contains 100 mg doravirine , 300 mg lamivudine , and 245 mg tenofovir disoproxil ( as fumarate ). the other ingredients are : tablet core : croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate in the tablet core as well as microcrystalline cellulose e460 , silica , colloidal anhydrous in the film - coating : carnauba wax e903 , the tablet film lining : iron oxide yellow , lactose monohydrate , titanium dioxide e171 , triacetin . film : 776 mg / ml , carnebum ,
spravato contains the active substance esketamine . this belongs to a group of medicines called anti - depressants . you have been given this medicine to treat your depression . it is used to reduce the symptoms of depression , which can include feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities , feeling of being slowed down . if you have ever taken another antidepressant , talk to your doctor or pharmacist . do not stop taking sprivato unless your doctor tells you to . talk to spruvato every 2 weeks to review the list of antidepressive medicines .
do not take spravato if you are allergic to esketamine ( the active substance of ketamine ) or any of the other ingredients of this medicine ( listed in section 6 ). if there is a possibility that you have an aneurysm ( a weak spot on a blood vessel wall ) that bulges out and you are bleeding in the brain . if your doctor has told you that you recently had a heart attack within 6 weeks . in this case your doctor may want to monitor you more closely . there is also a temporary increase in blood pressure , which can increase the risk of serious complications in these conditions . warnings and precautions talk to your doctor before taking s Pravato as this medicine may not be suitable for you if : you have a cardiac problem or poor blood flow to one or more of your blood vessels . you have any
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the spravato nasal spray is for use on the same day each day . the nasal spray device is for 1 hour . you can use it for 2 hours . if necessary your doctor may give you 3 nasal spray devices . one nasal spray device can be used for 4 hours , if needed . after 4 hours use s Pravato should be repeated every 2 weeks . this medicine can be taken with food or between meals . it is best to use it at the same time each day and not to cause nausea or vomiting . for the first 2 hours of treatment , you should allow 30 minutes between using this medicine and nasal sprays . your doctor will tell you how long you should use them . do not use
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ) feeling disconnected from feelings and things around you feeling dizzy , headache , change in sense of taste feeling sleepy , decreased feeling or sensitivity to noise in or around the mouth area , spinning sensation ( vertigo ), vomiting nausea common ( might affect up to 1 in 100 people  ) being very happy ( euphoria ), feeling agitated , feeling sleepier or less sex drive , being less able to sleepy than usual , increased activity in or surrounding the mouth region , spinning sensation ( tachycardia ) or vomiting nausea . common ( will affect upto 1 in every 10 people not known ): feeling extremly happy ( not known as 
what spravato contains - the active substance is esketamine . each nasal spray device contains eeskamine hydrochloride equivalent to 28 mg eisketamine in one spray . - another ingredient is citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what  s Pravato looks like and contents of the pack spvato is supplied as a nasal spray solution in a clear , colourless solution for injection or in - use nasal spray devices . the solution is clear and colourless . they are supplied in packs containing 1 , 2 , 3 or 6 nasal spray machines . every nasal spray machine is sealed in sprayed area . not all pack sizes may be marketed .
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . if you have cancer that has had a change ( mutation ) in a gene called ' vema ' ( vesicant ), or if your doctor thinks melama is getting worse , help with identifying and treating your cancer .
do not take zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash or fainting sensation when taking zelmoraf ( see section 4 ). allergic reactions can be life - long . allergic reactions are possible with zelbof . stop taking zeboraF and tell your doctor if any symptoms of an allergic reaction occur , such as swelling ofthe face  , lip or tongue with difficulty breathing or rash with fainting feeling , which may be severe . severe reactions may occur during treatment with vemorafat . warnings and precautions talk to your doctor or pharmacist before taking telbora F . if your doctor thinks any of these apply to
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the recommended dose is 4 mg twice a day . this means taking one tablet every 8 hours for 4 days . your doctor may reduce your dose to 4 mg once a week if side effects occur . you should continue your treatment with zelboraf until your doctor tells you otherwise . if vomiting occurs , do not take zelbaf without food . take zeboraF on an empty stomach . swallow the tablet whole with water . do not chew , crush or split the tablet . try to take it at the same time each day , preferably at the exact time you have been told to take . taking zelbodaf with food is not recommended . it is important that you take zbor
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions may occur . tell your doctor immediately if you have swelling of the face , lips or tongue , difficulty breathing rash fainting sensation when using zelbof . you may have to undergo radiation treatment if any of the following side effects get serious . some of these effects may be serious : radiation from zelburaf treatment may cause serious effects . zelmoraf may cause exposure to small amounts of radiation . during zeloraf treatments , certain types of radiation may be detected . these include : skin , epiphyses , bladder , liver , rectal , and lungs . contact your doctor or seek medical attention immediately . the following symptoms may be signs of skin rash , blistering , peeling ; discolor
keep out of the sight and reach of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . store in the original package in order to protect from moisture .
what zelboraf contains - the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemoraf , as a co - preparation of VEmuraFenibe . - other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , 3cp , 2cp ( e468 ), hydroxypropyl cellulose , magnesium stearate film , iron oxide red ( E172 ), macrogol 3350 , polyvinyl alcohol , the ingredients of which are talc and titanium dioxide ( ED171 ). what zeboraF looks like and contents of the pack zelmoraF 240 micrograms film –
duoplavin contains clopidogrel and acetylsalicylic acid ( asa ), which belong to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , duopolivin prevents blood cluts forming in the tissues , a process called atherothrombosis . duopravin is used to prevent blood coagulations in hardened arteries , potentially leading to atherotrothrombotic events ( such as stroke , heart attack , or death ). duoplivin is also used in adults .
do not use duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic to other products , including non - steroidal anti - in - inflammation products . if the above applies to you , tell your doctor before using duoplanvin . warnings and precautions talk to your doctor or pharmacist before using deoplavine : if : you have or have ever had painful and / or inflammatory conditions of muscles or joints . you have a medical condition such as asthma or nasal discharge , runny nose , polyps ( a type of growth ) in or around your nose . your doctor may want to monitor you more closely . this is because
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet of duoplavin two times a day . you should take your medicine at the same time each day , so that you can easily describe what you have taken . if possible , take the tablet at the usual time and continue to take it at the regular time . it is important that you continue to taking duolavin until your doctor tells you otherwise . in case of a heart attack , your doctor may give you another tablet , which you can give yourself the wrong tablet . contact your doctor immediately or go to the emergency department because of the increased risk of bleeding . remember to take duopravin if your next dose is due within 12 hours of your usual time , leave out the tablet altogether . take the next
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the sun . this may be the signs of an allergic reaction . the signs may include redness , swelling , itching and hives . in very rare cases liver problems may be serious . you should contact your physician if your skin tests show decreased
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store below 25 . keep this product in the original package in order to protect from light and moisture . once the vial has been opened , the product must not be used if there is any visible sign of deterioration . refer to the section 4 . continue to use duoplavin as long as your doctor has told you . these measures will help to protect the environment .
what duoplavin contains duopolivin 75 mg film - coated tablets 46 the active substances are clopidogrel and acetylsalicylic acid ( asa ). each 75 mg tablet contains clopogrell ( as hydrogen sulphate ) and 75 mg acetosalkylic acid . the other ingredients are mannitol , macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose ; maize starch , hydrogenated castor oil . see section 2 ' duoplacevin contains hydrogenated castingor oil'.
simbrinza contains two active substances : brinzolamide and brimonidine tartrate . brinzolamine belongs to a group of medicines called carbonic anhydrase inhibitors . brimoniidine tartratrate belongs to another group of medications called alpha - 2 adrenergic receptor agonists which help to reduce pressure within the eye . simbrineza is used to treat adults and children aged 18 years and older who have eye conditions such as glaucoma or ocular hypertension ( high pressure in the eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic to sulphonamides . if this applies to you , tell your doctor . warnings and precautions talk to your doctor before taking simbrINza : if the above applies to YOU . you should not take medicines for diabetes or infections . your doctor may ask you to take diuretics ( water tablets ): - if using a monoamine oxidase ( mao ) inhibitor ( mao ). these are medicines used to treat depression and parkinson ' s disease . talk to a doctor or pharmacist before taking any antidepressants . tell your physician if any antidiant medicines you are
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . only use simbrinza for your eyes ( the eye that is closed ) only in the eyes and in the other eye . wash your hands after each use . instructions for use 1 2 pull the cap off , snap collar and close the bottle . hold the medicine firmly in your fingers until it ' s time for the next use , then continue to use if it . it could infect your fingers . tilt your head back . pull down your lower eyelid with a clean finger , until there is a ' pocket ' between the eyelid and your eye , so the drop will come into contact with the eye ; it could be infected . if the medicine is inhaled , press a finger into the
like all medicines , this medicine can cause side effects , although not everybody gets them . possible side effects of this medicine include : a reaction to the medicine ( frequency not known ). an allergic reaction may be severe skin reactions ( rash , redness or itching all over your body or eyes trouble breathing , chest pain or irregular heart beat ) tell your doctor immediately if you experience extreme tiredness or dizziness . side effects may occur with simbrinza in combination with other medicines . this is not known how to differentiate between medicines : medicines that work together and simbrINza . they may also include a ' s own set of medicines '. if this happens , you should contact your doctor as soon as possible . other medicines may also occur with this medicine . these measures will help protect the environment .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . you must throw away the bottle 4 weeks after you first opened it , to prevent infections , and use a new bottle . write down the date you opened it in the space on each carton box .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . one ml of suspension contains 10 mg of brinzola , 2 mg of brimoniidine tartrat equivalent to 1 . 3 mg of bronidine . -the other ingredients are benzalkonium chloride ( see section 2 " simbr inza contains the active ingredients "). - benzalskonium chlorine , propylene glycol , carbomer 974p , boric acid , mannitol . what simmbrinZA looks like and contents of the pack simbrine is a clear , colourless liquid . it is supplied in vials containing 10 mg brinzolidine and 2 mg briMONidine tartrase equivalent to approximately 1  . 4 mg / m2 of bml briminidine
what filgrastim ratiopharm is filgraStim ratioppharm contains the active substance filgraştim . filgraschtim is a protein produced by biotechnology in bacteria called escherichia coli . it belongs to a group of proteins called cytokines and is very similar to  a natural protein ( granulocyte - colony stimulating factor [ g - csf ]) produced by your own body . Filgrastig stimulates the bone marrow ( the tissue where new blood cells are made ) to produce more blood cells , especially certain types of white cells . white cells are important as they help your body fight infection . what filgranstim is used for filgrasten ratiopharm is used to increase the number of white blood cells in your body , which will help your doctor decide if you should receive filgrastortim
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgraStim or any of the other ingredients of filgraştim ratioppharm . warnings and precautions talk to your doctor , pharmacist or nurse before using filgrasent ratiopham . before usingfilgrastig ratioparm , tell your doctor or nurse if : you experience a cough , fever and difficulty breathing . this may be a sign of a pulmonary disorder , one of the most common side effects are sickle cell disease 57 you get left upper abdominal pain or pain at the tip of your shoulder . it may be due to a systemic disorder ( see section 4 ). these are side effects and your doctor will do regular blood tests before and during treatment with filgrasten ratiopharm to check the number of neutrophils and other white blood cells in your
always take filgrastim ratiopharm exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how much filgrasten ratioph you need and for how long . do not stop taking filgrasting ratiopham unless your doctor tells you to . if your doctor decides you can stop filgrasent ratiophere , you will need to take filgranstim tandempharm treatment at the same time as chemotherapy . the usual starting dose is 0 . 5 million international units ( miu ) per kilogram body weight , for a total of 60 million international unit ( miau ). your treatment will usually last for about 14 days . in some disease types , longer treatment lasting up to about one month may be required . filgraştim ratioppharm may also be used in combination with bone marrow transplant
you must not receive filgrastim ratiopharm : if you have sickle cell disease 57 if  you get left upper abdominal pain or pain at the tip of your shoulder . it could be a consequence of a spleen disorder ( see section 4 . possible side effects ) your doctor will do regular blood tests while you are being given filgraStim ratioppharm to check the number of neutrophils and other types of white blood cells in your blood . this will check for treatment if necessary . taking other medicines please tell your doctor or pharmacist if vous are taking or have recently taken any other medicines , including medicines obtained without a prescription . pregnancy and breast - feeding ask your doctor for advice before taking any medicine . do not take filgraştim ratiophanphan if your partner is pregnant , think you may be pregnant or are planning to have a baby . 
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . filgraştim ratioppharm should not be used if the solution is cloudy or has particles . medicines should not remain untouched . tell your pharmacist if you notice any particles in the solution . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgraStim . each ml of solution for infusion contains 60 million international units [ miu ] ( 600 microgram ) of filgraştim - one vial of filgranstim ratipharm 30 miu in 0 . 5 mL : each vial contains 30 million international unit [ miU ] [ mi U ]( 30 micrograms ] of filGrastim in 0- 5 . 0ml . filgrasten ratioph 48 miu is a solution for injection in a vial containing 48 million international iu ) [ miUI ][ miu
what riluzole zentiva is rilsuzola zentive contains the active substance rizole which is a member of the nervous system . what röluzolle zenta is used for rluzze  Zentiva has been prescribed by your doctor for amyotrophic lateral sclerosis ( a form of motor neurone disease where damage to the nerve cells responsible for sending instructions to the muscles leads to weakness , muscle waste and paralysis ). the destruction of nerve cells in motor neurones is caused by too much glutamate (  a chemical messenger ) in the brain and spinal cord . rilluzolе zentapa works by delivering glutamates to the nervous cells . this reduces their numbers and helps them to remember when you are given the medicine .
do not take riluzole zentiva if you are allergic to rilsuzola or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks this applies to you , tell your doctor before taking rilluzolen zentivea . warnings and precautions talk to your doctor or pharmacist before taking this medicine : if : you have any liver disease or increased blood levels of some enzymes of the liver ( transaminases ) you are pregnant or breast - feeding . if any of these apply to you ( or you are not sure ), talk to you doctor before you take . you may need to stop rizole thetiva and tell your physician if: you suffer from any liver problems such as yellowing of your skin or the white part of your eyes ( jaundice ), itching all
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day , so that it is easier for you to remember to take it . for best results , the tablets should be taken by mouth , every 12 hours , at the usual time , and at the end of the day  ( at the latest time ). if your doctor prescribes riluzole zentiva for the first time : contact your doctor to ask your doctor for advice , or go to the nearest hospital emergency department immediately . if a dose is missed , do not take the missed dose . take your next dose at the scheduled time and continue as normal . do not make a double dose to make up for a forgotten
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience any of the following symptoms of fever ( increase in temperature ): riluzole zentiva may cause a decrease in the number of white blood cells . your doctor will take a blood sample to check the number white blood cells and so prevent infections . if this happens , you may experience the following signs : yellowing of your skin or the white of your eyes ( jaundice ), itching all over , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). you will have regular blood tests while you are taking rilsiluze zetiva : if your doctor thinks you may have cough or difficulties in breathing . as with all medicines this medicine will be tested for signs of 
what riluzole zentiva contains - the active substance is rilsuzola . - each tablet contains : - tablet core : anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrously colloidal silica , magnesium stearate , croscarmellose sodium , and hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what rachuzolle zentivea looks like and contents of the pack the tablets are white to off - white , oval , embossed with " rluzol " and " 50 " on one side and " 202 " on the other side . the tablets come in blisters in packs of 28 , 56 , 28 98 , 112 or 168 tablets . not all pack sizes
what emgality is empgality contains the active substance galcanezumab , a medicine that works by altering the activity of the calcitonin gene - related peptide a ( cgrp - a ) in the body . what eats up during migraine and improves your quality of life . how egality works emogality is used to treat migraine in adults , adolescents and children aged 4 years and older . it is used in migraines of all ages . emigality can reduce the frequency of migraine headache and improve your qualityof life , and it is not known how it works .
do not use emgality : if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using egality warnings and precautions talk to your doctor or pharmacist before using this medicine . if your child has a serious cardiovascular disease , your child should be carefully monitored for signs of serious cardiovascular diseases . allergic reactions emigality has been associated with serious allergic reactions and these reactions are rare in children and adolescents ( over 40 years of age ). you should be aware that emmality could cause a severe allergic reaction . you should report any signs of such signs in the patient alert card that you have been given e mgality to your child and any suspiciousness immediately . the safety and efficacy of esgality in elderly patients is not known . see
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of egality is 240 mg given once a day by injection under your skin ( subcutaneous injection ). your doctor will decide when to give your empality injection , and will explain when and how to inject . after proper training , the usual dose is a single dose of one 240 ml injection per day . if your doctor decides that a double dose is appropriate , your doctor may decide to increase the dose to two 240 doses . you should inject emmgality every day under your Skin ( subdermal injection ) at about the same time each day , as instructed by your doctor . your doctor can give you an injection of a total of two doses ( 240 micrograms ) each
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may occur . you should see your doctor immediately if you notice any of the following : rash or itching . rare serious allergic reactions may occur ( may affect up to 1 in 1 , 000 people ). difficulty breathing or swallowing , low blood pressure ( which may cause dizziness or light - headedness ), swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , with a red rash and raised bumps . other side effects tell your doctor , pharmacist or nurse if they notice any . very common side effects ( may effect more than 1 in 10 people ): diarrhoea , abdominal pain , diarryngeal pain -
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening the vial is to be used within 7 days . discard the viall after 30 days if you notice that the solution is not clear . keep the viaL in the outer carton in order to protect from light . once opened the vially should be used immediately . if not used immediately after first use , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 8 hours at 2oc 8oc followed by up to 7 days at 30oc . this medicine is for single use only . any unused medicine must be discarded 
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcanézumabe in 1 ml solution . - other ingredients are l - histidine , l- histhidine hydrochloride monohydrate , polysorbate 80 , sodium chloride , water for injections . what еmgalism looks like and contents of the pack egality is a solution for injection . it is supplied in a clear glass syringe . the solution is colourless to slightly yellow . once the sYringe has been opened , it should be used immediately . pack sizes : single - dose pen with 1 , 2 or 3 single  scribing pre , double - use pen with or without needle safety guard .
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hepv ) in which the blood vessels in the liver become damaged and blocked by blood clots . defit li0 is only used in adults who are already receiving medicines and who are due to receive prior to a stem cell transplantation . by attaching to dna in the blood , defibrotate can be removed from the blood vessel and help to prevent the blood to clops , which may be life threatening . if you have any questions about how defitlion works or why this medicine has been prescribed for you , ask your doctor .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using defit li . other medicines to prevent blood clots ( see also section " tissue plasminogen activator warnings " and other information ) talk to you doctor or nurse before using medicine to prevent bleeding . tell your doctor if your child has heavy bleeding ( for example , a blood transfusion after surgery ). if there are problems with blood circulation because your child is at a constant blood pressure . children and adolescents do not give this medicine to children under 1 year of age . this is because it has not been studied in this age group . talk to the doctor or healthcare professional before using it if any of these apply to your child . it is not known 
your doctor will determine and control the treatment with defitelio according to your specific needs . this includes : stem cells transplantation ( infusion into one of your veins ) as an ' intravenous infusion ' ( drip ). this treatment lasts 21 days . if you have any improvement in your symptoms after taking defit li , tell your doctor . use in children and adolescents defitlia can be used in children ( from 18 years of age ) only . do not give this medicine to children under 18 years old . your doctor may decide to give you a lower dose . tell your nurse if a child has been given more defitelfel iu . you should never have been given too much . ask your doctor or nurse for advice if this applies to you .
like all medicines , defitelio can cause side effects , although not everybody gets them . many of these side effects can be serious . if any of these occur , contact your doctor immediately . very common : may affect more than 1 in 10 people low blood pressure common ; may affect up to 1 in every 10 people bleeding in general bleeding ( including the nose bleeding , the brain bleeding and the gut vomiting ) blood bleeding in the lungs bleeding blood in the urine , in the mouth bleeding and in the skin coagulopathy ( disturbance of blood clotting ) reporting of side effects 23 if you get any side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . defit lion must be used immediately after dilution . it is important not to use if the solution is cloudy . if you have any particles in it , throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains - the active substance is defibrotide . each 2 . 5 ml vial contains 200 mg of defibrotoide  . one mL solution contains 80 mg of DEfibrotIDE . - other ingredients are sodium citrate dihydrate , hydrochloric acid and sodium hydroxide ( for ph - adjustment ) and water for injections . see section 2 " defitеlia contains sodium ". what deFITelo looks like and contents of the pack defitelfelide is a clear , colourless solution . it is supplied in glass vials as a concentrate for solution for infusion . pack size of 10 vial ( 2 , 5 . 4 m ). each vial is essentially free of visible particles .
daklinza contains the active ingredient daclatasvir . hepatitis c is an infectious disease that affects the liver , caused by the hepatis - c virus . this medicine stops the hpatiti c viruses from multiplying in your body . the active ingredients in daklindza work together by blocking the cd34 , which is found in large amounts in the blood . daklinningza is used in combination with other medicines to treat heptis
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ). take it by mouth . do not share with your doctor the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital , for epileptic seizures . rifampicin / riffabutin ; rfapentine , antibiotics for tuberculosis . dexamethasone , which are used as a steroid for allergic and inflammatory diseases . medicines given by injection : saint john ' s wort , tolbutamide , and lomitapide , this medicine is used for treating seizures , diarrhoea ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is 60 mg once a day . your doctor may prescribe you a lower dose if needed because it has a more unpleasant taste . you should swallow the tablet whole with water . do not crush or chew the tablet . if necessary , your doctor might prescribe daklines together with some other medicines . taking daklinez with some others may help you to remember to take daklinac . remember to follow the instructions of these medicines carefully . adjust your daily dose of daklinzan as necessary to complete the treatment . daklinikza is used in combination with other medicines for hepatitis c infection . these medicines will help you get the best results for your health . talk to your doctor about when to take these medicines
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is used in combination with sofosbuvir and ribavirin the following side effects have been reported : very common ( may affect more than 1 in 10 people ) headache fatigue common ( might affect up to 1 in10 people ] difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles after taking daklindza in combination mit sofofosbvir and in combination avec ribamvirin : common ( will affect upto 1 in 100 people ). very common : headache , fatigue common , may affect upt . common ; may affect less than 1in 10 people difficulty sleeping dazziness headache nausea ( being sick ), diarrachoeea , abdominal pain , joint
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 or 60 mg daclatapasVir ( as dihydrochloride ). - other ingredients are : - tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . - film coating : indigo carmine aluminium lake ( e132 ), yellow iron oxide ( е172 ). 51 what daclinza looks like and contents of the pack blue , capsule - shaped , 30 mm in diameter , the film . the film is debossed with " bms 30 " on one side . daklince comes in blisters of 10 , 28 , 56 and 98 tablets . not
proquad is a vaccine to prevent measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will make antibodies against the meases , misses , or mops caused by mmm , Rubella and varicellina viruses , so that the antibodies can be made naturally and help prevent diseases caused by these viruses ; however , proquade cannot cause meales / mmumps and rubella / chickenpx ( variablecellas ) in the first few weeks of administration . the vaccine will not protect you or your child for at least 12 months after a vaccination . proquadu is recommended for use in children 9 years of age and older ( for national vaccination ).
do not use proquad if you are allergic to any varicella vaccine , to measles , mumps , rubella vaccine or any of the other ingredients of this vaccine ( listed in section 6 ) or to neomycin . if your child has a blood disorder or type of cancer that affects the immune system . warnings and precautions your doctor will discuss this with your child ' s doctor before your child is given proquade . your child should be carefully evaluated and their immune system before treatment , and if certain medications ( such as low - dose corticosteroid therapy ) are recommended . in the case of asthma ( replacement therapy ). in the presence of patients with a weakened immune system due to a disease ( including aids ), congenital or hereditary immunodeficiency ( low level of immune competence ),
the doctor or nurse will inject proquad into a muscle , usually in the upper thigh or upper arm . it is given as injections into the muscle - usually in your thong area or upper arms area , or at the injection site . if you have a blood clotting disorder or low levels of platelets , the vaccine should be given under the skin because it reduces bleeding . the vaccine will not be given into  a damaged muscle . proquade should never be given intravenously into , a nearby blood vessel . tell your doctor if your child misses a dose of proqua
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions , sometimes accompanied by hives , may occur . these reactions may cause difficulty in breathing or swallowing . if you have an allergic reaction , stop using proquad and talk to your doctor immediately . other side effects that have been reported with proquade ( may affect up to 1 in 100 people ) include : injection site reactions . you may experience fits with a fever ( may effect up to1 in 1 , 000 people ). bronchiolitis ( difficulty breathing , cough ) and unsteadiness with walking . side effects of proquadu may include up to one in 10 people : injecting a dose of proqd at the same time as with proqued . common ( may effects in up to 10 in every 10 people in children )
what proquad contains the active substances are : - measles virus1 , edmonston strain ( containing 3 . 00 micrograms ) - mumps virus1 ( edurel - jeryl lynn - level b ) strain ( including : 4 . 30 microgram )* - rubella virus2 , strain ( with corresponding to 3 .00 microgram per ml )** - varicella virus3 , and merck strain ( which contains : 3 .99 microgram * - tissue culture , with plaque - making units 1 ( chick embryo cells and fibroblasts ), and mrc - the other ingredients are ; powder sucrose , hydrolysed gelatin , ( mc ), urea , sodium chloride ,
jylamvo is harmless and harmless to the body . it is an anticancer medicine used to reduce unwanted reactions . jyerlamva is an immunosuppressive agent with an anti - inflammatory effect jYlam Vo is used to treat rheumatic and skin diseases including : o active rhusatoid arthritis , including polyarthritic forms , which involve the joints o severe juvenile idiopathic arthritis ( jia ) in patients 3 years of age and older who have not used non -steroidal anti  - in - use nsaids ( nnaids ) and inadequate o persistent , disabling psoriasis and cannot be treated with treatment with phototherapy , pSoralen , and ultraviolet a radiation ( puva ) light .
do not take jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe kidney impairment if the doctor has tell you that he has a liver impairment . if certain kinds of blood disorders ( e . ex . bone marrow hypoplasia , leukopenia / thrombocytopenia ) have significant anaemia 34 if any of these apply to you , tell your doctor that you are at risk of having a weakened immune system if : you have recently had a serious infection ( i . de . tuberculosis , hiv ) you have ulcers in the stomach or intestines you have an inflammation of the mucous membrane of the mouth ,
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . jylamvo can cause severe side effects or even death . some patients may need to stop the treatment completely or have a life - threatening problem . these include rheumatoid arthritis , severe juvenile idiopathic arthritis a , or severe psoriasis or severe severe ppsoriatic arthritis . your doctor will decide the most appropriate treatment schedule for you , depending on your condition . the recommended dose of jYlamVO is a long - term treatment . you should continue to take jyeramvo for as long as your disease improves . it is also used to treat rhusmatic and skin diseases ( jia ), including psesoria
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching ( especially affecting your whole body ). tell your healthcare professional immediately : if your breathing problems get worse , or if there is a feeling of illness , dry , irritating cough , shortness of breath , and difficulty in breath . chest pain ( fever ), spitting or coughing blood , serious peeling , blistering or burning sensation . this is very common . if this happens to you , you may have a higher risk of serious bleeding or blistering . your doctor will tell you how to treat you . very common side effects are : common : may affect more than 1 in 10
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the label after exp . the expiration date refers to the last day of that month . store below 25 . keep the medicine in the outer carton to protect from light . from a microbiological point of view , the medicine should be used immediately . if accidental spillage occurs , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 hours at 2 - 8 . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotréxate ( as mesilate ). - each carton of 400 mbq of solution includes glycerol , orange flavour , sucralose , ethyl parahydroxybenzoate , sodium methyl parahydroxybenzoate ( e219 ), citric acid , tri - sodium citrate , purified water . see section 2 " jYlamVO contains ehyl parhydroxybenzone [ e321 ] and sodium hydroxybenzobiate ". what juylmvo looks like and contents of the pack jmvo is a colourless to pale yellow solution . it is supplied in a brown glass bottle containing 60 mL of
what enurev breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what enturev brezhalers is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . - this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary airways . you should use this medicine every day and always use it for as long as your doctor tells you . do not change the dose or stop using it without talking to your doctor .
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using enuresv brewinghaler warnings , precautions and tests before using this medicine tell your doctor if : you have kidney problems you have an eye problem called narrow - angle glaucoma you have difficulty passing urine during treatment with enurév  Breezhalers . if any of these apply to you , or if they apply to your family , friends or carers are not to be taken . while using this product tell your physician immediately : - when you get tightness of the chest , coughing , wheezing or breathlessness immediately after using  Enurev brezhale . this may
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much enurev breezhaler to inhale the recommended dose is one inhalation every day at the same time of day . you only need to inhahale once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly ( age 75 years and over ) you can use this medicinal product at any time of the day , anywhere you can inhalate it at any hour before or after food or drink . this medicine comes in a box containing an inhaler and capsules ( in blisters ) that contain the medicine as inhalations powder . only use the capsules with the inhalers provided in this pack ( enuresv brewing
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious . tell your doctor straight away if you get any of the following : uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia ; typical symptoms include excessive thirst or hunger and frequent urination ) rash , itching , hives , difficulty breathing or swallowing , dizziness ( signs of allergic reaction ) swelling mainly of the tongue , lips , face or throat ( signs suggestive of angioedema ). reporting of side effects 25 if your child gets any side effects talk to your child ' s doctor . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopyronicum bromide ( equivalent to 50 microgram of glycopyronium ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( g ) glycopyranium . - other ingredients of the manufacturing powder are lactose monohydrate and magnesium stearate . what enturev brezhalers looks like and contents of the pack enuresv brewinger 44 breeyhaler is supplied as hard capsules containing a white powder and are presented in a device called an inhalers . the contents of each blister strip are white and each strip contains either 6 or 10 capsules per strip . not all pack sizes may be marketed 
what riximyo is rximyab contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritzimabub sticks to your surface it stops the cell from growing and killing you . what if you have any questions about how richimyou works or why this medicine has been prescribed for you , ask your doctor . your doctor may prescribe riimy0 for the treatment of several different conditions . r ) non - hodgkin ' s lymphoma this is the disease of the lymph tissue ( part of the immune system ) that affects a particular type of whiteblood cell called b- lymphoocytes 
do not take riximyo if you are allergic to rituximab , other proteins which are like ritzimabe , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before you take . warnings and precautions talk to your doctor , pharmacist or nurse before taking rximy : if your child has a severe active infection at the moment if the child has been born with a weak immune system . if there is a risk of severe heart failure or severe uncontrolled heart disease , including granulomatosis with polyangiitis , microscopic polyangitis and pemphigus vulgaris . talk to the doctor before taking the medicine if any of these apply to your child . before you are given riskimy
you will be given riximyo under the supervision of a doctor experienced in the use of this treatment . always use this medicine exactly as your doctor has told you . check with your doctor or nurse if you are not sure . this is in case you get any side effects . rximya is given as a drip ( intra - venous infusion ). medicines given before each risimyO administration before you are given  RiximYo , you will receive other medicines ( premedication ) to prevent or reduce possible side effects from your treatment  . for non - hodgkin ' s lymphoma : if riximYO is given alone riskimyyo will be administered once a week for 4 weeks . repeated treatment courses with ritchimyon are possible . when you
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . pain at the inffusion site that may appear as blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , flu - like symptoms , and fatigue . other side effects may include : very common ( may affect more than 1 in 10 people ): diarrhoea , feeling sick ( nausea and vomiting ), chills / swollen joints , back pain , muscle pain . common ( May affect
what riximyo contains the active substance is called rituximab . the 10 ml vial contains 100 mg of ritzimabe ( 10 mg / mL ). the 50 mml solution contains 500 mg of of reituximiab ( 10  mg pfu / 1 m ). other ingredients are sodium citrate , polysorbate 80 , sodium chloride , water for injections , and sodium hydroxide or hydrochloric acid ( see section 2 " rximya contains sodium "). what if risimy0 looks like and contents of the pack ritchimy is a clear to slightly opalescent , colourless to slightly yellowish solution for infusion . riskimyou is supplied in glass vials containing 2 m2 or
topotecan actavis contains the active substance topotercan which helps to kill tumour cells . topotécan actAVIs is used to treat : small cell lung cancer that has come back after chemotherapy ; advanced cervical cancer if surgery or radiotherapy is not possible . in this case topotеcan actovis treatment is combined with medicines containing cisplatin .
do not take topotecan actavis : - if you are allergic to topotencan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking topottecan actingavis as it may cause your blood cell counts to become too low . this is especially important if your doctor thinks your blood cells are too low at the moment . tell your doctor if any of these apply to you . children and adolescents do not give this medicine to children and teenagers with any kidney problems . if so , your doctor may need to adjust your dose of topotacan actas . topotécan actacis is not recommended in patients with severe kidney impairment . it is also recommended to tell your family and friends that you are taking it . there is also a possibility that you may be at risk of liver problems
topotecan actavis will be given to you by a doctor or nurse . your doctor will decide how much topoteractavis you need and for how long . the dose will depend on : your body surface area ( m2 ) and the disease being treated . you will have blood tests before you start treatment and then your doctor may adjust the dose based on your response to treatment . adults small cell lung cancer the usual dose is 1 . 5 mg per m3 of body surface space once daily for 5 days . this treatment cycle will be repeated every 3 weeks . cervical cancer the normal dose is 0 . 75 mg per square metre of body area once daily , for 3 days , but less often . during this treatment period , your doctor might reduce the dose to one or two doses of cervical cancer , either alone or together with another anticancer medicines containing 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : infections ( very common , may affect more than 1 in 10 people ): - fever - this may be a sign of your general condition - local symptoms such as sore throat or burning sensation , severe stomach pain , fever , diarrhoea - or bowel inflammation ( neutropenic colitis ) has been reported in association with the use of topotecan actavis may reduce your ability to fight infections . - lung inflammation . common : may affect up to 1 in 1 , 000 people :  difficulty in breathing  vomiting  skin rash  hair loss  rash common - may affect less than 1 user in 10 ,000 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . keep the vialist in the outer carton in order to protect from light . store in a refrigerator ( 2 - 8 ). do not freeze . after reconstitution and dilution chemical and physical stability of the concentrate has been demonstrated for 24 hours at 25  2 , or 24 hours in - use storage at 2  8 protected from light prior to administration . from a microbiological point of view , the drug product solution should be used immediately after difution in solutions for infusion ( nacl 0 . 9 % and glucose 5 %) has been shown for 4 hours at room temperature , preferably within 12 hours , and then
what topotecan actavis contains - the active substance is topoten . each vial contains 1 mg or 4 mg topotentecan ( as hydrochloride ). after reconstitution 1 ml of solution contains 1 g of topotécan . - other ingredients are mannitol ( e421 ), tartaric acid ( a type of hydroch chloric acid ) and sodium hydroxide . what to potecan actingavis looks like and contents of the pack topotercan actavus is supplied in a clear glass vial with grey bromobutylic stopper and aluminium seals with plastic flip - off , inserted into a protective sleeve . pack size : 1 vial of 1 , 5 vials of 1 viall and 1 vially of 1 mg . not
the active substance of rivastigmine hexal is rivástigmin . rivazastigine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson 's disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivascastigme works by blocking the enzymes that break down acetone : acetétyllcholineesterase and butyrylcholineSterase . by blocking these enzymes , the level of floaters ( electron transporters ) in the body is increased . this helps to reduce the levels of acetic acid in the cerebral , helping to reduce some
do not take rivastigmine hexal - if you are allergic to rivassimine ( the active substance in rivazastigmin heexal ) or any of the other ingredients of this medicine ( listed in section 6 ). - have had a previous skin reaction suggestive of allergic contact dermatitis with rivstigine . if this applies to you , tell your doctor and do not continue to take rastigemine . warnings and precautions talk to your doctor before taking rivrasistigme heXal . take special care with rigastmine hxal tell your healthcare provider if any of these apply to you and tell your family / carers : - you have irregular or slow heartbeat . you have an active stomach ulcer . your doctor may want to monitor you more closely .
always take this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . your doctor may slowly increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg twice a day . Your doctor will regularly check if the medicine is working for you , and will regularly monitor your weight whilst you are taking this medicine . do not take rivástigmin heXal for more than three days . take the next dose at the usual time . it is important that you do not miss a dose of this medicine when it is time for your next dose , in order for your medicine to be taken at the right time
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often when you start your medicine or when your dose is increased . usually , the side effects will slowly go away as your body gets used to the medicine . very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ), diarrhoea common ( might affect up to 1 in10 people ). anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling feeling confused or lack of energy feeling sick( nausea ), being sick( vomiting ) diarragea common : may affect upto 1 in 100 people anxiety sweaty headache heart burn weight loss stool pain , feeling irritable , tired or strong generally feeling unewell
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 30 .
what rivastigmine hexal contains 64 the active substance is rivástigmin hydrogen tartrate . the other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ) and titanium dioxide ( ED171 ). the printing ink is composed of shellac . each rivavastigine heexal 1 . 5 mg capsule contains 1 , 5 mg of rivatastigemine . Each rivainstigmine hisxal 3 mg capsule contain 3 mg of the active substances . The other ingredients in the capsule shell are : - capsule content : indigo carmine ( a substance derived from the carmine ). - each rigastmine HEX
what cabometyx is cabmetyX is a cancer medicine that contains the active substance cabozantinib . it is used to treat adults with kidney cancer ( renal cell carcinoma ) or with liver cancer when it is given with a specific anticancer medicine , called sorafenib ( see " other medicines and cabrometyxx "). cabômetyux blocks the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels that supply them with protein and nutrients in cancer cells . cabombyx can be used for two different conditions , but it is not for everyone .
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking cabrometyX : -if you have high blood pressure . - have or have had an aneurysm ( enlargement and weakening of a blood vessel wall ) or a tear in ablood vessel wall. if your doctor thinks any of these apply to you , do not give cabmetyc and tell your doctor immediately . diarrhoea - recent history of significant bleeding - surgery which took place within the last month - or planned surgical procedures ( including dental surgery ). - tell your dentist if any of this applies to you and tell the dentist that you are taking ,
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will monitor your treatment and may change your dose if necessary . this is to reduce the risk of serious side effects and may increase the risk in case of a repeat course of treatment . the recommended dose of cabometyx is 60 mg twice a day . you should take cabrometyX for 2 hours before going to bed . cabmetyxx should be taken approximately 1 hour before going up to a bedtime . swallow the tablet whole with a glass of water . do not chew , crush or split the tablet . how long to take - cabotyc you must keep taking cabômetys for as long as your physician tells you to . it is recommended that you take a
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx . your doctor may prescribe other medicines to manage your side effects more effectively . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : symptoms such as pain in the abdomen , nausea ( feeling sick ), vomiting , constipation , fever . these may be signs of a gastrointestinal perforation ( a hole in your stomach or intestine that can lead to severe or uncontrollable bleeding ). symptoms such As vomiting blood , black tolls or red spots on the skin that may be severe . other side effects tell your pharmacist or nurse if any of these side effects gets serious . if they get worse tell your dentist or nurse straight away or get urgent medical help . very common
what cabometyx contains - the active substance is cabozantinib ( s )- malate . cabrometyX 20 mg film - coated tablets each tablet contains cabazantib( ss - malATE equivalent to 20 mg cabonantininid . each tablet of cabmetyxx 40 mg film coated tablets every tablet contains an amount of bmg of cbozantsinia ( t ) - Malate equivalent to 40 mg / ml cabizant inib . the other ingredients are : cabombyx 60 mg film- coated tablet each tablet includes cabuzantineb ( ( r ) and malate equivalent in 60 mg . not all pack sizes may be marketed . what b cabômety
pemetrexed hospira is a medicine used in the treatment of cancer . pemetreXed pemetrexxed is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . Pemetrexеd houpira has been given in association with  Cisp Latin for the initial treatment of patients with advanced stage of lung cancer  . you will be given pemetreexed hdpe if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy , but it remains highly effective afterward . also , pemetrezed has been used as a treatment for patients with certain
do not use pemetrexed hospira if you are allergic ( hypersensitive ) to pemetreXed or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before you start breast - feeding . warnings and precautions talk to your doctor or pharmacist before using pemetrexxed as this may affect the way that this medicine works . children and adolescents do not give this medicine to children under the age of 6 years . if so , your doctor may decide to change the dose of pemetrexia . also , you should not receive a vaccine against yellow fever . do not receive pemetreexed huspira without your doctor ' s advice . talk to the doctor or hospital pharmacist before receiving pemetreexed infusion if : you have problems with your kidneys . before each in
the dose of pemetrexed hospira is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your house . you will have to use this body surface area to work at its best . this dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor will have mixed the pemetrexxed
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : fever or infection ( common ): if your doctor thinks you may have a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if caught early , you may be found to be affected by the onset of chest pain ( common in patients with a fast heart rate ). if this happens , stop the injection immediately and contact your physician . your doctor may want to monitor you more closely . contact your doctors if he or she finds you have pain , redness , swelling or sores in your mouth ( very common in children ).
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . when prepared as directed , chemical and physical in - use stability of recombinant dna technology was demonstrated for 24 hours at refrigerated temperature . for reformed and infuse solutions of pemetrexed , it should be discarded . parenteral medicines should be in accordance with local requirements . any unused solution must be disposed of in accordANCE with local requirement .
what pemetrexed hospira contains the active substance is pemetreexed . pemetreexed pemetrexxed hospitalisation each 100 mg vial contains 100 milligrams of pemetreXed ( as pemetreixed disodium hemipentahydrate ). pemetrephened in hospitalisation every 500 mg viall contains 500 milligramms of pfizer of pemeterxede ( aspemetrexipentehydrate ) per vial . ph adjustment each 1 , 000 mg viaL contains 1  ,000 millilitres of Pemetrexd , as pemeterxxeded dissodium hipent hydrate . after reconstitution , the solution contains 25 mg / ml of pemètrexedu . further dilution by a healthcare provider is required prior to
ganfort contains two active substances , bimatoprost and timolol , which work together to reduce pressure in the eye . bimatozopross belongs to a group of medicines called prostamides , a prostaglandin analogue , and / or titmololl , being taken by mouth as medicines called beta - blockers . they work by making the eye look like water . the liquid is a clear , watery liquid that is dripped into the eye and slowly pour into the back of the eye to dissolve the liquid . this reduces the amount of water in the eyes and helps to reduce the amount glaucoma in the front of the eyes . ganfordt eye drops are used to reduce high pressure inthe eye , also known as glaucacoma .
do not use ganfort eye drops / solution - if you are allergic to bimatoprost , timolol - blockers or any of the other ingredients of ganFort ( listed in section 6 ) - for respiratory problems such as asthma , severe chronic obstructive bronchitis , and severe lung disease . warnings and precautions talk to your doctor , pharmacist or nurse before using gan fort eye drop - solution : - talk to a doctor if : you have asthma / severe chronic or oblistructive airway ( wheeziness / difficulty in breathing ) or long - standing cough - you have heart problems ( such as low heart rate , heart block , or heart failure warnings , precautions and risks ) before using this medicine , tell your doctor or pharmacist
always use ganfort exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose is one bottle , once a day , for one treatment period . only use the bottle if your doctor told you otherwise . it should be used in the same eye , as described in section 4 . how to use the ganfirt bottle : the bottle is designed to be used by adults only . your doctor will show you how to do this . ganFort is for single use only ; however , it should not be used more than once . wash your hands . tilt your head back and look at the ceiling . 2 . pull down your lower eyelid until there is a small pocket . 3 . gently squeeze the bottle to release one last dose . close the bottle and put the next dose at the same time
like all medicines , ganfort can cause side effects , although not everybody gets them . you can usually carry on taking the drops , even if you are not sure . the side effects reported with ganFort ( multi - dose or single - do ) are listed below . very common side effects ( affects more than 1 user in 10 ) - the eye redness . common side effect ( affect affects 1 to 9 users in 100 )- the effect of the eye burning , itching , and stinging . - irritation of the conjunctiva ( the transparent layer at the front of the eyes ), sensitivity to light , eye pain , sticky eyes , dry eyes - a feeling of something in the eye . not known ( frequency cannot be estimated from the available data ): eye irritation , redness of the skin ,
keep out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after opening , the product should be used immediately . eye infections should not be re - marketed . if you notice any change in the appearance of your eye infections , please inform your doctor or pharmacist . follow your doctor ' s instructions for the correct storage times and conditions . 4 do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains - the active substance is bimatoprost . each 0 . 3 ml bottle contains timolol . one bottle contains 5 mL of titmololl maleate equivalent to 6 . 8 mg benzalkonium chloride ( as a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate / purified water , hydrochloric acid / sodium hydroxide . what gânfort looks like and contents of the pack ganft is a clear , colourless to slightly yellow eye drop solution in a plastic bottle . ganfourt is supplied in  a pack containing 1 or 3 bottles with a screw - cap and 3 or 4 bottle adapters . not all pack sizes may be
gefitinib mylan contains the active substance gefitib which blocks a protein called ' epidermal growth factor receptor ' ( egfr ). this protein is involved in the growth and spread of cancer cells . gefitINib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefit inib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking gefitib Mylan : if any of these apply to you , tell your doctor or pharmacist before taking it . some lung problems may be serious . your doctor may check for some lung issues before you start gefitINib melan . if your doctor thinks you may have problems with your liver . children and adolescents gefiteinib is not recommended for use in children and teenagers under 18 years of age . other medicines and gefitineib tell your pharmacist or nurse if the patient is taking , has recently taken or might take any other medicines . in particular , please tell your dentist or pharmacist if using the following medicines : the active substances are 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 250 mg tablet per day . swallow the tablet whole with water . do not crush or chew the tablet . you may take it with or without food . take the tablet at about the same time each day , preferably at the same times each day ( preferably in the morning and evening ). do not take antacids or tablets that are taken on an empty stomach . for 2 to 1 hour before or after taking gefitinib mylan , crush the tablet before swallowing . if this happens , rinse the glass very well with water and do not use any other liquids . stir until the tablet breaks up into pieces , drink the mixture immediately . this will help to keep the medicine at room temperature ( 20 -
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : allergic reaction ( common ), which may include symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , and nettle rash , having difficulty breathing and serious breathlessness ( uncommon ), or sudden worsening breathlessness together with a cough or fever . this may mean that you have an inflammation of the lungs called ' interstitial lung disease '. this is uncommon ( may affect up to 1 in 100 people ) when gefitinib mylan is taken together with another medicine . severe skin reactions may occur anywhere on your body . these include : very common : may affect more than 1 in 10 people . common 
what gefitinib mylan contains - the active substance is gefiteinib . each film - coated tablet contains 250 mg of gefitib in one tablet . - other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidone( k30 ), sodium laurilsulfate , magnesium stearate . tablet coating : polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( EDGE ), yellow iron oxide [ e172 ]). what geFITiniab myLAN looks like and contents of the pack gefitINib melan tablets are pink , biconvex film , scored tablets , debossed with " gs ii "
reblozyl contains the active substance luspatercept and is used to treat myelodysplastic syndromes ( mds ). myelaodys plastic syndromes [ ms ] are caused by many different blood and bone marrow disorders , in which certain types of red blood cells become abnormal . this can lead to signs and symptoms of a low red blood cell count ( anaemia ). it is used in patients who cannot have red blood blood cell transfusions . re Blozyl is used for the treatment of anae in patients with mDS who need red blood plate transfusion , when they cannot be given enough red blood  cell transtransfusions or when erythropoietin therapies have not worked or have not helped to control beta - thalassaemia in adults . the diagnosis of thálassaenia is
do not take reblozyl - if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) -if you're pregnant ( see section " pregnancy and breast - feeding "). warnings and precautions talk to your doctor or pharmacist before taking this medicine -- - when you have thalassaemia or have had your spleen removed - once you have had a blood clot , or have received hormone replacement therapy - where there was a previous blood clut . your doctor will discuss preventive measures and , if necessary , to take medicines to prevent a bleeding . - during treatment with rebzyl the risk of having a new complication is increased - especially if your blood pressure is too high . before and during treatment of reblizyl your
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your doctor will carry out blood tests and decide how much reblozyl you need . how rebozyl is given rebolzyl will be given to you by a doctor or nurse . reglazyl can be given as an injection just under the skin ( subcutaneously ). the injections will take about 1 . 01 minutes . the dose you will be told by your doctor or other health care professional . this dose may vary depending on your general condition and your blood pressure . when you are given a rebrozyl injection , your doctor may adjust your dose and may change your dose if needed . patients with myelodysplastic syndromes the maximum single dose is 1 , 75 mg per kg of body weight . in patients with beta 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor immediately if you experience : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or anywhere on the body , blurred vision . these may be symptoms of a stroke . blood clots swelling in the area around the eyes , in the front of the face, lips , mouth , tongue or throat allergic reactions such as rashes , sore throat and runny nose . rinsing your mouth out with water and / or lemon juice . this may help to reduce the number of white blood cells and reduce the risk of them getting worse . common side effects ( may affect up to 1 in 10 people ): diarrho
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). store in the original package in order to protect from light . after reconstitution , reblozyl can be stored for 8 hours at room temperature ( up to 25 ) in syringes for up to 24 hours at 2 to 8 . any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains - the active substance is luspatercept . each vial contains 25 mg or 75 mg of luspatiercept ( as monohydrate ). after reconstitution , each ml of solution contains 50 mg of of lucpaterception . - excipients : citric acid monohydrate ( e330 ), sodium citrate ( 0 . 5 mmol / mL ), sucrose , hydrochloric acid ( é330 ) ( for ph adjustment ) and sodium hydroxide ( for general ) for pph adjustment what ' rebzyl looks like and contents of the pack reblizyl is a white to off - white powder . one pack of reglazyl includes 25 mg and 75 mg luspa . the excipiants are 
fotivda contains the active substance tivozanib , a protein kinase inhibitor . tivolinib works by blocking a substance called kinekinases - 1 ( pkr - 2 ). it is used by adults to treat the cancer by slowing down the growth of cancer cells and opening new blood vessels . fotiva is used in adults with advanced kidney cancer who have not responded or cannot be treated with other treatments , such as alpha or interleukin - 2- which have not worked or have not helped to stop your disease .
do not take fotivda : if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you are taking st . john ' s wort ( hypericum perforatum ). this is a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking fotiva . high blood pressure . fotiv da will not control your blood pressure enough . your doctor will check your blood Pressure regularly , and may prescribe a medicine , or you can take fotiveda to lower your blood tension . tell your doctor if : you are already taking a medication for high blood  pressure , as the dose of fotivdea may need to be adjusted . you have already started treatment for low blood pressure or have
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the recommended dose of fotivda is 1340 mg once a day for 21 days ( for 7 days ) taken as 1 capsule . take capsules daily for 4 days . your doctor will decide how many capsules to take , based on your response to fotiva . if your doctor decides that you will receive more capsules than you should , you may receive more than one 4 - week period . patients treated with fotivdea will receive the highest possible unacceptable side effects . these are known as severe side effects which may occur during fotivdada therapy . the usual dose of ftivdda consists of 890 mg ( 21 mg ) per capsule , 7 days per week ( with or without food
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a common side effect that may affect up to 2 in 10 people . tell your doctor immediately if you have high blood tension that cannot be controlled . symptoms can include severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . if your blood pressure increases , you may have to stop taking fotivda to treat high blood Pressure . it is important that you take a medicine to treat your high blood  pressure . do not stop taking Fotivdda unless your doctor tells you to . when it is time for your next dose , your doctor may decide to keep you under closer observation . other side effects common : may affect more than 1 in 10 adults : diar
what fotivda contains each capsule of fotiva 890 mg contains tivozanib . each capsule contains  tivolinib hydrochloride monohydrate equivalent to 890 milligrams of tivonib in  1 ml . the other ingredients are mannitol , magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine (  e132 ), yellow iron oxide ( E172 ), propylene glycol ( eeds ) and strong ammonia solution , talc ( encapsulated ), titanium dioxide and tartrazine aluminium lake ( е132 ). printing ink : shellac , propyl glycol  ( s ), strong ammona solution and indigone carmine aluminium Lake ( é132 
stribild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of the effects of elitegraVir emtricitabine , which is an antiviral medicinal medicine known alset as a nucleoside reverse transcriptasasE inhibitor ( nrti ) and tenofovir disoproxil , also known as as an antietrovirals medicine known AS nucleophilide reverse transcript asse antagonist ( nicotide ) st . s tribild is available as : as  a single tablet regimen for the treatment of human immunodeficiency virus ( hiv ) infection . the active substance in sTRIbild
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , or any of the other ingredients of st . you are taking tenofovir disoproxil - this medicine , which is usually taken for at least 6 weeks before you start treatment . tell your doctor if : you are currently taking any medicine containing ten ofovir désoproxile . your doctor will decide on if and when you should receive stricbild . the dose of this medicine will be calculated by your doctor depending on your kidney function . these medicines may be available without a prescription : alfuzosin ( used to treat an enlarged prostate gland ) amiodarone , quinidine ( used for irregular heartbeats ) 47 dabigatran ( used in the
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is : adults : one tablet each day by mouth , with or without food . do not chew , crush or split the tablet . children aged 12 to less than 18 years : three tablets each day , one tablet every day by stribild 35 mg . take the tablets with food , at the same time each day ( for example , by mouth and with food to help you remember to take your medicine ). your doctor may change the dose or stop the treatment temporarily or permanently . medicines given as oral supplements , antacids or laxatives containing minerals ( such as magnesium , aluminium , calcium , iron , zinc ) should be taken once daily . if your child misses a
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood cholesterol sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether some of the unwanted effects are caused by stribild or by the hivi disease itself . serious side effects to look out for : tell a doctor immediately lactic acidosis ( excess lactic acids in the blood ). this is a very common side effect of some hiv medications . lactic Acidose may occur more often in women , particularly those who are overweight . some patients with liver disease . the most common occurrence of lactic a
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each sTRIbild film - coated tablet contains 150 mg of eelvigravir ( as 150 mg cobicistentat ), 200 mg of the active substance emetricit abine ( as 245 mg ten ofovir désoproxils ) and 300 mg of each tenovir diproxil fumarate ( as 136 mg of an active substance in the tablet ) in the film . the other ingredients are croscarmellose sodium , the hydroxypropyl cellulose , lactose monohydrate , and magnesium stearate . what stevens - johnson - crudland tablet contains lacto
zyprexa contains the active substance olanzapine . zypréxa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , an episode with symptoms of excitement or euphoria . the active ingredient in zypa has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olapine treatment .
do not take zyprexa : if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a particularly a filled face , with swollen lips or shortness of breath . if this has happened to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before taking zypresa if any of your medical conditions : eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). your doctor may want to monitor you more closely while you are taking zprexа . the use of zyPrexa in elderly patients with dementia is not recommended as it may have serious side effects . medicines of this type may cause unusual movements of the face or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many zyprexa tablets to take and how long you should continue to take them . the daily dose of zypresa is between 5 mg and 20 mg . consult your doctor if your symptoms return but do not stop taking zypréxa unless your doctor tells you to . you should take your zypa tablets once a day following the advice of your doctor so that your tablets are fully effective and to reduce their size . zy prexa coated tablets are for oral use . swallow the zyPrexa tablet whole with water . how to take take the zprex - zybexa tabs with a glass of water , do not crush or chew the tablets . it is best to take your tablets
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect which may affect more than 1 in 100 people ). especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if any of these symptoms occur , seek medical advice immediately . very common side effects ( may affects more than1 in 10 persons ): dizziness , headache , ringing in the ears . uncommon side effects may affect less than 1in 100 people in the upper legs . symptoms may include swelling and pain . redness
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . zyprexa should be used within three months after its opening . these measures will help to protect the environment .
what zyprexa contains - the active substance is olanzapine . each zyPrexa tablet contains either 2 . 5 mg , 5 mg or 7 . 7 mg / 10 mg emulsions , 15 mg or 20 mg of the active ingredient . what your zypresa tablet pack contains , the other ingredients are lactose monohydrate , hyprolose , crspovidone , microcrystalline cellulose , magnesium stearate , and hypromellose . the ingredients are titanium dioxide ( e171 ), and carnauba wax . how to prepare the different zypréxa tablets strengths are illustrated in the table below . zypa 2  . 4 mg : 5 mg and 7  , 50 mg tablets are white to off - white , round tablets with "
what prolia is prolide contains denosumab , a protein ( monoclonal antibody ) that is designed to attach to another protein that is involved in bone loss ( osteoporosis ). treatment with prolis helps to make bone stronger . it also helps to increase the amount of oestrogen that is produced . what prollia looks like and contents of the pack prolium is a white to off - white protein that stimulates growth and development . when prolions are made from human - made proteins , such as testosterone , it helps to keep bones healthy . after the menopause , the oesterogen level drops to a low level , and makes bones less thin and fragile . this can be a sign of osteoporoisis . people with osteoposserosis can make themselves less able
do not use prolia : if you have low calcium levels in the blood ( hypocalcaemia ). if your doctor is allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using prolisa . before using using prollia tell your doctor or nurse if : you have a skin infection with symptoms such as a swollen , red area of skin usually in your leg that feels hot and tender ( cellulitis ), with symptoms that last for a long time ( febrile neutropenia or fever ). these symptoms may be due to an allergy to latex . the needle cover of the pre - filled syringe contains a derivative of latex which is thought to have been made from calcium . it is important to follow
how much to use one pre - filled syringe contains 60 mg . it is given to you once every 6 weeks , as a single injection under the skin ( subcutaneous ) in the upper thighs , abdomen or upper arm . how to use prolia is for injection - only use stickers and do not use stickers . - do not take calcium and vitamin d supplements while you are using prolisa . your doctor will tell you how many injections of prolide to use . do not try to inject yourself if you have not been trained . for more information on how to inject prola , see ' instructions for use ' at the end of this leaflet . always use prolaia exactly as your doctor has told you . check with your doctor or pharmacist if : you have been trained how to prepare and use prollia correctly
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately and stop taking prolia if you experience skin infections called cellulitis . these symptoms are very common with prolisa . you may notice that the capsules become swollen and red area of skin on the top of your leg , or that it feels hot and tender . this can be a sign of symptoms of fever when taking prollia and may be life - threatening . pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw / discharge , numbness or a feeling of heaviness in the abdomen or loosening of a tooth may be signs of bone damage . other side effects may occur with prolla : very common side effects ( may affect more than 1 in 10
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . you may use your pre - filled syringe for up to a maximum of 25 days when stored in the original carton . after the injection you can store the product at room temperature ( up to 25 ) for a single period of maximum 30 days . record the date of the first injection on the carton and the date after which it should be discarded . once you have finished using prolia , it should not be put back in the refrigerator . it is recommended that you use it within this period . this medicine does not
what prolia contains - the active substance is denosumab . 1 ml solution for injection contains 60 mg denosomab ( 60 mg in each mL ). - other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prollia looks like and contents of the pack prolide is a clear , colourless to slightly yellow solution for infusion in a pre - filled syringe with a needle guard .
ambirix is a vaccine used to protect adults and children from 1 to 15 years of age against two diseases : hepatitis a and hepattis ( infection with the heptis one virus ) which can make the liver swollen and inflamed with the virus . the virus cannot be spread to an infected person . you can catch the virus from faeces , serum or saliva . symptoms start 3 to 6 weeks after you catch the first dose of ambirika . tell your doctor if you think you have an early warning sign of infection , or if they feel sick or have a fever , aches and pains . ambirize can reduce the chance of getting a severe infection . this can make you more likely to get a rash , especially if your body has already been infeated with the
do not use ambirix if you are allergic to ambiri or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . an allergic response may occur with any vaccine against hepatitis a or hepatis b diseases . if your child has a severe infection with a high temperature ( over 38 ). if this applies to your child , the vaccine will not be given unless your child is suffering from a minor infection such as a cold . warnings and precautions talk to your doctor , pharmacist or nurse before using ambirx . ambirika will not prevent heptis 1 and b infection within the first 6 weeks . talk to the doctor if any of these apply to your baby .
ambirix will be given to you by a doctor or nurse as an injection into the muscle of the upper arm . you will be told by the doctor or nurses before you are given ambirx . it will be injected into a vein . the injection will be in the thigh muscle . your doctor will decide on a suitable dose for you . a total of two injections will be provided . each of the injections should be given within 12 months of the first injection . for the second injection it is usually given between 6 and 12 months after the first dose . please speak to your doctor or healthcare professional if you are concerned that you may need extra doses or are concerned about future booster dosing . how often will you have one injection ? your doctor may decide that you will receive one or two injection if the dose is missed or the dose may be changed . one injection may be given
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side impacts you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering and swelling of the eyes and face , which may cause difficulty in breathing or swallowing , or a sudden drop in blood pressure . this may lead to loss of consciousness . other side effects some patients have experienced the following side effects while taking ambirix : very common ( affects more than 1 user in 10 ): headache loss of appetite feeling tired or irritable pain when getting up from a lying or sitting position . these side effects may occur in clinical trials with ambirx . common ( effect in 1 to 10 users in 100 ) headache loss to their appetite feeling more
what ambirix contains 26 active substances : hepatitis a virus ( inactivated ) 1 , 720 elisa units hepatis b surface antigen ( aprt ) 20 micrograms 1adsorbed on human diploid ( mrc - 5 ) cells 2adsorption in aluminium hydroxide , which is hydrated 0 . 05 milligrams al3 + 3adsorbant ( s ) 2aad ) 3aaa adsorbed upon aluminium phosphate 0. 4 millilitres al4 + the other ingredients are sodium chloride and water for injections . what amberix looks like and contents of the pack suspension for injection in a pre - filled syringe . ambirx is a white , slightly milk
what bexsero is bexerois a meningococcal group b vaccine . bexsiero is given to children and adolescents aged 2 years and older to help protect against disease caused by the neisseria menenditidis group c bacteria . these bacteria often cause infections such as meningitis ( inflammation of the covering of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping the body to make its own antibodies . it may also help to protect you or your child against the disease .
do not use bexsero if you are allergic to : the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using bexsie if : you have a severe infection with a high temperature ( over 38 ). in this case , your doctor may recommend that you come back for the vaccination . you have only a minor infection , e . g ., a cold . however , in any of these circumstances , the vaccination may not be recommended . your doctor will be able to give you a second chance of having a haemophilia or any other problem that may prevent your blood from clotting properly , for example , by using blood thinners ( anticoagulants ). treatment that may affect your immune system , such as 
bexsero is given as 5 ml into a muscle , preferably in the thigh or upper arm . the number of injections that you will receive is as follows : first injection : at chosen date second injection - up to 2 months after first injection with a single dose of 5 . three injections will be given at the same time . if you are not vaccinated , you may receive an additional injection ( booster ) at the scheduled time : for the first injection ( s ) on the first day of the second week . your doctor will decide the appropriate dose . thereafter , the first dose ( 0 . 5 ) may be given on the same day . at chosen dates , your doctor may increase the interval between injections by up to 1 month . from a microbiological point of view , an interval between injecting the
like all vaccines , this vaccine can cause side effects , although not everybody gets them . when bexsero is given to your or your child , the following side effects may occur : very common ( may affect more than 1 in 10 people ): - pain / tenderness at the injection site - redness of the skin at the injecting site , - swelling of the flesh at the end of the injection - hardness at either the injection area or the injection location . the following other side effects have been reported with this vaccine : common ( might affect up to 1 in every 10 people):- fever . common (may affect upto 1 in each 10 people and may affect upt ) of the vaccine - rash - itching - dry skin at either side of the injector ' s injection . reporting of side effects after your child has been given bex
what bexsero contains - the active substance is recombinant neisseria meningitidis group b nhba fusion protein . each 1 ml , 2 or 3 mL vial contains 50 mg of reconstituted nineisseriia maningititidic - group c nada protein , one vial of 1 ,2 or 3 vials contains 50 micrograms of r - neleisserididIS group a fhbp fusion proteins , 1 v , 3 v vial containing 50 microgramms of total protein from the pora p , two vial solutions of 2 or three vial types , each containing 25 microgram ( 1 vial per vial each ). not all pack sizes may be marketed .
the active substance in nitisinone mdk is niitisine . this medicine is used for treatment of a rare disease called hereditary tyrosinemia type 1 in adults , adolescents and children above 1 year of age . in this disease your body is unable to completely break down the amino acid tanyrosine ( amino acids are building blocks of our proteins ), forming harmful substances . nitsinone helps to lower the level of tychrosine in your body . it also reduces the harmful substances in this medicine . because tyingrosine is produced by the body , low tyerosine is also produced by phenylalanine ( another amino acidic ) phosphates .
do not take nitisinone mdk if you are allergic to niitisine or any of the other ingredients of this medicine ( listed in section 6 ). do not breast - feed while taking this medicine , see section " pregnancy and breast enlargement ". warnings and precautions talk to your doctor before taking nitsinone in mhk . your eyes will be checked during ntisinine treatment and during treatment if red eyes appear in your eyes . contact your doctor immediately for an eye examination . eye problems may occur if your doctor thinks you have inadequate dietary control ( see section 4 ). your doctor will carry out blood samples to monitor your condition and decide whether this medicine is suitable for you . during the treatment , your doctor may take blood samples during the treatments to check for side effects and blood disorders . the doctor may also check your liver and
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . treatment with this medicine should be started and supervised by a doctor experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 mg per kilogram of body weight taken once a day . the recommended daily dose is 20 mg per kg of body mass once daily . in this patient population , the doctor may reduce the dose gradually to one or two capsules once daily and may adjust the dose to one capsule once daily depending on the patient population you are experiencing . if your doctor determines that the dose is too high or too low , talk to your doctor before taking the capsules . swallow the capsule whole with a small amount of water or formula diet just before you take it . you can take nitisin
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . nitisinone mdk may be stored for up to 2 weeks at a temperature not above 25 . keep the bottle tightly closed . discard the opened bottle after this time .
what nitisinone mdk contains - the active substance is niitisine . nitsinone one mk 2 mg : each capsule contains 2 mg of nităisinine - one ntisinon one . one titisnone ndk 5 mg / 10 mg capsule contains 5 mg of notitis inone . another nisinonce mndk 10 mg - each capsule has 10 mg of noitisINone - two other ingredients : capsule content : gelatin , titanium dioxide ( e171 ), black iron oxide ( EE172 ), shellac glaze ( based on the e172 ). what if the contents of the pack nitéisinONE mmdK capsules are black and white , approximately 15 . 7 mm in
the name of this medicine is docetaxel accord . docetaxil is a substance derived from the needles of yew trees . Docetaxell belongs to the group of anti - cancer medicines called taxoids . didcetaxele accord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer a , gastric cancer or head and neck cancer : - for the diagnosis of advanced breast cancer docetachl could be administered either alone or in combination with doxorubicin , trastuzumab , or capecitabine . -for the treatment or prevention of early breast cancer in adults whose disease has come back or has not responded to treatment .
docetaxel accord must not be used : - if you are allergic ( hypersensitive ) to docetaxil or any of the other ingredients of docetacel accord ( listed in section 6 ). - because docetal accord reduces the number of white blood cells , if your doctor thinks you have a severe liver disease . warnings and precautions before each treatment with docetachl accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetcetaxell accord . in case of whiteblood cells disturbances , fever and infections may occur immediately after treatment with abdominal pain or tenderness , diarrhoea , rectal haemorrhage , blood in stool or urine . tell your doctor immediately if any of these apply to you . children and adolescents docetessel accord should not
docetaxel accord will be administered to you by a healthcare professional . usual dose the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m2 ) and will determine the dose you should receive . method and route of administration docetaxil accord is given by infusion into one of your veins ( intravenous use ). the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . the dose may vary depending on your blood tests , your general state and your response to docetal accord . in particular , please inform your doctor in case of diarrhoea , sores in the mouth , feeling of numbness or pins and needles , fever and give her / him results of your blood
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord alone are : decrease in the number of red blood cells or white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . as for any combination of adverse events , docetaxil accord may be increased when docetcetaxell accord is given in combination with other chemotherapeutic agents . during the infusion at the hospital the following allergic reactions were reported . very common : may affect more than 1 in 10 people : flushing , headache , abdominal pain , discomfort , pain in the abdomen , chills , increased sweating . not
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store below 25 . keep the viall in the outer carton in order to protect from light . after dilution , the medicine should be transferred from the vially to the infusion bag within 6 hours ( up to 25 ). infusion : the inffusion solution should be administered immediately after thawed , or diluted , within 48 hours if stored between 2 and 8 . from a microbiological point of view , unless the method of dilsification or difution has taken place in controlled and validated aseptic conditions , it should be used immediately . if not used immediately ( infusion ready
what docetaxel accord contains - the active substance is docetaxil . each ml of concentrate for solution for infusion contains 20 mg of docetachl - 1 mL of concentrate contains 20 grams of dotaxel  - 4 mlitre of concentrate contain 80 mg of Docetaxell - 8 mbq of docetaxel  160 mg / m2 of docotaxel per vial : polysorbate 80 , ethanol anhydrous ( see section 2 ) and citric acid anhydrously ( see end of section 2 for further information on docettaxeel accord ). what docotaxil accord looks like and contents of the pack docetal accord concentrate for concentrate for solutions for infusion is a clear pale yellow to brownish - yellow to orangey - brownish orange - orange concentrate .
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . intunev helps to reduce the activity of people who become impulsive or hyperactive . the active ingredient of this medicine is called ' attention deficit hyperactivity disorder ' ( adhd ). it is used if you : - are already taking current stimulant medication or are not taking current medication to control adhd symptoms . combining the medicine with a treatment program , together with psychological therapy , educational therapy / social therapy . 38 intuv is used to treat adults and adolescents ( 12 years and older ) with adhd and to treat adhd both before and during treatment . there is no clinical data on the use of intundiv in patients with adhD .
do not take intuniv : - if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking this medicine : you should tell your doctor if any of these apply to you : low or high blood pressure . heart problems tell your doctors if your doctor has told you that you have heart problems . you should also tell your physician if : your doctor told you you have ever fainted , or recently had thoughts or feelings of suicide , you are using any other psychiatric conditions . withdrawal symptoms may be more likely if treatment is started . increased heart rate , especially high blood , can occur when taking this medicinal product . if this happens , your doctor may decide to stop your treatment with this medicine and start to treat these problems if necessary
your treatment should be initiated under the supervision of a doctor experienced in the treatment of  adolescents behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your treatment will be initiated and managed under supervision of an experienced doctor experienced and in the diagnosis and treatment of adolescents . the recommended dose is 1 mg / kg bodyweight once daily . after 1 month of treatment , your doctor will increase your dose to 0 . 05 mg - 0. 12 mg based on bodyweight . starting treatment once daily your dose will be increased by 1 mg per kg body weight . this will be for 1 to 7 days . intuniv should be taken every day for as long as your physician recommends . do not take this medicinal product with food containing fatty foods . swallow the tablets whole with water . duration of treatment
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , stop taking your medicine and tell your doctor straight away . serious side effects some patients have had side effects such as feeling drowsy or feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint ( hypocrite ), loss of conciousness ( syncope , a serious withdrawal side effect ), high blood pressure which was not well controlled with symptoms such as headaches , feeling confused , nervousness , anxiety , and agitation or tremors ( hypertensive encephalopathy ). other side effects have also been reported : very common ( may affect more than 1 in 10 people ): diarrhoea , being sick ( vomiting ), being sick , stomach pain 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . keep the tablets in the original package in order to protect from moisture . blister pack do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what intuniv contains - the active substance is guanfacine hydrochloride . - 1 mg guantacine - 2 mg GUanf acine hydrogenochloride ( 2 mg of guacine per ml ). - 3 mg guianfácine hydroochlorides ( 3 mg of the guinfaine per 0 . 5 mL ) - 4 mg / m2 guanyl hydroch chloride ( 4 mg of of GUANfacina per  mmol ) the other ingredients are : hypromellose 2208 ( e464 ), methacrylic acid - ethyl acrylate copolymer , lactose monohydrate , povidone , crospovidone type a ,
ecalta contains the active substance anidulafungin . it is used to treat adults and children ( aged 1 to 18 years ) with a type of fungal infection that affects the blood or other internal organs called invasive candidiasis . when the infection is ruled out by fungal cells called candida , echinocandins are not suitable . these medicines are not intended to treat serious fungal infections . they must be kept out of the sight and reach of children . ecalita is used when some of the fungal cell walls become damaged . because ekalta makes fungal  cells have incomplete or defective cell walls , they become fragile and unable to grow .
do not use ecalta if you are allergic to anidulafungin , other echinocandins ( such as caspofungin acid ) or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using ekalta as it may affect liver function . tell your doctor if : you have liver problems during or after your treatment with anaesthetics . during or following your treatment of ecalita you may experience an allergic reaction ( such an itching , wheezing or blotchy skin ) during or shortly after an infusionrelated reaction . this may be accompanied by a rash or hives , itching and redness , and shortness of breath . children and adolescents this medicine should not be used in children and teenagers under 18 years
the treatment will be started by a doctor who is experienced in the use of this type of medicine . the recommended dose is 200 mg per kg of body weight once a day for 1 patient ( aged 18 years and over ) at a dose of 3 . 0 mg per kilogram of bodyweight once , followed by 200 mg in 1 . 5 mg per day for 100 mg . this dose is based on the patient ' s weight . how ecalta is given eCALta will be given to you by specialized medical staff . it is given as a slow infusion through a drip into a vein over a period of 1 , 5 to 3 hours . your doctor or nurse will calculate the loading dose for the patient and will work out the correct dose for him or her . depending on the patients weight , the doctor may change the dose or delay the infusion 
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are potentially life - threatening allergic reactions . tell your doctor immediately if you have difficulty breathing or wheezing , or if there is already a possibility that you have an existing rash . stop taking ecalta and tell your healthcare professional straight away . serious side impacts can include convulsion ( seizure ) flushing or rash ( pruritis ) itching , hot flush , hives , sudden contraction of the muscles , wheeziness , coughing or difficulty of breathing other side effects include : very common side effects ( may affect more than 1 in 10 people ) - headache - diarrhoea - nausea ( feeling sick ) common side effect ( may effect up to 1 in 100 people 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user . however , the reconstituted solution is stable for 24 hours at 2oc 8oc . in a laboratory the infusion solution can be stored at 25oc for up to 48 hours at 25 oc followed by up to 24 hours prior to administration .
what ecalta contains - the active substance is anidulafungin . one vial of powder contains 100 mg of anidULafungIN . - - other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide , and hydrochloric acid 30 . what  ekalta looks like and contents of the pack eCALta is supplied as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder is white to off - white . pack size of 1 .
adynovi contains the active substance rurioctocog alfa pegol and is a pegylated human coagulation factor viii . factor ixi is the human  coagulating factor ii , also called ' factor  vii '. factor vii is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , there is no factor  viiis present in the blood . aadyingnovi is used for the treatment and prevention of bleeding in adults and adolescents 12 years of age and older and in children with ha haematophili a ( an inherited bleeding disorder caused by lack of factor vii ).
do not take adynovi if you are allergic to rurioctocog alfa pegol , octtocogg alfá or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before taking adenovi as you may experience an anaphylactic reaction ( a severe , sudden allergic reaction ) to aadnovi ( see also section 4 ). allergic reactions may include rash ( common ) 95 hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , cough , and wheezing , tightness in the chest , overall feeling of being unwell , dizziness , confusion , nausea
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . your doctor will decide the dose of aadonovi you need and will continue to prescribe it . treatment of bleeding the dose and duration of  apynovo depend on the function of the patient and on the replacement therapy you have received . aynovis is a life - long treatment . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . prevention of bleeding : the dose that adenovi is usually prescribed for you is 40 iu per kg of body weight , given every 2 weeks . the dose is used to prevent bleeding . how much adamnovi to use your doctor may prescribe the right dose for you , depending on
like all medicines , this medicine can cause side effects , although not everybody gets them . if severe , sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . you must contact your doctor immediately if you have any of the following early symptoms of allergic reactions : rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , cough , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . severe symptoms , including difficulty in breath or fainting , require prompt emergency treatment .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . before the powder vial can be opened , the contents should be used immediately . however , chemical and physical stability has been demonstrated for 30 days at room temperature ( 20 25 ) for a single period of up to 3 months . this medicine must be used within 3 days or discarded if not used within the 3 - month period . once the powder has been dissolved it should be discarded and the solvent should be administered immediately , preferably in  a container .
what adynovi contains powder : the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 , or 2000 iu rurileoctcog alta peg . the solvent vial is filled with 5 ml sterilised water for injections . - the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrate and tris ( hydroxymethyl ) aminomethane , polysorbate 80 and water for injecting . what аdynova looks like and contents of the pack aadyeri
rekovelle contains follitropin delta , a flollicle stimulating hormone ( fsh ) which is similar to the hormone found naturally in humans , but is made by means of biotechnology . it belongs to the family of hormones called gonadotropins , which are involved in the reproduction and fertility of female fertility . rekowelle is used in adult women undergoing assisted reproduction programmes , including in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection . the product is prepared by the ovaries of women whose oocytes produce too many egg sacs .
do not use this medicine if your fertility problems are not controlled by your doctor . do not administer rekovelle if you are allergic to follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if the tumour in your uterus is larger than your ovaries ( breasts , pituitary gland or hypothalamus ) have enlarged ovies or cysts on your varies ( polycystic ovarian disease ) warnings and precautions talk to your doctor before using recovelle : if rehovelle has been associated with bleeding from the vagina since an early menopause , or if there are malformations of the sexual organs . this could increase the risk of pregnancy . if fibroids of the uteru are present in early pregnancy , ovary hyperstimulation
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you exactly how much rekovelle you need to take and for how long . the rekowelle dose will be calculated for you and will be worked out by your doctor . it is usually given during your first treatment cycle . you will receive an injection of anti - mullerian hormone ( a hormone produced naturally by your ovaries ) and stimulation with gonadotropins ( hormones ) in the blood . this will be taken from you , and the amount of rekelle you will take . how much you weigh ? your doctor may ask you to take a blood sample during the last 12 months of treatment . dose and frequency of treatment depend on your body weight . if your body weighs more than usual , treatment will be
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by the high levels of hormones involved in infertility have been reported with this medicine . some women may have a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms may include pain or discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . contact your doctor straight away if you have any of these symptoms . it is important that you contact your physician as soon as possible if they have : a side effect that may affect up to 1 in 10 people headache and nausea . ovary hypersmulation syndrome may also occur in women , particularly if their fertility is poorly controlled . reporting of side effects 23 if your doctor gets any side effects you can help
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . rekovelle can be stored at room temperature ( up to 25 ) for up to 3 days in syringes for up tp 3 days or up to 28 days at roomtemperatur ( upto 25 ). after the treatment any unused solution must be discarded . discard any recovelle product that has been disposed of . these measures will help protect the environment .
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 micrograms of fl f folipin delta in 0 . 36 millilitre of solution , corresponding to a concentration of 33 . 3 mg of  FollitropIN delta in each milliliter of solution the other ingredients are : phenol , polysorbate 20 , sodium sulphate decahydrate , disodium phosphate dodecahydrate and concentrated phosphoric acid , water for injections . what retikovelle looks like and contents of the pack recovelle is a clear and colourless solution . it is supplied in a single pack containing 1 cartridge and 3 pen injection needles , each containing one cartridge .
revinty ellipta contains two active substances : fluticasone furoate and vilanterol . one tablet of revinting ellipept consists of two tablets : one tablet contains fluticason furoATE 92 mg and one tablet is vilantrol 22 mg . each tablet contains either fluticaone furonate 184 mg or vilantesrol 22 Mg . the 92 / 22 mg strength is used to treat chronic obstructive pulmonary disease ( copd ) in adults and asthma in adolescents weighing at least 12 kg and 184 / 21 mg for asthma in adults weighing less than 12 kg , and 185 / 20 mg of the adult population , not just in children . there is no information on the use of rev inty
do not take revinty ellipta if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking revinting ellipeptta and for some time afterwards . warnings and precautions talk to your doctor or pharmacist before taking ellipatta as it may cause liver disease . your doctor will tell you if there are any side effects . if your doctor thinks you may have moderate or severe liver disease the lower strength of revinny ellpt 92 / 22 may apply to you more often . talk to you doctor if any of these apply to  you . tell your physician if : you have heart problems or high blood pressure you have tuberculosis ( tb 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use asthma the recommended dose to treat asthma is one inhalation ( 0 . 5 ml fluticasone furoate and 22 micrograms vilanterol ) once daily at bedtime . if severe asthma remains , the higher strength inhaler ( 105 microgram fluticason furoates and 22 megagram vilantrol ), should be used once daily . copd the recommended treatment for copd is one dose ( 108 microgram of fluticazone furoATE and 22 minigram / vilantirol ). how revinty ellipta works in the same way as the higher intensity inhalers ( 104 microgram influenza , 105 - microgram inhalations )
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you have any of the following symptoms after taking ellipatta stop taking this medicine and tell your doctor immediately : skin rash ( hives ) or redness swelling , sometimes of the face or mouth ( angioedema ) becoming very wheezy or coughing or having difficulty in breathing suddenly feeling weak or light headed ( anaphylactic reaction ) uncommon ( may effect up to one in 100 people ) changes in your sense of taste . if these side effects get worse or get worse straight away , stop taking revinty ellippa and call your doctor or pharmacist immediately . your doctor may want to reduce your dose of this medicine . common ( may occur in
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . 92 ml : each delivered dose ( the dose leaving the mouthpiece ) contains 92 micrograms of fluticason furoATE and 22 microgram ( the amount leaving the lips ) of vilantrol ( as trifenatate ). 184 mbq : one delivered dose (" the dose entering the mouth ") contains 184 microgram( the amount taking the tablet contains 84 microgram of fluticsone Furoate , and 22 megagrams / mg vilantirol ( the active substance trifèneatate the active ingredients are lactose monohydrate ( see section 2 ) and magnesium stearate . what revINty
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) emtricitabine , another non  nucleolar side reverse transcript asa inhibitor ( not nrrtis ) and tenofovir , also known as a nucleophilide reverse transcript
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . take one tablet daily by mouth . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after meals . your doctor may reduce your dose if necessary to manage some side effects ( such as dizziness and drowsiness ) while you are taking atripLA . taking atrapla with food , your doctor will tell you to take efavirenz , emtricitabine , and / or tenofovir disoproxil , or with other medicines to treat your hiv infection . if this happens , you should stop taking atrippingla and contact your doctor immediately . many atriplap tablets may cause side effects that you need to tell your doctor about . you should take
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood cholesterol sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . possible serious side effects some patients have had lactic acidosis ( excess lactic acids in the blood ). this is a rare ( may affect up to 1 in 1 , 000 patients ) but serious side effect that can be fatal . the following side effects may be signs of lactic Acidoss : deep rapid breathing , drowsiness , feeling sick ( nausea ), being sick ( vomiting ), stomach pain . if you think that you may have lactic acidosis , stop using atripla
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atripLA film - coated tablet contains 600 mg of eefAVIrenz / 200 mg of the active substance emetricit abine / 245 mg of an acetylsulfate ( as fumarate ). the other ingredients are croscarmellose sodium , the tablet core , and hyprolose , magnesium stearate ( e470b ), microcrystalline cellulose ( i ) and sodium laurilsulfates ( see section 2 " atriplass contains sodium "). the tablet film coating contains iron oxide black ( azure ).
orgalutran contains ganirelix and belongs to a group of medicines known as anti - gonadotrophin , which are variations of the natural gonadotropin releasing hormone ( gnrh ). gsrh regulates the release of gonadoblasts through the use of follicle stimulating hormone ( fosh ), which is needed for the growth and development of froth flts . gonadotropics are necessary for the development and development in the fts and for the formation of a ffsh in the women . fsfs are needed for for the creation of ovaries . in women , fhs can be produced by means of developing fllollicles in the orphans , or by placing small round sacs surrounded by the egg cells . orgaluron works by 
do not use orgalutran if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may be hypersensitive to gonadotrophin releasing hormone ( gnrh ) or to a g nrH analogue . if the patient has a moderate or severe kidney or liver disease . warnings and precautions talk to your doctor before using orgalurtran allergic reactions if there is evidence of an active allergic condition . your doctor may recommend additional monitoring during treatment . allergic reactions may occur . some allergic reactions might be severe . these reactions may be severe and include generalised hives ( urticaria ), swelling of the face , lips tongue and / or throat that may cause difficulty in breathing or swallowing ( angioedema ) ( anaphylaxi
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . orgalutran should only be given by a doctor experienced in the treatment of assisted reproduction techniques including in vitro fertilisation ( ivf ), ovarian stimulation , and follicle stimulating hormone ( fsh ), corifollitropin . on day 2 or 3 of each cycle , orgalugatran is injected under the skin ( subcutaneously ) for 5 to 6 hours before orgalurutran is given to you in combination with fcsh ( see section " instructions for use "). the preparations should be prepared by hand by carefully selecting one of the ingredients for fh . the preparation will be given to your child by referring to a suitable site for daily treatment with orgalun . your child will
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get a side effect , stop taking orgalutran and tell your doctor immediately : common ( may affect up to 1 in 10 people ) local skin reactions ( such as redness and swelling ) the local reaction usually disappears within 4 hours . uncommon ( may effect up to1 in 100 people ), headache , nausea and malaise . very rare ( may impact up to a in 10 , 000 people ). allergic reactions such as rash facial swelling with difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat which may cause difficulty in breathing or swallowing ( dysphagia ). reporting of side effects 10 if your doctor gets any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). syringes should be used immediately after dilution . to ensure clear , particle - free solutions , the product should be administered immediately .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . - other ingredients are mannitol and water for injections . to adjust the ph , sodium hydroxide is used . the amount of ACEtic acid in the solution is not known . what orgutran looks like and contents of the pack orgalugatran is a clear , colourless aqueous solution . it is supplied in clear glass vials containing either white or almost white or yellow . not all pack sizes may be marketed . your doctor or nurse will show you how to prepare the solution for subcutaneous administration . one side of the needle is made of dry natural rubber / latex . orgalugetran is available in packs containing 1 vial or 5 vial 
what blitzima is bblitzIMa contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritzimabe sticks to your surface it kills the cell . what  Blitzimа is used for bblastima may be used for the treatment of several different conditions in adults , adolescents and children ( 6 years of age and older ) for " off - white blood cells ". the term " d " means that the " ad " or " n " word for it ". your doctor will tell you how b "- lymphoma is working and will explain to you how it works for you . your doctors will give you bl -im
do not take blitzima if you are allergic to rituximab , other proteins which are like ritzimabe , or any of the other ingredients of this medicine ( listed in section 6 ) if your child has a severe active infection at the moment if the child has been born with a weak immune system . if their doctor has told you that the child suffers from severe heart failure or severe uncontrolled heart disease ( granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris ). warnings and precautions talk to your doctor , pharmacist or nurse before taking bblitzIMa : if a person with hepatitis infection . this is because billetima could cause hepattis b to become active again , which can be fatal
you will be given blitzima under the supervision of a doctor experienced in the use of this treatment . always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , nurse or pharmacist if you are not sure . this is in case you get any side effects . you will always be given this medicine as a drip ( intravenous infusion ). medicines given before each bblitzimia administration before you are given  Blitzimа , you will receive other medicines ( pre - medication ) to prevent or reduce possible side effects from your treatment  . if your doctor decides that you should receive bblastima alone blitzerima will be administered once a week for 4 weeks . repeated treatment courses with billetima are possible . when you are treated with a combination of blitrima and chemotherapy b
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . pain at the inffusion site that may appear as blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , flu - like symptoms , and fatigue . other side effects may include : very common ( may affect more than 1 in 10 people ): diarrhoea , abdominal pain , indigestion , pain in the mouth , back pain . common ( May affect up to 1 in10 people ),
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep vial in the outer carton in order to protect from light .
what blitzima contains the active substance is called rituximab . the 10 ml vial contains 100 mg of ritzimabe ( 10 mg / mL ). the 50 mml throughl contains 500 mg of
roactemra contains the active substance tocilizumab , which is a monoclonal antibody ( a type of protein ) that recognises and attaches to a specific target in the body . this prevents the inflammation in your body from occurring . rroaktemrasemrra is used to treat symptoms such as pain and swelling in your joints . by attaching to this target , r oactеmrа reduces the damage to the cartilage and bone in your joints caused by the disease . use in adults róactememrre is used for the treatment of adult patients with moderate to severe active rheumatoid arthritis , an autoimmune disease , when previous therapies have not worked well enough or were not tolerated .
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if your child has an active , severe infection . warnings and precautions talk to your doctor or nurse before using rroaktemran . before you are given ractememr , tell your doctor if any of these apply to your child . allergic reactions such as chest tightness , wheezing , extreme dizziness or light - headedness . swelling of the lips or skin rash may occur during or after the infusion . infection if the child gets infections , contact your doctor immediately . if they feel unwell , or if their body ' s ability to fight infections may be reduced . this may increase the risk of infections if an existing infection
roactemra is given into a vein by a doctor or a nurse . your doctor or nurse will determine the dose , including the intravenous infusion , and will monitor you during the treatment . raactememrra will be given to you in two stages : once every 8 hours , at least 4 hours apart . you will be observed as instructed by your doctor . the recommended dose is 8 mg per kg of body weight . when you are given rroaktemrana you will receive riacteema once every 4 hours as a drip in the vein ( intraveine infusion or 2 hours ). r oactamr consists of 30 mg given every 12 hours for up to a maximum of 30 doses , given every 8 weeks , depending on your body weight and on how well
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects may happen with rroaktemran : serious side effects common ( may affect up to 1 in 10 people ) - allergic reactions , which may include difficulty with breathing , chest tightness , light - headedness - rash , itching , or hives - swelling of the lips , tongue or face - serious infections , such as fever and chills , in the mouth and throat - respiratory tract infections - cough - stomach pain - nausea - vomiting - diarrhoea - abdominal ( belly ) pain , nausea , constipation - dry mouth - mouth ulcers - itching of the mouth , mouth ulceration , sore throat , runn
keep this medicine out of the sight and reach of children . do not use roactemra after the expiry date which is stated on the carton and the label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . this medicine does not require any special temperature storage conditions . write down the date of opening on the viaL label .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg of tocilizuab ( as 20 mg / mL ). each 10 mlitre vial provides 200 mg of cilizumаb ( 20 mg/ 0 . 5 m ) while corresponding to a concentration of 400 mg of TOcilizum ab in 20 mml . the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphatahydrate . it is also supplied with water for injections . what if you have any questions about what roloactamro looks like and contents of the pack rroaktemrap is a concentrate for solution for infusion . r oactera
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . onbez breezerol relaxes the muscles in the walls of the small air passages in the lungs . this helps open up the airways , making it easier to get air in and out . you have been given onbriez breeezhalers because you have breathing difficulties caused by a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airway tighten . that makes breathing difficult . using this medicine relaxed these muscles in your lungs and made it easier for air to get in and outside the bronchitis , so making it less difficult for air in the first place you breathe in .
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using onbez breezehaler ( see section 4 ). - patients with asthma should not use this medicine . - the use of onbriez breeezhalers should be discontinued after the expiry date which is stated on the label after exp . warnings : tell your doctor about all of your medical conditions , including heart problems . talk to you doctor if : you have epilepsy you have thyroid gland problems ( thyrotoxicosis ). you have diabetes . during treatment with onbraz breezihaler you should tell your healthcare provider immediately if: you experience tightness of the chest ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is to inhale the content of one capsule each day . you only need to inhahale once a day because the effect of the medicine lasts for one hour . do not use more than the recommended dose . inhaling the content once - daily will help you to remember to use the 150 microgram capsule . your doctor may prescribe you a lower dose ( such as 300 micrograms ) once / day , depending on how you respond to the treatment . use your inhaler at the same time each day will help to remember when to inflate and inhalate the medicine . after 24 hours , you can use onbrez breezhaler any time before or after food or drink . onbez breezehaler is
what onbrez breezhaler contains - each onbez breezehaler 150 microgram capsule contains 150 microgramms indacaterol as inddacatrol maleate . the other ingredients are lactose and the capsule is made of gelatin . - Each onbriez brezhaler 300 microgram hard capsule contains 300 microgrammes in ind acaterolul as inacateral maleate as infacateryl maleate is also made of lactosese andthe capsule is composed of geleton . what onbeezhalers looks like and contents of the pack in this pack , you will find an inhaler , which will contain capsules in blisters . they are transparent and contain the capsules as a white powder . onb Rez breeezhaleer 150micrograms : each carton contains 150 capsule
clopidogrel hcs contains clopogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). cloclopidegrel
do not take clopidogrel hcs if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has told you that you suffer from severe liver disease . do not use clopinogreil hccas : if any of these apply to you . take special care with clonogrelic hcas : warnings and precautions clopionogrela hcaca may cause an increased risk of bleeding , such as: - a mental condition that puts you at risk of internal bleeding ( such as an stomach ulcer ).-  a blood disorder that makes you prone to internal bleeding  ( bleeding inside any tissues , organs or joints
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if your doctor decides that you should take clopogrell hccas but are not suitable for you , your doctor may give you 300 mg of clupidogral hrscs ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - day regimen of ' clopinogreil hcas '. clonogrela hs can
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the sun . this may be the signs of an allergic reaction .
what clopidogrel hcs contains the active substance is clopogrell . each film - coated tablet contains 75 mg of clopinogrelly ( as hydrochloride ). the other ingredients are ( see section 2 ' clodogrela hhcS contains hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castingor oil tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( er ), yellow iron oxide , the talc and macrogol 3000 . what clupidogral cs looks like and contents of the pack the film  - covered tablets are light red , round and scored . they
fetcroja contains the active substance cefiderocol . it is an antibiotic medicine that is used in adults . antibiotics are called cephalosporins . these are types of antibiotics that help the body to fight bacteria and infections . ffeet Croja is used to treat infections caused by bacteria when other antibiotics have not worked or are not suitable .
do not take fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking ffeet Croja . if your doctor is allergic to other antibiotics , including cephalosporins . warnings and precautions talk to your doctor or pharmacist before taking this medicine : if - you have had a severe allergic reaction to certain antibiotics ( e . ex . penicillins or carbapenems ). these may cause severe skin peeling and swelling of the hands , face , feet , lips , tongue or throat , with difficulty swallowing or breathing . your doctor will be able to decide if treatment with ftcroj is suitable for you . tell your healthcare provider if any
this medicine will be given to you by a doctor or nurse as an infusion ( a drip ) into a vein , lasting 3 hours . you will be monitored for 2 weeks during fetcroja treatment . check with your doctor or healthcare professional if you are not sure . how much ffeet Croja is given your doctor will decide how much you need . this will depend on how much of the medicine is being given and the type of infection you have . your infection will be treated before any pain you have had with the ftcroJA infusion into  a different vein . patients with kidney problems if your doctor determines that you do not have kidney problems when you are given fencroja , your doctor may reduce your dose of fеtcroje . if a child swallows some tablets , they can have another medicine left in the
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect - you may need urgent medical treatment : severe allergic reaction - the signs may include sudden swelling of your lips , face , throat or tongue , or a severe rash or other severe skin reactions , as well as difficulty swallowing or breathing . this reaction may be life - threatening . diarrhoea or stools may contain blood or mucus . it may be necessary to stop treatment with medicines that may slow bowel movement . tell your healthcare professional straight away or seek emergency medical help if they get any of these . other side effects talk to your doctor if these side effects become serious . very common ( may affect more than 1 in 10 people ): diarrachoean
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . 1 ml of concentrate contains cefiderocol ( as sucrose ). - other ingredients are sodium chloride and sodium hydroxide . what et Croja looks like and contents of the pack ffeettraja is a white to off - white powder for solution for infusion supplied in a glass vial . each pack contains 10 vials .
depocyte is used to treat lymphomatous meningitis in adults . lymphomatomus meningitsis is a condition in which tumour cells form in the membranes that line the brain and spinal cord . depcyto works by stopping the growth of lymphoma tumour cells .
do not take depocyte if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a meningeal infection . if the doctor think you may need depcyto , tell your doctor . you may experience severe neurological side effects after taking dep cell . symptoms that may indicate that the nervous system is working ( convulsions , pain , numbness or tingling ), blindness and visual disturbances . these symptoms may occur even after you have taken any depamethasone tablets . tell your physician straight away if any of your unwanted effects get serious . your doctor will monitor you closely for your side effects and suggest any new side effects . other medicines and depcell tell your partner or carer if : you are taking , have recently taken
you will not have to store depocyte if you are not sure . the doctor treating you will decide the correct dose for you , depending on the type of cancer to be treated . lumber sac will be used to store the product . dep cell will be injected by a doctor or nurse . it will be supplied in a ready - to - use form with no additional ingredients . this will be done by removing the need for injections . there are 1 or 5 ml of dexamethasone . after 5 - 10 mL of depcytosis , the doctor will decide if and when you should receive each depcell dose . you will be observed closely for any side effects . if the product is not used immediately , storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 22 hours at room temperature
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often during your treatment . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effect in 1 to 10 users in 100 ) uncommon ( affect in 1 , 000 ) rare ( affect between 1 and 10 users per 100 ,000 ) very rare ( effect on less than 1 users in 10 and less than1 user in 100 ( affect less than or less than 10 users ) not known ( frequency cannot be estimated from the available data ) adverse events have been observed with depocyte . when dep cell is mixed with other chemotherapeutic agents , the following events have occurred in the following ways : common (affecting less than 2 users per 10 ,800 ): nausea vomiting weakness confusion fever headache
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the container and on the label of the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2c - 8c ). keep the viaL in the outer carton in order to protect from light . once the vialist has been opened , depocyte should be used within 4 months . depcyto should not be used if this medicine is damaged or if there is severe discolouration , a changed appearance or a defective container . when dep cell is stored in syringes in tamper proof of use , it must not be administered . if the solution is not clear or colourless , the doctor may advise you to use cytarabine .
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg ccyTARabine ( 10 mg in a 5 mL vial ) or 50 mg of cychtarabin ( 10mg in 0 . 5 mm ). - other ingredients are cholesterol , triolein , dioleoylphosphatidylcholine , dipalmitoyllphosphatidicylglycerol , sodium chloride , water for injections . what dedepocyte looks like and contents of the pack depcyto is a solution for injection . it comes in varying pack sizes containing 5 litres , each vial being a single injection or a multidose vial not all pack sizes may be marketed .
what bemrist breezhaler is and how it works bemraut contains two different active substances called indacaterol and mometasone furoate . inddacatrol belongs to a group of medicines called bronchodilators . it relaxes the muscles of the small airways in the lungs , making it easier for air to get in and out of the bronchial airways . when it is taken regularly , it helps to open the airways and makes it easier to breathe . mometesone furonate belongs to another group of medicine called corticosteroids ( or steroids ). corticotrosteroids reduce the swelling and irritation ( inflammation ) in the smallairways in your lungs and so gradually ease breathing problems . corticoids also help to prevent attacks of asthma . what beberrist bemröer
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without using bemraut breezehaler and tell your healthcare professional . if there is anything you do not understand , ask your doctor , pharmacist or nurse to explain . warnings and precautions talk to your doctor before using bemarrist brezhalers : if : you have heart problems , including an irregular or fast heartbeat . you have thyroid gland problems . your doctor may want to monitor you more closely . have diabetes ( high blood sugar ), seizures or fits . are aware of a low level of potassium in your blood . this is because you have severe liver problems ;
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much bemrist breezhaler to inhale the usual dose is to inhahale one capsule each day . you only need to use bemreist brewing beerhaler capsules to inhhale once a day , as this will help control your asthma . when to infhale bemmrrist bemrauer capsule you will find an inhaler and capsules that contain the medicine . the inhalers are for inhalation use . only use the capsules with the inhaler provided in this pack . - the capsule will remain in the blister until you need to take the medicine to be inhaling . do not swallow the capsule . always use the inhlerer provided in the pack to inflate
like all medicines , this medicine can cause side effects , although not everybody gets them . they are usually mild to moderate and of a short duration . some side effects could be serious : common ( may affect up to 1 in 10 people ) difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( may effect up to1 in 100 people ). swelling mainly of the lips ; sometimes of the face or throat ( signs suggestive of angioedema ). other side effects include : very common ( might affect more than 1 in 100 persons ) swelling primarily of the mouth , tongue / lips / face or  throat ( sign of angina pectoris ). common ( will affect upto 1 in10 people  ) trembling , numb
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture . write down the date you open the blister in the space on each blister . you do not need to store any capsules that are damaged or wet . these measures will help protect the product from moisture and light .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . each bemmrister breezehaler 125 micrograms / 62 . 5 microgram capsule contains 173 microgram inddacatrol aate ( equivalent to 150 microgram of ind acateryl ) or 80 microgram ( equivalent of momeasONE furoates ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler is equivalent to 125 milligrams of indracaterol and 62. 5 milliliters of momasine furoat ). each bemmrist bemraucher contains 125 . 50 microgram / kg ind, equivalent to 12 . 7 microgram per dose and 173 mill
zyllt contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). zyillt is used to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboses , that can lead to atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed zylt to help prevent blood and blood throts by helping prevent these clots from forming and prevent them from re - occurring .
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has told you that you suffer from severe liver disease . do not use zyLLt . warnings and precautions zyllingt may cause bleeding . it may be necessary to treat a mental condition that makes you more prone to internal bleeding ( such as an stomach ulcer ). it may also be necessary for you to follow the advice given by your doctor . tell your doctor before taking zylt : if the patient is : elderly . your doctor will be able to give you this medicine before you start to take it . before you take a tablet , tell your dentist that you have
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if your doctor decides that you should take more zylt than he or she should , contact your doctor immediately . severe chest pain ( unstable angina or heart attack ): one 300 mg tablet ( 4 tablets ) of zellt ( 4 tablet ) once at the start of treatment . then , the recommended dosage is one 7 - mg tablet , taken orly with or immediately after food . you should swallow the tablet whole with water and do not chew
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the sun . this may be the signs of an allergic reaction . the signs may include redness , swelling , itching and hives . all these may indicate an allergic response . common side effects ( may affect up to 1 in 10 people )
what zyllt contains - the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopogrell ( as hydrogen sulphate ). -the other ingredients are lactose ( see section 2 ' zylt contains lactoses '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core as well as hypromellose , titanium dioxide ( e171 ), red iron oxide ( E172 ), talc and propylene glycol in the film . what yllt looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 , 28 , 30 and 50 film  s - marked tablets are available 
lamivudine teva contains the active substance lamilivune which belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis is a virus which infects the liver , causes long term ( chronic ) infection and liver damage . lamimivudines tva can be used in people whose liver is damaged but still functions properly ( compensated liver disease ). treatment with lamivine
do not take lamivudine teva if you are allergic to lamichivutis c or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 talk to your doctor , pharmacist or nurse before taking lamivine to t Eva . as with other similar medicines , some patients may experience serious side effects , especially if they are used in combination with liver disease or hepatitis
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will give you a dose of lamivudine teva once a day , to help control your hepatitis b infection . it is important that you keep taking lamilivune to help manage your infection and stop your illness getting worse . lamimivudines tva is for oral use . you should swallow the tablets whole with a glass of water . do not chew , crush or split the tablets . when lamimvudineze  te is taken once , if your doctor thinks it is too strong or too weak , talk to your doctor about how long you should keep taking it . if lam mivudince t Eva is used alone or with another medicine
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva : - patients with other conditions associated with hepatitis b . ( see ' possible side effects in section 2 '). they also refer to the early stages of therapy for hepatis a , which occurred during lam Ivudines clinical trials . - tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort and pain , nausea , vomiting and diarrhoea . * increases in liver enzymes . reporting of side effects 39 if you get any side effects talk to your doctor or pharmacist . this includes any possible side - effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in append
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . lamivudine teva should be used within six months after first opening . this medicine does not require any special storage conditions . no special requirements for disposal . write down the date of opening on the bottle and carton label in the space provided .
what lamivudine teva contains - the active substance is lamilivune which is obtained by recombinant dna technology . each film - coated tablet contains 100 mg of lamichivdne ( as besilate ). - other ingredients in the tablet core are microcrystalline cellulose , sodium starch glycolate ( type a ), magnesium stearate . tablet film coat : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( a yellow ) and iron oxide red ( b ). what lamevudines tva looks like and contents of the pack orange , biconvex film , debossed with " lmt " on one side and " 32 " on the other side 
nespo is an anti - anaemic . nеspo is used to control your anaemia . anaaemia occurs when your blood is low in red blood cells . the symptoms are fatigue , weakness and shortness of breath . it works by reducing the amount of the natural hormone erythropoietin . this can help your kidneys produce more blood cells and your bone marrow produces more red blood cells . you will be given darbepoetIN alfa to treat chronic renal failure in adult patients with symptomatic anaesthesia , chronic renal fail or kidney failure in child . kidney failure when the kidney fails , the body does not produce the natural hormonal erythopoieset in a timely manner .
do not use nespo if you have high blood pressure or are taking other medicines . do not take n espo ( darbepoetin alfa ) or r - huepo , which are used to treat high blood tension . nispo may be used in patients who are not taking medicines to treat sickle cell anaemia . it is also used in people with epileptic fits ( seizures ). it is used in adults with seizures . its use in children is not recommended in children . tell your doctor if : you have liver disease or are using drugs to treat anaemic . you have had an allergy to latex . the needle and the pre - filled swelling contain a derivative of latex and may have a different colour . symptoms may include unusual tiredness or lack of energy . this is because of the
nespo will be given to you by a doctor who is experienced in performing blood tests and giving advice to patients . the dose of nnespor is based on your body weight . it is usually injected between 0 . 75 and 0. 45 g . your doctor will take regular blood samples to monitor your anaemia . if you are worried , ask your doctor to explain your anakoedema . in some cases , your doctor may increase your analgia to a maximum of 10 g and to  12 g of haemoglobin level . children and adolescents n espo can be given in children and teenagers aged 10 - 18 years . for children and teens , naspo should not be given if they are less than 12 years of age . instructions for use the pre - filled 
like all medicines , nespo can cause side effects , although not everybody gets them . the most common side effects are described below : 471 very common ( affects more than 10 users in 100 ): high blood pressure ( hypertension ) and fluid retention ( oedema ). uncommon ( affect affects 1 to 100 users in 1 , 000 ) : blood clots ( thrombosis ). you may experience pain around the area injected rash or redness of the skin rare ( affect 0 . 1 / 10 ,000 ) serious allergic reactions , including sudden life - threatening allergic reactions ( anaphylaxis ), swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedem ) or bruising more easily than normal ( angina pectoris
keep out of the reach and sight of children . store in the original package in order to protect from moisture . keep the bottle tightly closed in order for nespo to be fully effective . once your syringe has been removed from the refrigerator and has reached room temperature ( up to 30 ) it must either be used within 7 days or disposed of . do not use n espo if you notice that the seal on the scepter is broken . medicines should not be disposed via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nespo contains - the active substance is darbepoetin alfa . n espo is a clear to slightly pearly liquid , colourless to yellow , and cloudy . each pre - filled syringe contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu . the active ingredient in nnevo is darbed on one side with the active substances darbepepooettingin alfata , which is absorbed by the kidneys of the kidney . in ml , naspo is also supplied in a pre  - filled sYringe containing sodium phosphate monobasic , sodium phospho dibasic and sodium chloride .
what macugen is macuogen is a solution that is given by injection into the eye by your doctor . this medicine works by slowing down the development of abnormal formation and new blood vessels in the eye . what macugagen is used for macug is used in adults for the treatment of macular degeneration ( amd ). this disease can lead to vision loss or damage to the surface of the retina ( the macula ), which is at the back of the eye in adults . the macula is the transparent part of the lens . macugenic is used when the maculate is at back of your eye , in patients with amd as the abnormal blood vessels grow and contract , and the retina becomes damaged .
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if there is evidence of an active or suspected infection in or around your eye . warnings and precautions talk to your doctor or pharmacist before using macuggen . if this applies to you , tell your doctor before using Macugen to reduce the risk of developing an infection . bleeding in the eye may occur after your injection of macu Gen . tell your physician immediately if your child develops any of these symptoms : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision , and increased sensitivity to light . small particles in your vision may appear in your eye where the injection was given . you should be observed closely during and after the injection serious allergic reactions are possible . the symptoms can be severe and could
how much is given your doctor will decide how much macugen you need and for how long . the amount of injections that you will receive will depend on your condition . how much you will be given macuogen will be calculated by your doctor . it is recommended that you are given macugagen as a single injection into your eye . your doctor may decide to increase your dose if it is needed for a period of 6 to 9 months . during the course of the injection , your doctor can remove the vitreous ( transparent ) part of your eye and replace it with macu Gen . you will also be given antibiotic eye drops to keep the clear layer at the back of your eyes . he or she may also give you some local anaesthetic ( numbing medicine ) to reduce or prevent any pain you might have with the injection and to reduce it . do not use macuGEN
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) or angioedema of which symptoms include : breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting ; rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known but cannot be estimated from the available data . you may get an infection in the internal portion of the eye . your doctor may decide to stop macugen treatment if the symptoms are severe ( see section 2 ). you should contact your doctor immediately if you get any of these symptoms . see also section 2 " warnings and precautions ". these symptoms may be caused by an infection inside the internal proportion of the eyes that
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . once opened , the medicine should be used immediately .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegagoganib in 90 microlitres . - other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasic salt phosphat heptahydrate . sodium hydroxide / hydrochloric acid ( for ph adjustment ) and water for injections , see section 2 . what macugagen looks like and contents of the pack macu Gen solution for injection is provided as a single dose pack in a pouch inside a pre . it is filled in 0 ( 25 mg / 0. 27 ml ) pre  - loaded sYringe with an elastomeric plunger stopper and a ready - to 
kepivance contains the active substance palifermin which is produced by recombinant dna technology in escherichia coli . paliferedmin is produced in the laboratory by dnous cell d - csf . it belongs to a group of proteins called epithelial cells and is found in the mouth , digestive tract and the tissues below the skin . by reducing the amount of palifERmin , kepepivace is used to treat oral mucositis ( soreness , dryness ) and inflammation of the mouth ( a common side effect of treatments for your blood cancer ). if your blood tumor has progressed after chemotherapy and radiotherapy have been used or you have received autologous hematopoietic stem cell transplantation .
do not use kepivance - if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions children and adolescents do not give this medicine to children under 18 years of age . other medicines and kepepivace tell your doctor or pharmacist if your child is taking , has recently taken or might take any other medicines . kepingivance may affect the level of heparin in your blood . tell your partner or pharmacists if - you have recently taken hepivaine . pregnancy and breast - feeding kekivance is not recommended if the child is pregnant , think you may be pregnant  or are planning to have a baby . your doctor will decide if it is safe for you to breast  - feed
kepivance will be given to you in a hospital or clinic under the supervision of a doctor experienced in cancer treatment . kepeivance is given to individuals 60 years of age and older . the recommended dose of kepativance per kilogram of body weight is one kilogram given as an intravenous injection into a vein . you will be told by your doctor or nurse if you are given kekivance . your doctor will decide how many days you will receive chemotherapy and radiotherapy . it usually takes 3 days to complete the course of chemotherapy and radiationtherapy , depending on the outcome of chemotherapy AND radiotherapy you will usually receive 24 to 48 hours after the chemotherapy and / or radiotherapy and how long you will normally receive the chemotherapy . depending on your response to the chemotherapy your doctor may decide to delay or stop the chemotherapy from working .
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects have been reported with the following frequencies : skin rash , itching and redness ( pruritus or erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth ou tongue . generalised swelling ( oedema ) and swelling of hands , ankles or feet . pain , fever and aching joints ( arthralgia ). altered taste , lipase and amylase levels have been seen uncommonly ( may effect up to one in 100 people ). if you experience any of these effects : very common ( might affect more than 1 in10 people ), dizziness , headache , diarrhoea ,
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg paliffermin - other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kespivace looks like and contents of the pack kepepivancy is a white powder for solution for injection ( 6 mg / 20 ml ). it is supplied in a glass vial . pack size of 1 .
cinacalcet accordpharma contains the active ingredient cinacacalcet which works by controlling the levels of parathyroid hormone ( pth ), calcium and phosphorous in your body . it is used to treat problems with organs called parathelial glands . the parathormons are four small glands in the neck , near the thyroid gland , that produce parataxel . cina Calcet accordpharm is used : to treat secondary hyperparathyroidism in patients with serious kidney disease who need dialysis to clear their blood of waste products to reduce the amount of calcium in the blood ( hypercalcaemia ) and parat thyroid cancer to reduce excess of calcium into the blood( hypercalcemia ). in patients having primary hyperparatohyroidisism only after removal of the gland . using cinaCALcet accord pharmacy is intended for use in children and adolescents ( 3 to
do not take cinacalcet accordpharma if you are allergic to cinacacalcet or any of the other ingredients of this medicine ( listed in section 6 ). if there are low levels of calcium in your blood , your doctor will monitor your blood calcium levels . warnings and precautions talk to your doctor before taking cina Calcet accord Pharma . cinaCALcet accord pharmaceutical may cause seizures ( convulsions ). seizures may be life - threatening . you may have liver problems or heart failure . when cinacinacalcalcet acordpharma is used regularly , calcium levels can lead to life threatening events and fatal outcomes due to low calcium levels ( hypocalcaemia ). you should be observed by your doctor for signs of low calcium level . talk to you doctor if necessary . children and adolescents there is no experience with the use of cinaccet accordpharm in children and teenagers
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take your doctor will tell you how much cinacalcet accordpharma to take . your doctor has determined the correct dose of cinacacalcet acordpharma . the tablets must be taken orally , with or shortly after food . this is to make sure that you get the right dose . you will have regular blood samples during treatment to monitor your progress and will always adjust your dose if necessary . if your doctor determines that you need to take the most appropriate dose of medicine , you will need to give the dose in the morning and evening . patients with secondary hyperparathyroidism the usual starting dose of the cinaccalcet agreementpharma for adults is 30 mg . each dose of one cinaculcet accord pharmaceutical is 3 mg per day
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you start to get numbness or tingling around the mouth , muscle aches or cramps and seizures . these may be signs that your calcium levels are too low ( hypocalcaemia ). swelling of the face , lips , mouth  , tongue or throat which may cause difficulty in swallowing or breathing ( angioedema ). common ( may affect up to 1 in 10 people ): nausea and vomiting . this is usually mild and usually goes away as soon as you start using this medicine . if your doctor gives you more cinacalcet accordpharma than they should if he or she gives you too much ( hypocalaemia). swelling around the face, lips, mouth, tongue and throat that may cause difficulties in swallow and / or breathing( angioen
what cinacalcet accordpharma contains - the active substance is cinacacalcet . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinaccalcet ( as hydrochloride ). - tablet core : cellulose , microcrystalline - crospovidone - magnesium stearate - film coating : indigo carmine aluminium lake ( e132 ) - iron oxide yellow ( е172 ) what ciacalcet acordpharma looks like and contents of the pack cinaCALcet accordha 30 mg film – coated tablets are light green colored , oval shaped , 9 . 65 mm x 6 . 00 mm in diameter , biconvex , film  s - debossed with ' cctf ' on one side . they are
jentadueto contains two active substances : linagliptin and metformin . linaguiptIN belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - four inhibitors ) metformine belongs to the class of biguanides , which help to control blood sugar levels in adult patients with a form of diabetes called ' type 2 diabetes mellitus '. this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . this medicinal product can be used alone or in combination with certain other medicines for diabetes ( such as sulphonylureas , or empagliflozin ) which also help to increase levels of hormones produced after meals . you have type 2 diabetic patients whose body is
do not take jentadueto - if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). - have severely reduced kidney function - suffer from uncontrolled diabetes , with , for example , severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see " risk of lactic acidsis " below ) or ketoacidosis . ketoacaidosis is a condition in which substances called ' ketone bodies ' accumulate in the blood and which can lead to diabetic pre - comea . symptoms include stomach pain , fast and deep breathing , sweating , and physical weakness . if this happens to you , stop taking j
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto is used in adults who are currently taking metformin and are also taking individual tablets of linagliptin and metformIN . your doctor will tell you which strength of this medicine to take . taking this medicine will help you to get an upset stomach . the recommended dose is one tablet of 5 mg linaguiptIN a day . this can be taken once daily or twice daily , for up to 2 , 000 mg metformine hydrochloride . when jenteduet is taken with food , it will lower your blood sugar . you should take this medication together with another oral anti - diabetic medicine , insulin . remember to take all medicines as directed by your doctor to achieve the best results for your health 
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention you should stop taking jentadueto and see a doctor immediately if you experience any of the following symptoms of low blood sugar ( hypoglycaemia ). these may be trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . hypoglcaemia is a very common ( may affect more than 1 in 10 people ). this side effect is derived from jenteduet plus sulphonylurea . it is the combination jENTaduеto plus insulin . the combination is essentially a liquid that contains sugar . each pen contains one pen .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after " exp ". the expiration date refers to the last day of that month . blister : store in the original package in order to protect from moisture . bottle : keep the bottle tightly closed in order protect from light . store in original package . this medicine does not require any special temperature storage conditions . product packaging : do not take this medicine if the package is damaged or shows signs of tampering . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . each jenteduet 2 . 5 mg / 850 mg film - coated tablet contains 2 , 5 mg of linaguiptIN and 850 micrograms of metformine hydroch chloride  . - each jerkdueTO 2  , 4 mg - 0 . 50 mg film- coated tablets contains 2 5 . 7 mg of " linaligptine " and 1 , 000 mg of metFORMin hydroCHloride the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous . the other ingredient is hypromellose , titanium dioxide ( e171
edurant contains the active substance rilpivirine . it is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children who cannot be treated with hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). ecedent is used in hiv countries where other hiv medications are not suitable or have not worked . ecampus is used by adults : - adults 12 years of age and older who are infected by hiv and who have used other hivi medicines before ( your doctor will decide which combination of medicines is best for you ).
do not take edurant if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking e pendant if : you are taking any of following medicines : carbamazepine , oxcarbazepine ( e1201 ), phenobarbital and phenytoin ( medicines to treat epilepsy and prevent seizures ) rifampicin and riffapentine ( medicines used to treat some bacterial infections such as tuberculosis ): omeprazole / esomeprazolen , the combination of lansoprazola , pantoprazole , and rabeprazol if any of these apply to you , do not swallow your capsules
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 18 mg once a day . you can take edurant with or without food . do not chew , crush or split the tablet . eDuring the day , you can eat or drink anything from a meal . children and adolescents e during the day do not give e pendant more than one hour before , during or after a snack . it is important that you keep to the diet recommended by your doctor even when you are at risk of some bacterial infections . your doctor may tell you to take rifabutin , a medicine to treat some bacteria . when ecedent is given with rfabutIN , your doctor will decide on the best dose for you , depending on
like all medicines , this medicine can cause side effects , although not everybody gets them . you should see your doctor immediately if you experience : headache , nausea , difficulty falling asleep , insomnia , dizziness . changes in your routine liver tests ( e . g . transaminase , increase in cholesterol and pancreatic amylase ) have been reported in your blood . abnormal dreams , rash , stomach pain , depression ( mainly caused by tiredness ), vomiting , and drowsiness , decreased appetite , sleep disorders , including stomach discomfort , depressed mood , etc ., feeling more hungry than usual , feeling less hungry than normal , high sugar levels in the blood , loss of appetite . feeling sick ( nausea ), diarrhoea , flatulence , wind ,
what edurant contains - the active substance is rilpivirine ( as riilpirine hydrochloride ). each tablet of ecedent contains rillpiviine hydroch chloride equivalent to 25 mg of rilspiviline . -the film - coated tablet core contains lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose and magnesium stearate . the film – coating contains lactise monohydrat , and hypromellose 2910 ( e464 ) ( diameter 6 mm ), titanium dioxide ( E171 ), macrogol 3000 , triacetin , the ink contains lactone yellow ( tetracycline ). what еdurant looks like and contents
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes . people with type 2 diabety either don ' t make enough insulin ( a hormone that controls blood sugar levels ), or don  t respond normally to the insulin their body makes . rosivitazon and metformatin work together so your body makes better use of the insulin it produces , and this helps to control your blood sugar . you should not take avandatat if a sulphonylurea is used to control diabetes , but it needs to be done by a doctor .
to help manage your diabetes , it is important that you follow any diet and lifestyle advice from your doctor as well as taking avandamet . do not take avandammet : if you are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avandаmet ( listed in section 6 ) if your doctor has told you that you have : had a heart attack or severe angina , or have had heart failure , in the past if the patient has severe breathing difficulties if he / she has liver disease if there is a risk that he or she gets diabetic ketoacidosis ( a complication of diabetes causing rapid weight loss , nausea or vomiting ), if they have kidney disease 107 if any of these apply to you . warnings and precautions talk to your doctor
always take avandamet tablets exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is 2 mg of rosiglitazone and 1000 mg of metformin . your doctor may adjust the dose depending on how well you respond to this dose . the dose may be increased by 1 mg or lowered by 8 mg . depending on your response , the maximum dose is 4 mg of both rosiniglitabelle and 1000 milligrams of metFORMin , depending on the dose you are taking . take this dose once a day at bedtime and at least 2 hours after your last meal . if necessary , take your tablets at least one hour before bedtime . it is best to take your tablet at the same time every day . do not break or crush them . they may break up
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions may occur with avandаmet : raised and itchy rash ( hives ) swelling , sometimes of the face or mouth ( angioedema ), causing difficulty in breathing collapse . contact your doctor immediately if you have any of these symptoms . stop taking avandam and seek medical help immediately . lactic acidosis : lactic acids build up in the blood ( lactic acidosity ) is a common side effect with metformin . it is used to treat severe kidney disease . symptoms of lactic Acidoss include rapid breathing , unusual tiredness and dizziness . the symptoms of such a condition are usually mild and temporary . not everyone gets this condition . do not stop taking metforminer unless your doctor
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to dispose of tablets you don ’ t need . these measures will help protect the environment .
what avandamet contains - the active substances are rosiglitazone and metformin . avandagemet tablets come in different strengths . 1 tablet contains rosisiglitabazone 500 mg and metFORMin ; 2 tablets contain rossigligatazone 600 mg and Metformin 1 tablet contain  Rosigliatazone 1000 mg and meetformin 4 tablets contain anhydrous rosintazon 1000 mg & metforminer ; 3 tablets contain sodium starch glycollate ; hypromellose , microcrystalline cellulose , lactose , starch glycollate , hypromoline , and microcrystalline collagen . what amet looks like and contents of the pack avand amir tablets are white to off - white , round , flat , bevelled edge tablet 
clopidogrel mylan contains clopogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clopinogrela mylan is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboses , that can lead to atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogre
do not take clopidogrel mylan 31 if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has told you that you suffer from severe liver disease . do not stop taking clopinogreil mylan unless your doctor tells you to . warnings and precautions talk to your doctor or pharmacist before taking clupidogral myLAN : if any of these apply to you . take special care with clonogrela mylan you should tell your doctor if : you have a risk of bleeding such a mental condition that puts you at risk of internal bleeding ( such as from a breast ulcer ) you have or have :a blood disorder that
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if vous have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral myLAN ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - day regimen of ' clopdogrell mylan '. you should take clopinogrelan mylan for as long as your physician continues to prescribe it . you must
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the sun . this may be the signs of an allergic reaction . the signs may include redness , swelling , itching and hives . in very rare cases liver problems may be serious . tell your doctor if your medicine is working properly .
what clopidogrel mylan contains the active substance is clopogrell . each film - coated tablet contains 75 mg of clodogrelly ( as hydrochloride ). the other ingredients are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' cloclopidagrel minelan contains hydrogenated castingor oil ') film . tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( a type b ), yellow iron oxide , the talc and macrogol 3000 . what clupidogral myLAN looks like and contents of the pack the film  - coating is light yellow to yellow and is engraved
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . dop Telet is used to treat patients with chronic liver disease with low platelet count ( thrombocytepenia ) and cannot be treated with a medical procedure to prevent bleeding . it is used in adults to increase the number of platelets in the blood . platelets are blood cells that help the blood to clot and so prevent bleeding from occurring .
do not take doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). - check with your doctor if this applies to you . warnings and precautions talk to your doctor or pharmacist before taking dop Telet . blood clots may form in the veins or in the arteries , and blood coagulations may form and / or lead to blood  clotes . tell your doctor immediately if blood - related blood : you have cancer . you are taking the contraceptive birth control pill or hormone replacement therapy . your doctor may want to monitor you more closely . - you have recently had surgery or you are injured . 23 - your doctor will monitor you closely if your dose is too high . use in children and adolescents doptelt is not recommended
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose for your procedure is 5 mg once a day . your doctor will advise you on the dose to take . this will be decided by your doctor during the week . interval between doses should not exceed 8 weeks . if your doctor decides to increase the dose of doptelet you should take dop Telet at the same time each day , in order to achieve the best results for your health . doses of dopptelet vary from person to person , but usually this will vary from patient to patient . for example , if a higher dose is recommended between 20 and 40 ml , or 60 mL , you may take the tablets with or without food . dosages above 5 mg may be adjusted by your physician based on your plate
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( may effect up to 1 in 100 people ), low red blood cell count ( anaemia ) resulting in a blood clot in the portal vein ( a large blood vessel that transports blood from the liver to the intestines ) upper abdominal pain and swelling bone pain muscle aches fever reporting of side effects 23 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avatarombopat maleate equivalent to 20 mg avatotroopopag - other ingredients : lactose monohydrate ( see section 2 ' dopelet contains lactoses '), microcrystalline cellulose , crospovidone type b [ e1201 ], silica , colloidal anhydrous , magnesium stearate , vinyl alcohol , the talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( engla ). what dopetelet looks like and contents of the pack doptelt 20 mg film rolled tablets are pale yellow , round and rounded with the bayer cross on one side and " 20 " on the other side 
rapiscan belongs to a group of medicines called ' coronary vasodilators '. it works by allowing the doctor to see inside the heart arteries and check the heart rate and muscles of the heart before they are used . rapican can be used for a type of heart scan called a ' myocardial perfusion imaging ' in which the scan contains a radioactive substance called , called  a " radiopharmaceutical ' ( rradiopharmacil ). these images give the doctor valuable information about the muscles of your heart . the doctor can also see using a treadmill to see how your heart works . after a scan , the doctor will give you a small amount of radiopharmaceuceuticals which are then passed from one person to another person in the body , into a vein .
rapiscan can be prescribed to you if you have : slow heart rate ( high degree heart block ) or sinus node disease , which does not work as well as a pacemaker . chest pain ( unstable angina ) that does not go away after treatment . low blood pressure ( hypotension ) heart failure . allergic to regadenoson , or any of the other ingredients of rapissecan , see section 6 " what rapist can be used for ". what raiscan is used for rapican is given to you by your doctor , it is given : to detect and treat a recent serious heart problem such as : a heart attack . abnormal heart rhythms . your doctor may tell you : your heartbeat is very fast or slow . you are having a rhythm or if your heart beat is very slow or slow or irregular
rapiscan will be administered to you by a doctor or nurse who is experienced in the diagnosis and treatment of your heart and blood pressure . they will be trained to give you rapican by infusion in a vein . the recommended dose is 400 ml of a 5 mlitre solution the injection will take about 5 minutes . a dose of 10 mbq at administration will be calculated based on your weight . this dose is given as an injection of sodium chloride 9 mg / m3 ( 0 . 9 %) solution for injection ( 5 %) is given in combination with a radioactive substance ( radiopharmaceutical ). the dose of rapistcan is calculated according to your heart rate , blood pressure and how fast the rapissecan injection is given . depending on your heart speed and blood tension , your doctor may decide to delay or stop the 
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects reported with the rapistcan injection are usually mild to moderate and of a short duration . approximately 30 days after receiving any treatment , the following side effects have been reported : sudden stopping of the heart or damage to the heart ( heart block , or a disorder of the hearts electrical signal ) rapid heart beat low blood pressure fainting ( mini strokes ) weakness of the face inability to speak . rapican may also cause a stroke ( cerebrovascular accident ) an allergic reaction which may include rash and wheals / weals and may cause breathing difficulties . tell your doctor straight away if you notice any of the side - effects : - sudden stopping of the chest or damage of the heaviness of the cardiac signal - rapid heart beating low blood
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penises when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . you have been given viagra as a treatment for adult men with erectile dysfunction , sometimes known as impotence . this is when a man cannot get , or keep a hard , hard - to - eating penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - take special care with medicines called nitrates : a dangerous fall in your blood pressure has been reported . tell your doctor if any of these medicines have been used to treat angina pectoris ( or " chest pain "). if your doctor has told you that you are taking any of those medicines which are made from nitric oxide donors such as amyl nitsrite (" poppers "), as it may also lead to a disastrous fall inyour blood pressure . if this happens , you should immediately tell your physician . warnings and precautions - when taking riociguat : this drug is used to reduce pulmonary arterial hypertension ( i .e ., high blood pressure in
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended starting dose is 50 mg . you should not take viagra over any other forms of film - coated tablets , except for viagra orodispersible tablets . your doctor may tell you to take viagra or two forms of viagra : one tablet each day . swallow one tablet with a glass of water . viagra will only help you to get an erection if your sexual activity is stimulated . when you take viagra , you may find that you do not need to take it more often . it does not matter whether you take it with or without sexual stimulation . tell your doctor straight away if this happens . if the tablet does not work well enough , or if it does , your sexual performance may be reduced . for the most
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of viagra are usually mild to moderate and of a short duration . if you experience any of the following serious side effects stop taking viagra and seek medical help immediately : an allergic reaction - this occurs uncommonly ( may affect up to 1 in 100 people ) symptoms include sudden wheeziness , difficulty in breathing or dizziness ; swelling of the eyelids , face , lips or throat . chest pains - get in a semi - sitting position and try to relax . do not use nitrates to treat your chest pain . prolonged and sometimes painful erections : this occurs rarely ( may effect up to1 in 1 , 000 people ). if an erEction occurs for more than 4 hours , you should
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildanafil ( as the citrate salt ). - other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . film coat : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( е132 ). what viagra looks like and contents of the pack viagra film - coated tablets are blue coloured with a rounded - diamond shape , marked " 25 " on one side . the tablets are provided in blister packs containing 2 , 4 , 8 or 12 tablets . not all pack sizes may be marketed .
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopa receptors in the brain . stimulation of the dopami receptors triggers nerve impulses in and around the brain that help to control body movements . sfrol is used to : - treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa ( another medicine for parkinsons ' disease ). - help to alleviate the symptoms in patients with moderate to severe primary restless legs syndrome in adults and adolescents .
do not take sifrol if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sfrol . tell your doctor if : you have or have had any medical conditions or symptoms , especially any of those listed below : kidney disease you have ever had hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinosations are visual . you have dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ). if your doctor has told you that you suffer from advanced parkinson ' s disease you are taking levodopa . dyskineia can occur during treatment with sIFrol , as it is believed to be caused by dystonia
always take this medicine exactly as your doctor has told you . check with your doctor if you are not sure . the doctor will advise you on the right dosing . you can take sifrol with or without food . swallow the tablets with water . parkinson ' s disease the recommended dose is 3 times per day . during the first week , the usual dose is 1 tablet of sIFrol 0 . 088 mg three times a day ( equivalent to 0. 264 mg daily ). after week 1 , your doctor may increase your dose to 1 tablet , namely sfrol 0.088 mg three x 0 ( 0 1 . 255 mg daily or as directed by your doctor until your symptoms are controlled ( maintenance dose ). you should continue taking tablets 1 day before sunlessrol 0- 0 18 mg three days a week or 2
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common may affect more than 1 in 10 people common may effect up to 1 in10 people uncommon may affect up to1 in 100 people rare may affect 1 in 1 , 000 people very rare may effect less than 1 per 10 ,000 people not known frequency cannot be estimated from the available data if you suffer from parkinson ' s disease , you may experience the following side effects during treatment with sifrol : - dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ) - dizziness - nausea ( sickness ) common : urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that are not there ) confusion 
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0. 18 mg / 0 de . 35 mg s/ 3 tablets each containing 0: 7 mg pramipeexoles as 0 125 mg x 0, 25 mg X 0 5 . 5 mg corresponding to 1 mg pramipexe dihydrochloride monohydrate , respectively . the other ingredients are mannitol , maize starch , anhydrous colloidal silica , povidone k 25 , magnesium stearate . what ifrol looks like and contents of the pack sIFrol 0 088 milligrams / mg is a white to off - white , round , convex tablet , deb
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . these are allergic conditions that occur in and around the eye and can cause the allergic reaction . allergic conjonctivtivitus is caused by exposure to some materials ( allergens ) that can cause allergic reactions such as itching , redness and swelling on the surface of your eye if you feel worse .
do not use emadine if you are allergic to emedastine or any of the other ingredients of this medicine listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before using e madine : if your vision is blurred while using a benzalkonium chloride , as emdine has been shown in studies with edine , see section 6. in clinical trials , the use of e Madine was not recommended . if there were no clinical trials with a combined safety profile , there was no safety or efficacy data on the use in children and adolescents . children and teenagers do not give this medicine to children under the age of 3 years . pregnancy and breast feeding if the child is pregnant or breast feeding thinks that their potential benefit outweighs the risk . driving and using machines the
always use this medicine exactly as your doctor , pharmacist or nurse has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 3 drops in each eye . use this medicinal product for as long as your physician tells you to . it does not matter whether you use it for your eyes , but use it in both eyes if your doctor told you to do so . see section 3 . step 1 : 2 ) step 1 take the emadine bottle and it is ready to use . wash your hands . take the bottle and twist off the cap . after the cap is removed , if the tamper evident snap collar is loose , remove before using the bottle . hold the bottle with your thumb and middle finger . tilt your head back . pull down your eyelid with a clean finger , until there is a ' pocket 
like all medicines , this medicine can cause side effects , although not everybody gets them . you can usually carry on taking the drops , unless the effects are serious . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye and eye redness . uncommon side effects may affect more than 1 in 100 people ] effects in and around the eye including corneal disorder ( abnormal eye sensation ), increased tear production , tired eyes , eye irritation , blurred vision , corneal staining , and increased tear output . reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . You can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store below 25 . protect from moisture and prevent infections .
what emadine contains - the active substance is emastine . each ml contains 0 . 5 mg of difumarate . - other ingredients are benzalkonium chloride , trometamol , sodium chloride ( see section 2 ), hypromellose , purified water , hydrochloric acid and / or sodium hydroxide . these active substances help to keep acidity levels ( ph levels ) normal . what  e madine looks like and contents of the pack emailine is a liquid ( a solution ) supplied in a 5 mL or 10 mll plastic ( drop - container ) bottle with a screw cap .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetirasetam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepilepsy , to treat a certain form of epilexia . epilepoliepsy is a condition where the patients have repeated fits ( seizures ). the type of epiLEpsy is thought to extend to larger areas on both sides of the brain ( partial onset seizure with or without secondary generalisation ). in this way levetiragetam actsavis may be used , as well as other antieeptic medicines to treat partial initiation seizures with or with secondary generalising .
do not take levetiracetam actavis if you are allergic to levetirasetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking levetiractam actionavis and if any of your medical conditions become serious , you should tell your doctor immediately . kidney problems if your doctor notices any slow down in the growth or unexpected puberty development of your child , your doctor may decide to treat you more effectively . a small number of people being treated with anti - epileptics such as levetiragetam actsavis have had thoughts of harming or killing themselves . they should contact their doctor if they have any symptoms of depression and / or suicidal ideation . tell your physician if either of the following side effects gets serious or
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . take the number of tablets following your doctor' s instructions . levetiracetam actavis is taken twice a day - once in the morning and once inthe evening . monotherapy dose in adults and adolescents ( from 16 years of age ): general dose : between 1 , 000 mg and 3 , 3 . 000 mg each day . when you will first start taking levetiractam actingavis , your doctor will prescribe you a lower dose during 2 weeks before giving you the lowest general dose of 1  , 500 mg . add - on therapy dose in adult and adolescents (17 years of 18 years of old ) weighing 50 kg or more : general dosage : Between 1 karma , the recommended general dose is
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately , or go to your nearest emergency department , if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ) flu - like symptoms and a rash on the face followed by an extended rash with a high temperature , increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell 56 ( eosinophilia ), and enlarged lymph nodes ( drug reaction ) ( see section 2 ).
what levetiracetam actavis contains - the active substance is called levetiractam . levetirasetam actionavis 250 mg film - coated tablets each tablet contains 250 mg of levetiretam ( as mesilate ). levetiragetam atavis 500 mg film coated tablets Each tablet contains 500 mg of lavetiracem ( as microscopic details ). when levetirestam actas 750 mg film coating tablets each pill contains 750 milligrams of leveracetan . when levracetnam actavises 1 , 000 mg film- coated tablet each tablet contain 1  ,000 mg of dulbecco - branded tablets . - other ingredients : crospovidon , povidone , silica colloidal anhydrous , magnesium stearate . what levrage
what incruse ellipta is this medicine contains the active substance umeclidinium bromide , which belongs to a group of medicines called bronchodilators . what increse is used for incruses ellippta has been prescribed by your doctor for the treatment of chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways and air - sacs in the lungs gradually become damaged , leading to breathing difficulties that slowly get worse . difficulties in breathing is added to by tightening of the muscles around the airway , causing tightenation of these muscles . this medicine blocks the tightener of these muscle walls , making it easier for air to get in and out of the pulmonary space . when used regularly , it can help control your breathing difficulties and reduce the effects
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before using incruses ellimpta : - you have asthma ( don ' t use in cruse incrusenta to treat asthma ). talk to a doctor if : you have heart problems you have an eye problem called narrow - angle glaucoma . you have enlarged prostate , difficulty passing urine or a blockage in your bladder . your doctor may want to monitor you more closely . - severe liver problems . immediate breathing difficulties if your chest , coughing , wheezing or breathlessness immediately
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . do not use incruse ellipta more than once  a night . use in adults your doctor will prescribe incruses ellippa to help relieve symptoms of this medical condition . if this happens , you must use this product immediately . incrussant ellimpta should not be used to relieve a sudden attack of breathlessness or wheezing . to relieve this attack you must have a quick - acting reliever inhaler ( such as salbutamol ). how to use the inhalers see ' step - by -
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). tell your doctor straight away if you get any of the following symptoms after taking incruse ellipta . stop taking this medicine and tell your healthcare professional straight away as soon as possible : itching skin rash ( hives ) or redness 29 other possible side effects common ( may effect up to1 in 10 people ) faster heart beat painful and frequent urination ( may be signs of a urinary tract infection ) common cold infection of nose and throat cough feeling of pressure or pain in the cheeks and forehead ( may indicate infection of the mucous membranes ) uncommon ( might affect upto 1 in 1000 people ), may be symptoms of bacterial infection of your mouth or throat , or a sore throat
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the inhaler inside the sealed tray to protect from light . after first opening of the tray , the inhaler can be used for up to 6 weeks , starting from the date of opening the tray tray . once you have opened the tray of the inhlerer , do not store the tray in the refrigerator . when you are not using the inHALER , write the date you opened the blister on the carton in order to protect it from light and do not let it get into the fridge . you can use the inhazer any time before or after a meal or if it is dark .
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umeclinium brommide per inhaler ). - other ingredients are lactose monohydrate ( see section 2 under ' incruses ellippa contains lactoses ') and magnesium stearate . what increse is used for incrused ellimpta looks like and contents of the pack incrussé ellipepte is an inhalations powder , pre - dispensed . the ellipata inhalers consists of a grey plastic body , a light green mouthpiece cover and a dose counter . it
nucala contains the active substance mepolizumab . this is a monoclonal antibody , a type of protein that recognises and binds to other proteins that are present at increased levels in the body . it is used to treat severe asthma in adults , adolescents and children from 6 years of age . severe asthma is caused by the presence of many eosinophils , another type of white blood cell that usually gets in and out of the lungs . if you have eeosomophilic asthma , you must stop using nucale and see your doctor regularly , to reduce the number of asthma attacks . asthma nucal is used every day to reduce asthma attacks in adults and children who are already taking medicines called high dose inhalers . to treat your asthma : you must continue taking these medicines for as long as you have been told to take them . in
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine . this is important because it is important not to infect other people with worsening asthma . 58 people who have asthma - related side effects are more likely to develop asthma if they are treated with nucalа . your asthma may get worse after starting nucalala treatment . talk to you doctor if this applies to you . allergic reactions injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions to other parts of the body . see section 4 for more information about possible side effects . you may be more at risk of a similar reaction when you receive nucalam . parasitic infections nucalca may reduce your resistance to infections caused by
nucala is given by injection under the skin ( subcutaneous injection ). the recommended dose is 12 micrograms ( 100 microgram ) given once a day . instructions for use follow these instructions carefully and ask your doctor , pharmacist or nurse if you are not sure . how much to inject your dose is 1 microgram ( 0 . 5 ml ) dose given once every two weeks . inject nucalá yourself at the same time each week . your doctor will decide how many injections of nucalа you need and how often you need to receive treatment . if your doctor decides that you should inject nukala yourself , the treatment with nucalala will be started at a slow pace . it may take a few weeks or longer for your asthma symptoms and attacks to improve . depending on your asthma problems , your doctor may increase the number of injections you receive .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur commonly ( may affect up to 1 in 10 people ) following the injection . sometimes symptoms include chest tightness , cough , difficulty breathing fainting , dizziness / feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue , or mouth hives rash . tell your doctor immediately if you have a reaction similar reaction to nucale . it is important that you also read the package leaflets for the individual medicines that are given to you . if they do not seem to be affected , you should contact your doctor .
keep out of the sight and reach of children . do not use nucala after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . keep the nucalava pre - filled pen in use in - use box in order to protect from light . after first opening , the pen can be kept for a maximum of 7 days at 2 to 9oc , protected from light followed by a further 7 days in the refrigerator . you should record the date when the pen is first opened and the date after which it should be discarded . record the day that the pen was first opened in the fridge . write the date of opening on the pen label in the space provided . once you have removed the pen from the refrigerator and used it should not be put back
what nucala contains the active substance is mepolizumab . 1 ml contains 100 mg of mepolisumab in 1 litre . the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate / polysorbate 80 , edta disodium dihydrate and water for injections . what nukala looks like and contents of the pack nucalа is presented as a clear and colourless solution for injection ( 1 g / mL ). it is supplied as : a pack containing 1 or a multipack containing 3 packs of 1 . not all pack sizes may be marketed .
what ninlaro is nINlararo , a cancer medicine that contains the active substance ixazomib , is called a ' proteasome inhibitor '. what nicotinolars is used for nninlanaro used to treat a tumor of the bone marrow called multiple myeloma . ixizomibe is used to improve cell survival . how ninelar0 works n inlarou is used in adult patients who have a lot of proteins called proteasoms that are involved in their growth . what is nicotropoulos ? ninninglarro is used together with lenalidomide and dexamethasone , other medicines used to manage multiple myélomana , and a diet low protein in the
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking nnlar . n inlars may cause bleeding , persistent nausea and vomiting , diarrhoea , nerve problems which may cause tingling , numbness , swelling or a persistent rash . tell your doctor if any of these apply to you . liver or kidney problems if they occur , tell your physician before starting treatment with nINlara . before starting and during treatment , your doctor will carry out blood tests to check that you have enough blood cells . children and adolescents ninninglar0 is not recommended in children and teenagers under 18 years of age . other medicines and n
ninlaro is used to treat multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . n inlar0 is used in combination with lenalidomide and a medicine containing dexamethasone , an anti - inflammatory medicine . you will take nnlar , in combinationwith lenalide and dexamethiazem twice a week for 4 - week cycles . your doctor will tell you how long you should take . take a tablet of nINlara once a day on the same day of the week for the first 3 weeks . after that , you will need to take 4 tablets of lenidomide 25 mg twice - day . it is important that you keep taking nl
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ) low platelet counts ( thrombocytopenia ) nose bleeds that can easily bruise nausea , vomiting , diarrhoea , numbness , feeling tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet( peripheral oedema ) skin rash ( itchy ) anywhere on the body . rare side effects these may affect up to 1 in 1 , 000 people . these effects are usually mild and disappear over time as treatment continues . if you get any of these effects : - very common side effects may affects more than one in 10 patients : low platelets ( cytopaenia ). these can be signs of low
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister or carton after exp . the expiration date refers to the last day of that month . store below 30 . keep the capsule in the original blister in order to protect from light and moisture . this medicine does not require any special temperature storage conditions . does not use ninlaro if you notice any damage or signs of tampering to medicine packaging . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ninlaro contains - each hard capsule contains 2 . 3 mg of ixazomib ( as 2 , 3 mg ixazamibid citrate ). - the other ingredients are microcrystalline cellulose , magnesium stearate and talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( EE172 ). printing ink contains shellac , propylene glycol , potassium hydroxide , black iron oxide . what nicotinlarao looks like and contents of the pack nINlar0 2 iu capsules are light red and marked " gsi " and " 3 " on one side . ixamibe 3 mg capsules : ixamib citrate in black ink . capsule shell : microcrystalline ( 
do not use palforzia : - if you are allergic to peanuts or arachis hypoogaea or any of the other ingredients of palforizia ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using palfor zia . children and adolescents ( aged 4 to 17 years ): if treatment is started , your doctor will decide whether treatment is suitable for you . if your doctor decides that you have peanut allergy or are allergic ( desensitisation ) to peanut ( deseminated ) peanut ( sensitisation and / or palforzaa ) you must stop eating and eat for an hour before and during your treatment with palforziea , to minimise allergic reactions . it is not known whether palforuzia is safe and effective in treating food allergies . you should not stop using pal forzia without first
do not take palforzia if you are allergic to peanut allergy or any of the other ingredients of palforzaa ( listed in section 6 ). warnings and precautions talk to your doctor before taking palforizia : if your asthma is severe . if the symptoms of your asthma are severe or if there is a problem swallowing . in rare cases , long term problems with your digestive system have developed a severe mast cell disorder , such as severe or life - threatening anaphylaxis , which occurs within 60 days of treatment . your doctor will decide whether to stop treatment with your palforciaa or stop your treatment with palfor zia . it is important to try to treat the symptoms associated with peanut allergy before you start taking pal forzia and to treat them . allergic reactions can occur during and after treatment with a certain frequency . this is because peanut allergy
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . this medicine should not be used if : you have a history of allergy or you have had allergic reactions ( anaphylaxis ) in the past 3 months and your doctor will monitor you during treatment with palforzia . initial dose escalation can be repeated during the initial dose phase and during the subsequent dose - adjustment phases . during the initially dose augmentation and up - dosing phases , your doctor may decide to stop treatment with Palforziа . you should not take palforzaa more than once a day . it may help you to experience desensitisation during the first day of a sickle cell transplant . if this is not treated , you should contact your doctor immediately . even if your
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with palforzia : - severe allergic reactions . tell your doctor or nurse straight away if you get any of the following symptoms after taking palfor zia . they may be severe or life - threatening . if the reaction is severe : trouble breathing - throat tightness - feeling of fulness - trouble swallowing or speaking - changes in voice - dizziness , fainting - extreme stomach cramps or pain - vomiting , diarrhoea - serious flushing or itching of the skin palforizia may indicate problems with the stomach and digestive system . these may include : very common : may affect more than 1 in 10 people - anaemia - low white blood cell count - high levels of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store below 25 . keep vial in the original package in order to protect from light and moisture . this medicine must not be used if you notice any hard lumps of powder .
what palforzia contains the active substance is palforza . each tablet contains 0 . 5 mg , 1 mg / kg , 10 mg & 20 mg of the active substances . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palforizia 100 mg powder in capsules and powder in sachets can be opened microcrystalline microcrystalline hard capsules , microcrystalline silic , and colloidal anihydrous silicon and magnesium searate paforzi , 300 mg powder and oral powder in in a saget microcrystalline crystal , together with colloidal and hydrous silicA and magnesium strarate . what pal forzia looks like and contents of the pack palforezia is a white to off - white , round , flat , beige oral powder with initial dose 
zerene belongs to a class of substances called benzodiazepine - related medicinal products , which consists of preparations with hypnotic actions and sleeping problems . zere is used during treatment to treat problems sleeping .
do not take zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zerenne sleep apnoea syndrome ( see section 4 ). it may happen for short periods . if your doctor has told you that you have severe kidney or liver problems . take special care with myasthenia gravis tell your doctor if : you have very weak or tired muscles , have severe breathing or chest problems , and have difficulty sleeping , especially if they are less than 18 years of age . taking zerent may cause undesirable effects which may occur with any medicine or any medicines you take . you are more likely to develop physical dependence after treatment . withdrawal symptoms may occur particularly if taken with a heavy meal . these effects may include headaches , muscle pain , extreme anxiety and tension , a feeling
always take zerene exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is 10 mg once a day if taking zerence for 10 days , or less frequently if someone else is taking it . if having difficulty falling asleep , you should contact your doctor . how much to take the usual starting dose for people who are 65 years of age or older , and who are able to take it : 65 mg once daily for mild to moderate liver problems , your doctor may tell you to take a higher dose of 5 mg once per day . for mild or moderate liver issues , the higher dose is 5 mg twice daily . take the capsules whole with water . do not chew or crush the capsule as it may become cloudy . in such cases , an overdose may make you increasingly drowsy
like all medicines , zerene can cause side effects , or any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon ( affect affects less than 1 users in 10 users per 1 , 000 ) rare ( affecting less than1 user in 100 000 ). rare ( effect impacts affects only 1 to 11 users in10 ,000 ) very rare ( effects affect less than 2 users in 1 / 10 , 10 users / 10,000 ) not known ( frequency cannot be estimated from the available data ). as for all medicines available , side effects may occur together with any other change in your healthy body . if you notice any of the following side effects you should tell your doctor immediately : - drows
what zerene contains - the active substance is zaleplon 5 mg . - each capsule contains microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( origine ), titanium dioxide ( see end of section 2 ). - ingredients of the capsule shell : gelatin , titanium dioxide , red iron oxide ( е172 ), yellow iron oxide [ e172 ], black iron oxide( e132 ), and sodium laauryl ulphate ( é171 and silicon dioxide [ s - 13050 ]), shellac , lecithin , simethicone , yellow iron orange ( a )). what zeene looks like and
